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ABSTRACT

Kefir grains were purchased from online, home kitchen vendors in the United States (n =
22), inoculated into UHT milk, and incubated at 25°C for 22 hours. Results indicated
lactobacilli, lactococci and yeast in all samples. Six out of 11 samples contained coliform, and
all samples contained pseudomonal and staphylococcal species. Using targeted genome
sequencing (16S) of kefir grain samples 1, 2, and 3 revealed that lactobacilli were the
predominant genera of bacteria. ITS sequencing revealed different fungal species in each grain.
Results indicated potential presence of menaquinone-4 and menaquinone-7 by UPLC-MS/MS
analysis.
The fermentation of whole and ground soybeans, chickpeas, and lentils by Bacillus
subtilis natto was examined. Day 1 post-fermentation microbial counts on TGY media were
significantly different (P <0.0001) across legumes. Soybeans (9.03 cfu/g), ground chickpeas
(8.99 cfu/g) and chickpeas (8.93 cfu/g) were greater than other legumes but were not different
from one another. Ground chickpeas (P <0.0001) had the greatest log cfu/g enumeration of
bacteria followed by ground lentils and finally by ground soybeans (P <0.0001). Whole
chickpeas were not different from ground chickpeas (P = 0.3498). Whole lentils and ground
lentils were significantly different (P <0.0001). Results indicated fermentation of chickpeas and
lentils both yielded the ability to dissolve blood clots comparable to soybean natto. Analysis of
natto validated presence of vitamin K1, menaquinone-4, and menaquinone-7.
The boron content was measured in a variety of different rendered animal products (n =
66) and plant feedstuffs (n = 23). There was a significant difference in boron content among
rendered animal products where meat and bone meal (MBM) had the greatest boron content
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(2.54 ± 0.24 mg/kg), and feather meal (FM) had the lowest boron content (0.33 ± 0.13 mg/kg) (P
<0.0001). Of plant feedstuffs analyzed, soybeans had the greatest boron content (31.66 ± 2.37
mg/kg) and barley had the lowest boron content (0.97 ± 0.21 mg/kg) (P <0.0001). Among all
products tested, soybeans had the greatest boron content. Boron content varied in rendered
animal products and plant feedstuffs; additional research is needed to compare boron absorption
from animal versus plant feedstuffs.

iii

DEDICATION

I would like to dedicate this dissertation to my parents, Brian and Kathryn McCurdy. Without
you, none of this would have been imaginable, let alone possible. We earned this degree
together. Thank you for everything, I love you both so much.

iv

ACKNOWLEDGMENTS

In the process of completing this dissertation I would like to acknowledge and thank
those who supported and helped me through the easy and difficult days. Firstly, I would like to
thank my major professor, Dr. Annel K. Greene, for taking a chance on a new student and
finding a way to make this dissertation possible. I would also like to thank Dr. William C.
Bridges, Jr. for his time and patience with me as we pieced together my projects and tried to
analyze the data properly. The amount of gratitude for the continual lessons in statistics cannot
be expressed solely by words. Dr. Atif Can Seydim and Dr. Zeynep Banu Guzel-Seydim were
also important support from a distance during the pandemic where they were still available for
questions and advice on my fermentation projects. It is difficult to learn everything from a
textbook so thank you both for your expertise. Dr. James Strickland cannot go without mention
in this dissertation as he has spent countless hours instructing, mentoring, and teaching me the
basics of analytical chemistry always with kindness and patience. This dissertation would not be
possible without the extreme amount of time and effort Dr. Strickland gave to me out of the
goodness of his heart. I would also like to acknowledge the administrative staff including Stacey
Miller and Lauren St. Clair. These two women are the pillars that run our department and have
always gone above and beyond their call of duty to ensure each graduate student is well cared for
and on the correct path. Disha Bhattacharjee, thank you so much for your time and patience
working with the data for the genomic portion of this dissertation. This would not have been
possible without you. To the farmers of Western Pennsylvania, thank you for sending feed
samples. The overwhelming support from home was appreciated more than you realize.

v

I would also like to thank my friends near and far. Many of you have been supportive
unintentionally when your friendship and words of advice were sorely needed unbeknownst to
you. Even at a distance, many of you were the reasons I kept pushing through. It is easy to lose
touch during times like these but thank you all for your continued love and support. Joe Britt,
Katie Wilkins, Becky Masterson, Kim Field, Jim Vinyard, Mary Storey, Maddie Oskey, and Joni
Stern, you have all made this process much easier for me, thank you. For my friends that are
nearby, we have created unique bonds throughout our time together in Clemson. I like to remind
everyone that in graduate school, none of us make it out alone and this dissertation is proof of
that concept. Dr. Mike Maloney, Dr. Matias Aguerre, Dr. Kristine Vernon, Lindsey Davis,
Chandler Wendel, Kayley Stallings, Casey Bishe, Kimberly Huffman, Catherine Garrett, Sarah
Heuer, Erik Antonio, Markus Miller, Jonathan Standish, Cerano Harrison, Toye Olowolafe,
Alissa Moritz, CheyAnn Roemer, and Kaitlyn Hart, you have all seen me at my best and my
worst. Thank you for sticking through this with me and helping me get to the end in one piece.
Above all, I would like to thank my family, Nick, Wesley, and Chantell, and of course
Jasmine and Dewey. Without them, I would never have had the encouragement, support, and
drive to complete such a distinguished degree. I was raised with a strong moral compass and a
drive to achieve my goals no matter the obstacles. With completion of this dissertation, I can say
I have achieved my greatest goal thus far in life. Mom and Dad, thank you for always pushing
me to be the best version of myself. I have watched you both sacrifice so much and hope I can
pay that sacrifice forward.

To everyone who has been a part of this journey, thank you.

vi

TABLE OF CONTENTS

Page
TITLE PAGE .................................................................................................................... i
ABSTRACT..................................................................................................................... ii
DEDICATION ................................................................................................................ iv
ACKNOWLEDGMENTS ............................................................................................... v
LIST OF TABLES .......................................................................................................... xi
LIST OF FIGURES ......................................................................................................xiii
CHAPTER
I.

LITERATURE REVIEW .............................................................................. 1
Probiotics ................................................................................................. 1
Probiotic Overview ...................................................................... 1
Probiotic Fermentation................................................................. 3
Prebiotics...................................................................................... 5
Fermented Foods .......................................................................... 6
Gut Health and Probiotics ............................................................ 8
Vitamin K............................................................................................... 12
History of Vitamin K ................................................................. 12
Chemistry of Vitamin K............................................................. 16
Absorption of Vitamin K ........................................................... 17
Metabolism of Vitamin K .......................................................... 19
Gla Residues of Vitamin K ........................................................ 21
Bone Density and Vitamin K ..................................................... 22
Vitamin K-Dependent Proteins – Coagulation Cascade ............ 23
Storage of Vitamin K ................................................................. 28
Requirement of Vitamin K......................................................... 29
Deficiency of Vitamin K ............................................................ 30
Bacterial Production of Vitamin K ............................................ 32
Kefir ....................................................................................................... 35
History of Kefir .......................................................................... 35
Kefir Grains ............................................................................... 37
Kefiran ....................................................................................... 40
Fermentation .............................................................................. 41
Lactic Acid Isomers ................................................................... 44
vii

TABLE OF CONTENTS (Continued)
Page
Kefir Composition ..................................................................... 45
Microbial Components............................................................... 47
Flavor ......................................................................................... 49
Product Quality & Storage ......................................................... 50
Antimicrobial Properties ............................................................ 51
Probiotics ................................................................................... 53
Intestinal Flora ........................................................................... 53
Hypocholesterolemia ................................................................. 55
Anticarcinogenic Properties ....................................................... 55
Conclusion ................................................................................. 57
Natto ....................................................................................................... 57
History of Natto ......................................................................... 57
Preparation of Natto ................................................................... 60
Flavor Profile of Natto ............................................................... 63
Health Benefits of Natto ............................................................ 66
Boron...................................................................................................... 71
History of Boron ........................................................................ 71
Boron Chemistry ........................................................................ 74
Boron Mechanics ....................................................................... 75
Boron and Serine Proteases ....................................................... 85
Therapeutic Agents Containing Boron ...................................... 89
Conclusion ............................................................................................. 91

II.

MICROBIAL AND CHEMICAL CHARACTERISTICS OF KEFIR GRAINS
OBTAINED IN THE U.S. MARKET ......................................................... 93
Abstract .................................................................................................. 93
Introduction ............................................................................................ 94
Materials and Methods ........................................................................... 96
Fermentation and Plate Count .................................................... 96
DNA Analysis ............................................................................ 97
Kefir Grain Preparation.................................................. 97
DNA Extraction ............................................................. 97
DNA Analysis ................................................................ 99
Vitamin Analysis ..................................................................... 101
Chemicals ..................................................................... 101
Extraction of Fat-Soluble Vitamins ............................. 101
UPLC-MS/MS ............................................................. 102
Statistics ................................................................................... 107
Results .................................................................................................. 107
Fermentation and Plate Count .................................................. 107
viii

TABLE OF CONTENTS (Continued)
Page
pH Analysis .............................................................................. 116
DNA Analysis .......................................................................... 117
Vitamin Analysis ..................................................................... 121
Discussion ............................................................................................ 125
Conclusion ........................................................................................... 133
III.

IV.

SOLID-STATE FERMENTATION OF WHOLE AND GROUND
SOYBEANS, CHICKPEAS, AND LENTILS WITH BACILLUS SUBTILIS
NATTO
134
Abstract ................................................................................................ 134
Introduction .......................................................................................... 135
Materials and Methods ......................................................................... 141
Fermentation and Plate Count .................................................... 141
Reagents ....................................................................... 141
Legumes ....................................................................... 141
Culture.......................................................................... 142
Solid-State Fermentation ............................................. 143
Enzyme Analysis ..................................................................... 143
Nattokinase Extraction and Purification ...................... 143
Casein Degradation Method ........................................ 144
Fibrin Degradation Method.......................................... 145
Vitamin Analysis ..................................................................... 146
Chemicals ..................................................................... 146
Extraction of Fat-Soluble Vitamins ............................. 146
UPLC-MS/MS ............................................................. 147
Statistics ................................................................................... 148
Results .................................................................................................. 151
Solid-State Fermentation ......................................................... 151
Casein Degradation .................................................................. 153
Fibrin Degradation ................................................................... 154
Vitamin Analysis ..................................................................... 154
Discussion ............................................................................................ 154
Conclusion ........................................................................................... 158

BORON CONTENT OF RENDERED ANIMAL PRODUCTS............... 159
Abstract ................................................................................................ 159
Introduction .......................................................................................... 159
Materials and Methods ......................................................................... 163
Feed Samples ........................................................................... 163
Statistics ................................................................................... 163
ix

TABLE OF CONTENTS (Continued)
Page
Results ........................................................................................................ 164
Discussion ............................................................................................ 166
Conclusion .......................................................................................... 169

V.

ONLINE VERSUS IN-PERSON INSTRUCTION IN A LABORATORYBASED ANIMAL AND VETERINARY SCIENCE COURSE ............... 170
Abstract ................................................................................................ 170
Introduction .......................................................................................... 171
Materials and Methods ......................................................................... 174
Results .................................................................................................. 180
Student Perception of Modality Pre-Assessment
(Online vs. In-Person) .............................................................. 180
Student Perception of Modality Post-Assessment
(Online vs. In-Person) .............................................................. 182
Student Performance ................................................................ 185
Discussion ............................................................................................ 187
Conclusion ........................................................................................... 194

VI.

CONCLUSION .......................................................................................... 196

VII.

REFERENCES .......................................................................................... 199

x

LIST OF TABLES

Table

Page

1.1

Microflora found in authentic kefir grains ................................................... 39

2.1

The ion transitions and corresponding MS parameters used for
vitamin K standards ............................................................................. 103

2.2

Tandem quadrupole mass spectrometer conditions for vitamin K
separation ............................................................................................. 104

2.3

UPLC standard curve calibration and recovery of vitamin K standards
in kefir product samples made from kefir grains purchased in the
U.S. market .......................................................................................... 105

2.4

UPLC gradient profile analysis of vitamin K ............................................ 106

2.5

Mean pH of duplicate kefir product at day 0 and day 1 of kefir
made from kefir grains purchased in the U.S. market ......................... 117

2.6

Percent recovery of vitamin K1, MK-4, and MK-7 in kefir product
samples made from kefir grains purchased in the U.S. market, milk,
and a commercially available kefir. ..................................................... 122

2.7

Mean ng/mL of vitamin K1, MK-4, and MK-7 in milk, commercial kefir
product, and kefir products from kefir grains 1, 2, 3, and 4 ............... 124

3.1

The ion transitions and the corresponding MS parameters used for the
vitamin K standards in legume samples fermented with Bacillus
subtilis natto ......................................................................................... 149

3.2

Tandem quadrupole mass spectrometer conditions for vitamin K
separation in legume samples fermented with Bacillus
subtilis natto ......................................................................................... 150

3.3

UPLC gradient profile analysis for vitamin K in natto .............................. 151

3.4

Microbial enumeration of different legume substrates and dry matter
content. Whole beans compared with ground beans (2mm) fermented
by Bacillus subtilis natto...................................................................... 153

4.1

Boron content (mg/kg) of rendered animal products and plant
feedstuffs collected across the United States ....................................... 165
xi

LIST OF TABLES (Continued)

Table

Page

5.1

Student perceptions of online vs. in-person class modality
pre-exam .............................................................................................. 180

5.2

Student perception of online vs. in-person class modality
post-exam ............................................................................................. 183

5.3

Student performance in online vs. in-person class modality
across all quizzes.................................................................................. 186

xii

LIST OF FIGURES

Figure

Page

1.1

Vitamin K1, K2, Menaquinone-4, and Menaquinone-7 2D chemical
structures ................................................................................................ 14

1.2

Vitamin K3, K4, and K5 Menaquinone-4, and Menaquinone-7 2D chemical
structures ................................................................................................ 16

1.3

Brief overview of the coagulation cascade pathway.................................... 25

1.4

Kefir grains .................................................................................................. 38

1.5

Soybeans fermented with Bacillus subtilis natto bacteria
for 24 hours at 37°C ............................................................................... 59

1.6

Borate, boric acid, and calcium fructoborate 2D chemical structures ......... 73

1.7

Chemical structures of Vitamin D3, estrogen, and testosterone................... 83

2.1

Mean log cfu/mL standard plate count of kefir made from kefir grains
purchased in the U.S. market ............................................................... 108

2.2

Mean log cfu/mL MRS lactobacilli plate count of kefir made from
kefir grains purchased in the U.S. market. ........................................... 109

2.3

Mean log cfu/mL M17 lactococci plate count of kefir made from
kefir grains purchased in the U.S. market ............................................ 110

2.4

Mean log cfu/mL PDA yeast and mold plate count of kefir made from
kefir grains purchased in the U.S. market ............................................ 112

2.5

Mean log cfu/mL VRBA coliform plate count of kefir made from
kefir grains purchased in the U.S. market. ........................................... 113

xiii

LIST OF FIGURES (Continued)

Figure

Page

2.6

Percent positive or negative results of spread plating kefir made from
kefir grains purchased in the U.S. market, on pseudomonas agar
out of four replicates ............................................................................ 114

2.7

Percent positive or negative results of spread plating kefir made from
kefir grains purchased in the U.S. market, on mannitol salt agar
out of four replicates ............................................................................ 115

2.8

Principal Coordinate Analysis (PCoA) plots of kefir grains 1, 2, and 3
based on distance matrices depicting the diversity within bacterial
(left) and fungal (right) population within each grain ......................... 119

2.9

Bar chart representing the relative abundance of bacterial species
using 16S targeted genomic sequencing (left) and fungal species
using ITS targeted genomic sequencing (right) of kefir grains
1, 2, and 3 with five replications each ................................................. 120

3.1

Casein degradation by purchased nattokinase (left) compared
with saline solution (right) ................................................................... 145

3.2

Fibrin degradation scale based on degradation by purchased
nattokinase ........................................................................................... 146

5.1

Class timeline for assessments ................................................................... 177

5.2

Class timeline for student questionnaire release ........................................ 179

xiv

CHAPTER ONE
LITERATURE REVIEW

PROBIOTICS

Probiotic Overview
The human gut is home to over 1010-1012 microbes per gram, most of which are
anaerobic bacteria (Phillips, 2009; Davani-Davari et al., 2019). Many of these microbes aid in
digestion of otherwise indigestible food, some produce vitamins, and some aid in removal and
metabolism of toxins and drugs (Phillips, 2009; Celiberto et al., 2018). It was not until the 20th
century that scientists proposed that gut microbial flora could be altered, removing harmful
microbes, and replacing them with beneficial bacteria (Williams, 2010). In the early 1900’s,
Russian scientist, Elie Metchnikoff was the first to apply Louis Pasteur’s fermentation discovery
to the microorganisms on human health by linking regular consumption of fermented dairy
products to the longevity of the Bulgarian rural people (Ozen and Dinleyici, 2015; Gasbarrini et
al., 2016). This application was linked to “Bulgarian bacillus” which was later correlated to the
counteractive effects fermented products had on the bacterial putrefaction in the large intestine
(Gasbarrini et al., 2016). The “putrefying bacteria” were later identified as proteolytic clostridia
(Gasbarrini et al., 2016).
In 1953, German scientist Werner Kollath introduced the concept of probiotics
(Gasbarrini et al., 2016). Probiotics, however, can be traced back to the origins of farming where
food fermentation became popular for consumption and storage (Gogineni et al., 2013;
Gasbarrini et al., 2016). This is where “acidophilus” and “bulgaricus” bacteria are thought to
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have been discovered due to the methods of storing foods in animal stomachs (Gogineni et al.,
2013; Gasbarrini et al., 2016). While the actual bacteria were unknown until the recent past,
there was an unintentional selection of these bacteria because of the positive organoleptic
impacts they had on fermented foods (Gogineni et al., 2013; Gasbarrini et al., 2016). Not all
bacteria are considered probiotics, but Kollath stated that probiotics were “active substances that
are essential for a healthy development of life” whereas in 1965, Lilly and Stillwell described
them as “substances secreted by one organism, which stimulate the growth of another” (Gogineni
et al., 2013; Gasbarrini et al., 2016). The most modern description, however, from Fuller in
1992, defined probiotics as “a live microbial feed supplement, which beneficially affects the host
animal by improving its intestinal microbial balance” (Gasbarrini et al., 2016; Celiberto et al.,
2018). Probiotics are defined as “live microorganisms, which when administered in adequate
amounts confer a health benefit on the host” (Williams, 2010; Weese and Martin, 2011;
Gogineni et al., 2013; Gasbarrini et al., 2016).
While no two people have the same microbiota, factors such as antibiotic use,
physiological stress, and diet can greatly impact gut microbes (Phillips, 2009; Celiberto et al.,
2018). Microbes in the gut impact health and the immune system, which is where probiotics
become greatly important to intestinal health (Phillips, 2009). Probiotics are considered
“generally recognized as safe” (GRAS) as dietary supplements and foods (Williams, 2010).
However, probiotics have been used for centuries because they are mainly found in various
fermented foods such as dairy products, vegetables, wine, beer, and mead (Williams, 2010;
Gogineni et al., 2013; Gasbarrini et al., 2016). Through consumption of these foods, humans
have been able to beneficially alter their gut flora to improve overall health. This practice was in
use for many years prior to the scientific discovery of probiotics. To be considered a true
2

probiotic, live bacteria must exhibit certain characteristics compatible with the intestinal system
when consumed (Williams, 2010; Celiberto et al., 2018). Plaza-Diaz et al., (2019) claimed that
ideally probiotics would be of human origin with resistance to pathogenicity and have active
antagonism against pathogens in the gut (Celiberto et al., 2018; Plaza-Diaz et al., 2019). A
stimulatory effect on the immune system that demonstrates benefits to the host is imperative
(Plaza-Diaz et al., 2019). Probiotics need to be able to survive intestinal conditions such as, low
pH, digestive enzymes, and biliary salts, but also must be able to grow and be active within the
host (Weese and Martin, 2011; Celiberto et al., 2018; Plaza-Diaz et al., 2019). Determination of
a carrier food to not only transport the bacteria through the stomach, but also to encourage
growth and colonization in the intestines while still providing a benefit to the host is just as
important as selecting the correct microbe (Gogineni et al., 2013). Processes such as
microencapsulation and nanoencapsulation have proven beneficial to increasing the survival
rates of bacteria, but consumption in food is still a viable delivery method with the main
difficulties being pH, temperature of the food itself, and the pH barrier of the stomach (Evivie et
al., 2017).

Probiotic Fermentation
Fermentation is the metabolic process in which an organism converts a carbohydrate,
such as starch, fiber, or sugar, into an alcohol or an acid (Gogineni et al., 2013; Davani-Davari et
al., 2019). There are two types of fermentation of interest when making fermented food
products, lactic acid and alcoholic fermentation (Ozen and Dinleyici, 2015). Lactic acid
fermentation using bacteria is more desirable in dairy products whereas alcoholic fermentation
using yeast is more desirable in beers and wines (Ozen and Dinleyici, 2015; Evivie et al., 2017).
3

The products of fermentation, specifically acids such as lactic acid, acetic acid, butyric acid, and
propionic acid lower the pH, improving preservation of the product in dairy products, beers, and
wines (Gogineni et al., 2013; Ozen and Dinleyici, 2015; Evivie et al., 2017; Davani-Davari et al.,
2019). Not only does fermentation preserve the product, but it offers new flavors and
improvement of digestion, which is what today is recognized as the probiotic effect (Gogineni et
al., 2013; Ozen and Dinleyici, 2015; Evivie et al., 2017). However, for probiotics to establish
themselves and thrive in the gut, they must have a nutritional source from the diet that is
consistent or else they will die (Hutkins et al., 2016; Davani-Davari et al., 2019).
While probiotics are capable of using nutrients from the diet for survival, bacteria thrive
on carbohydrates known as “prebiotics” (Hutkins et al., 2016; Davani-Davari et al., 2019).
Prebiotics are defined as “a non-digestible food ingredient that beneficially affects the host by
selectively stimulating the growth and/or activity of one or a limited number of bacteria in the
colon, and thus, improves host health” (Hutkins et al., 2016; Davani-Davari et al., 2019).
Prebiotic compounds although not digestible by mammalian enzymes, can be used as an energy
source by microorganisms (Hutkins et al., 2016; Davani-Davari et al., 2019). Described for the
first time in 1995 by Glenn Gibson and Marcel Roberfroid, the definition of prebiotics has been
minimally altered but it has been proposed that prebiotics can be more than indigestible
carbohydrates alone (Hutkins et al., 2016; Davani-Davari et al., 2019). Prebiotics can be byproducts of microbes that become substrates for other microbes, which is also known as crossfeeding (Hutkins et al., 2016; Davani-Davari et al., 2019). While many prebiotics are sources of
fiber, not all sources of fiber can be considered prebiotics (Al-Sheraji et al., 2013).
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Prebiotics
To be considered a prebiotic, a compound must exhibit several characteristics. For
example, the compound should be resistant to the low pH of the stomach and should not be
hydrolyzed by mammalian enzymes so it can remain intact once it reaches the intestines (AlSheraji et al., 2013; Davani-Davari et al., 2019). Specifically, the prebiotic compounds are
intended to reach the large intestine for fermentation (Al-Sheraji et al., 2013; Hutkins et al.,
2016). Prebiotics must also resist absorption into the intestinal tract. These compounds must be
fermentable by the microbes that populate the intestine in addition to causing a selective
stimulation of the growth and/or activity of the bacteria, which the prebiotic encounters (AlSheraji et al., 2013; Davani-Davari et al., 2019). The most common and effective prebiotics
include short and long chain β-fructans, fructo-oligosaccharides, galacto-oligosaccharides, transgalacto-oligosaccharides, inulin, and lactulose (Al-Sheraji et al., 2013; Hutkins et al., 2016;
Davani-Davari et al., 2019). When fermented, the gut microbes produce mainly short chain fatty
acids such as acetic, propionic, and butyric acid, all of which have been shown to improve
intestinal health as well as having a positive impact on distant tissues within the body (Hutkins et
al., 2016; Davani-Davari et al., 2019). Short chain fatty acids are easily absorbed within the
intestinal tract enabling them to have rapid positive impacts on the body (Al-Sheraji et al., 2013;
Davani-Davari et al., 2019). Some foods that contain prebiotic compounds include asparagus,
sugar beets, garlic, chicory, onion, wheat, honey, bananas, barley, tomatoes, rye, soybeans, milk,
peas, and various legumes (Al-Sheraji et al., 2013; Hutkins et al., 2016; Davani-Davari et al.,
2019). As a result, Al-Sheraji et al. (2013) claimed that when these food products are fermented,
it can be postulated that they may be both a prebiotic as well as a probiotic and create a synergic
effect (Al-Sheraji et al., 2013). This concept should be further investigated.
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Together, both prebiotics and probiotics are considered functional foods (Al-Sheraji et
al., 2013). Functional foods are simply defined as foods that provide health benefits to the host
(Al-Sheraji et al., 2013). These can be foods or food compounds that are bioactive, derived from
conventional foods or supplemented foods (Al-Sheraji et al., 2013). When adding prebiotic
compounds to a well know probiotic source, for example, yogurt, fat can be replaced with
substances such as inulin (Al-Sheraji et al., 2013). Although Al-Sheraji et al., (2013) claimed
yogurt to be a probiotic, the definition of a true probiotic microorganism is that it survives to
colonize the intestinal tract. Yogurt microorganisms do not fulfill this definition. In adjusting
the fat source for yogurts, the caloric density of these foods was reduced while the functionality
of these foods in the diet increased because of the addition of this prebiotic (Al-Sheraji et al.,
2013). It is possible that foods may be manipulated to be both a prebiotic and probiotic. The
concept of postbiotics is new and relatively unexplored (Plaza-Diaz et al., 2019). Postbiotics are
the use of soluble compounds that are derived from probiotic bacteria that are still biologically
active (Plaza-Diaz et al., 2019). In the future, it may be possible to combine prebiotics,
probiotics, and postbiotics as a complete treatment for digestive ailments.

Fermented Foods
Fermented milk is the first food product recorded to have been consistently fermented
and consumed with records showing use as early as 7,000 B.C. (Gogineni et al., 2013; Ozen and
Dinleyici, 2015; Gasbarrini et al., 2016). Around the time farming became more widespread,
food products were more readily available, thus preservation by fermentation was discovered
(Gogineni et al., 2013; Ozen and Dinleyici, 2015; Gasbarrini et al., 2016). Fermented milk
products such as cheese, kefir, and yogurt were the original products consumed, which were
6

likely discovered accidentally (Gogineni et al., 2013; Ozen and Dinleyici, 2015). The improved
shelf-life and taste of these products is what made fermentation so popular and allowed early
people to travel great distances without dairy product spoilage (Gogineni et al., 2013; Gasbarrini
et al., 2016). As a result, there are large variations in the types of fermented dairy products in the
world today. Taettemjolk, zabadi, doogh, dahi, koumiss, and cieddu are fermented milk products
from different countries that have similar organoleptic qualities to kefir (Gogineni et al., 2013).
Vegetables are another food group that have relied heavily on fermentation, especially in
Asian cultures (Gogineni et al., 2013). For example, pickling of cabbage, turnips, eggplants,
cucumbers, onions, squash, carrots, and many other vegetables have been fermented for over
6,000 years (Gogineni et al., 2013). These fermented foods are widely consumed and produce
similar health benefits compared with fermented milk products (Gogineni et al., 2013).
Sauerkraut is most commonly mentioned when discussing medicinal properties of fermented
cabbage (Gogineni et al., 2013). Sailors used to regularly consume sauerkraut to reduce risk of
scurvy and other digestive discomforts (Gogineni et al., 2013).
Another common early fermented food was bread where yeast was used to ferment dough
(Gogineni et al., 2013; Ozen and Dinleyici, 2015). Leaven, another fermented dough product, is
used to make products such as sourdough (Gogineni et al., 2013). Originally, bread was baked
immediately, but when left prior to baking for several hours, the dough would rise, which
consumers discovered was more desirable (Gogineni et al., 2013). While it was not understood
for some time that this rising was caused by yeast, the product was more desirable than the
denser, unfermented dough (Gogineni et al., 2013). Yeast was also used as a leavening agent in
beer as early as 4,000 B.C. (Gogineni et al., 2013; Ozen and Dinleyici, 2015). Beer and wine
originated between 9,000 and 7,000 B.C. when cereal crops became more popular after crop
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domestication (Gogineni et al., 2013). Starter cultures were reported to have been combined
with fresh juice in Roman culture to create wine, which varied from the common fermentation
process of beer (Gogineni et al., 2013; Ozen and Dinleyici, 2015). If left for too long, the fruit
juice spoiled but if consumed too quickly, there was no alcohol in the product (Ozen and
Dinleyici, 2015).

Gut Health and Probiotics
Probiotics were popular in the United States until the 1930’s when the Great Depression
occurred (Gogineni et al., 2013). It was not until the 1980’s when antibiotic resistance became a
widespread problem that probiotics regained popularity as alternatives to antibiotics since they
are considered nutraceuticals and not pharmaceuticals (Phillips 2009; Weese and Martin, 2011;
Gogineni et al., 2013). Probiotics served a role in treating recurring infections, reducing cost of
treatment, and preventing future infections where antibiotics were being overused (Gogineni et
al., 2013). One negative aspect of antibiotic overuse is altered intestinal flora, which can lead to
diarrhea and dysbiosis (Gogineni et al., 2013; Celiberto et al., 2018; Plaza-Diaz et al., 2019). It
also can allow for pathogenic bacteria such as Clostridium difficile to colonize and secrete toxins
in the intestinal tract (Gogineni et al., 2013; Plaza-Diaz et al., 2019). Clostridium difficile is
difficult to treat and can result in death of the host as can other pathogens that colonize the
intestines (Gogineni et al., 2013). This undesirable colonization of pathogenic bacteria can
happen for a number of reasons, mainly due to reduced microbial diversity in the intestines
which allows for other organisms to adhere to the luminal surface (Celiberto et al., 2018). A
combination of reduced microbial diversity and an increase in the anaerobic bacteria in the
intestines allows for considerable fluctuation in aberrant microbiota (Celiberto et al., 2018).
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Other diseases including irritable bowel syndrome can be caused by lack of or excess
growth of bacteria in the bowels (Phillips, 2009; Gogineni et al., 2013; Celiberto et al., 2018;
Plaza-Diaz et al., 2019). Administering high levels of viable probiotics organisms to patients
with recurring bowel distress is the only effective treatment, other than fecal transplantation,
discovered thus far (Weese and Martin, 2011; Evivie et al., 2017; Plaza-Diaz et al., 2019).
Disturbance in the naturally occurring microbiota within the gut also can lead to pancreatitis,
obesity, allergies, eczema, cancer, and other autoimmune diseases such as Crohn’s disease
(Phillips, 2009; Gogineni et al., 2013; Celiberto et al., 2018; Plaza-Diaz et al., 2019). While
probiotics have a positive impact on all these diseases, they are not recognized by the European
Food Safety Authority nor the United States Food and Drug Administration as treatments for
these diseases (Plaza-Diaz et al., 2019). Additionally, these agencies do not have a definition for
prebiotics and rely on vague definitions as guidelines rather than creating clear regulations
(Hutkins et al., 2016). This is mainly because the health outcomes are not well documented and
the bacteria are not well characterized; therefore, it is nearly impossible to make consistent
guidelines that can be regulated (Weese and Martin, 2011; Plaza-Diaz et al., 2019). Depending
on the probiotic, anywhere between 10 million and 50 billion colony forming units per milligram
(cfu/mg) are required each day to have an impact on gut health which makes characterization of
probiotics very difficult (Weese and Martin, 2011). However, probiotics are a viable method for
treating and preventing intestinal disease and discomfort as long as they are administered
consistently over a period of time with proper prebiotic supplementation (Celiberto et al., 2018;
Davani-Davari et al., 2019; Plaza-Diaz et al., 2019). When probiotics are administered to healthy
adults, production of short-chain fatty acids, fecal moisture, frequency of defecation, and volume
of stools are all increased (Davani-Davari et al., 2019; Plaza-Diaz et al., 2019). Although the
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health benefits may not be as drastically visible in healthy adults compared with individuals
experiencing discomfort, probiotics still have a positive impact (Plaza-Diaz et al., 2019).
Probiotic microorganisms are successful in replacing and outcompeting pathogens in the
intestinal tract because they exhibit competitive exclusion, or the ability of a bacterial strain to
outcompete another strain for adherence to intestinal receptor sites (Weese and Martin, 2011;
Plaza-Diaz et al., 2019). Bacteria can be outcompeted if one strain is better at accessing nutrition
in the gut; it can access the available luminal space more easily, it promotes epithelial barrier
function, mucus secretion, it can produce bacteriocin substances, or it makes the environment
unfavorable for the other bacterial strain (Weese and Martin, 2011; Celiberto et al., 2018; PlazaDiaz et al., 2019). Probiotics consist of a wide variety of bacteria, yeast, and fungal species in
both humans and animals (Weese and Martin, 2011; Gogineni et al., 2013). The main genera of
probiotics include Lactobacillus, Saccharomyces, Bacillus, Bifidobacterium, and Streptococcus
(Celiberto et al., 2018). Bacteria, such as Bacilli are spore forming bacteria, which are the most
tolerant to environmental factors in the gut and have the greatest persistence of the bacteria
considered to be probiotics (Weese and Martin, 2011). However, many probiotic bacteria are not
spore-forming and, therefore, have lower survivability in comparison (Weese and Martin, 2011).
Many probiotics, such as Bifidobacteria and some Lactic Acid Bacteria (LAB) can
produce bacteriocins in addition to enzymes such as β-galactosidase (Weese and Martin, 2011;
Evivie et al., 2017; Plaza-Diaz et al., 2019). These compounds will either kill or inhibit other
bacteria from growing in the intestinal lumen, allowing for colonization by the competitive
bacteria (Plaza-Diaz et al., 2019). Upon adhesion, colonization, and continued positive
interaction between the bacteria and the host, these bacteria can then be considered probiotics
(Weese and Martin, 2011; Plaza-Diaz et al., 2019). Lactic acid bacteria are one of the common
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strains of bacteria that are found in fermented dairy products (Evivie et al., 2017; Plaza-Diaz et
al., 2019). This is a group of heterogenous bacteria including multiple strains of organisms,
which produce lactic acid (Evivie et al., 2017; Plaza-Diaz et al., 2019). Lactic acid bacterial
colonization of the intestines can prevent pathogen colonization of the epithelial cells, decreasing
the release of lipopolysaccharides and pro-inflammatory cytokines, both of which cause
intestinal distress (Evivie et al., 2017). Lactic acid bacteria also produce exopolysaccharides,
which are compounds that enhance protection of bacterial and epithelial cells (Evivie et al.,
2017). Exopolysaccharides are responsible for some of the desirable textures in fermented dairy
foods (Evivie et al., 2017). It is suggested that the high viscosity of fermented dairy foods
decreases the rate of passage, which can improve the chance of colonization in the intestines
(Evivie et al., 2017). Lactic acid bacteria, specifically Lactobacillus and Bifidobacteria, are the
two main target organisms of prebiotics and can have the greatest impact on human health when
these lactic acid producing bacteria are properly paired with an effective prebiotic (Hutkins et al.,
2016).
The concept of “personalized probiotics” is also in question resulting from competitive
exclusion (Celiberto et al., 2018). Personal traits such as diet, intestinal environment, antibiotic
use, early-life immune system, and a combination of probiotic selection and frequency can be
combined to pursue a personalized probiotic therapy program (Celiberto et al., 2018). While this
would require time and precision, personalized probiotic therapy is possible in mice and could
become a common form of treatment for those with long and short-term digestive issues
(Celiberto et al., 2018).
In conclusion, prebiotics and probiotics have a significant impact on human and animal
health. While much research has already been completed on both topics, there are many areas
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yet to be explored. The concepts of food fermentation are of great interest specifically revolving
around fermentation of milk products and legumes for the purpose of this dissertation. Each area
will further be explored.

VITAMIN K

History of Vitamin K
In 1929, Danish scientist Henrik Dam was researching sterol metabolism in chicks by
controlling diet composition and lipid content (Dam and Schonheyder, 1934; Newman and
Shearer, 1998). He observed that chicks fed diets with no fat or cholesterol developed
subcutaneous and intramuscular hemorrhages, as well as dark lesions in the mucous membrane
of the stomach only after 16 days on the experimental feed (Dam and Schonheyder, 1934; Lippi
and Franchini, 2011). Initially, it was thought that this was caused by a dietary deficiency in
vitamin C as the symptoms were similar to scurvy, but not a deficiency in vitamins A, D, B1, or
B2 (Dam and Schonheyder, 1934; Dam, 1934; Lippi and Franchini, 2011; Ferland, 2012). In this
study, the diet was supplemented with large quantities of cod liver oil containing vitamins A and
D, and the grain in the ration contained vitamins B1 and B2 (Dam and Schonheyder, 1934; Dam,
1934; Lippi and Franchini, 2011; Ferland, 2012).
With further study on increasing ration components using vitamin C, mineral salts, hogliver, cereal grains, and plant sources in the diet, it was determined that the substance in question
was fat soluble (Dam and Schonheyder, 1934; Dam, 1935a; Dam, 1935b). In 1935, Dam
proposed the new, fat soluble anti-hemorrhagic factor to be known as vitamin K, in reference to
“koagulation” of the blood (Dam, 1935a; Dam, 1935b; Ferland, 2012;). When anemic and
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hemorrhaging chicks were supplemented with vitamin K, blood clotted at normal rates compared
with control chicks (Dam. 1935b; Schoenheyder, 1935). It was determined that vitamin K
deficient chicks lacked prothrombin, a vitamin K-dependent clotting factor which caused
excessive internal bleeding in those animals (Dam et al., 1936; Schoenheyder, 1936). However,
when prothrombin was examined in isolation, it was observed that prothrombin was still active
despite removal of respective lipids, and vitamin K concentrates alone could not form a blood
clot (Schoenheyder, 1936; Newman and Shearer, 1998). With reduced concentration of
available vitamin K, prothrombin concentrations were also reduced, reducing overall blood
clotting capacity (Schoenheyder, 1935; Dam et al., 1936; Schoenheyder, 1936). Therefore, it
was determined that vitamin K played a role in blood clotting but was not the sole cause of blood
coagulation.
Vitamin K can be found naturally in large quantities in a variety of leafy green vegetables
including, but not limited to spinach, turnip leaves, Brussels sprouts, broccoli, and alfalfa (Feiser,
1939; Booth et al., 1993; Newman and Shearer, 1998). Although vitamin K is found in animal
sources such as fish, liver, meat, and eggs, it is in lesser quantity compared with dark leafy green
vegetables (Booth et al., 1993; Newman and Shearer, 1998). During extraction of vitamin K
from these sources, it was discovered that there were two separate compounds of vitamin K.
Initially, vitamin K was isolated in 1937 by scientists Almquist and Stokstad in crystalline form
from alfalfa (Almquist and Stokstad, 1935; Dam et al., 1936; Almquist and Stokstad, 1937a).
Binkley et al. (1939) also were able to isolate vitamin K from alfalfa but determined that there
were two separate compounds of vitamin K (Binkley et al.,, 1939; Feiser, 1939). They named
one of these compounds’ vitamin K1, which is also known as phylloquinone (Binkley et al.,
1939; Feiser, 1939) (Figure 1.1).
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During this time frame, fish meal was also being analyzed as it had been observed in
more than one lab that putrid fish meal contained a similar antihemorrhagic effect (Almquist and

Figure 1.1 Vitamin K1, K2, Menaquinone-4, and Menaquinone-7 2D chemical
structures adapted from the National Center for Biotechnology Information
(2022).
14

Stokstad, 1937b; Binkley et al., 1939; McKee et al., 1939). Dam and Shoenheyder (1936)
determined that vitamin K was thermostable as well as fat soluble via blood clotting
experiments. This allowed for further differentiation of the forms of vitamin K (Dam and
Shoenheyder, 1936; Dam and Glavind, 1938). Upon further investigation, it was hypothesized
that vitamin K could also be synthesized from microbial action (Almquist and Stokstad, 1937b;
Binkley et al., 1939; McKee et al., 1939). McKee et al. (1939) defined the vitamin K variant
from putrefied fish meal as vitamin K2 and suggested that both vitamin K variants were quinoids
due to the 2,3-di-substituted 1,4-naphthoquinone structure viewed on the ultraviolet spectra
(Dam and Lewis, 1936; Ewing et al., 1939; McKee et al., 1939; Newman and Shearer, 1998)
(Figure 1.1). Two derivatives of vitamin K, vitamins K3, and K4, were also differentiated using
the ultraviolet spectra, but their function and relation to vitamin K were unknown at this time
(Ewing et al., 1939; Figure 1.2). The quinoid groups were renamed by IUPAC-IUB to
menaquinone, which is abbreviated to MK, and subsequently followed by the number of
isoprene units in the 3-substituted side chain (Newman and Shearer, 1998).
Three synthetic forms of vitamin K exist. Vitamins K3, K4, and K5 have been made
available commercially (Michalek, 1962; Dobrinescu et al., 2012). Vitamin K3 occurs naturally
as an intermediate form of the synthesis of menaquinone-4 (MK-4) from phylloquinone
(Dobrinescu et al., 2012; Ferland, 2012). Menadione, or vitamin K3, is commonly used in
animal feed but is inactive (Ferland, 2012). It must be converted to MK-4 to be biologically
available and is extremely toxic in high dosages (Ferland, 2012). Vitamin K4, menadiol
diacetate is a derivative of menadione (Dobrinescu et al., 2012). Menadione is reduced to
menadiol and acetylated twice to yield menadiol diacetate, which is the most stable form of
vitamin K with the lowest bioavailability of any vitamin K residue. Menadione is the most
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inefficient to synthetically produce (Dobrinescu et al., 2012). Vitamin K5, 4-amino-2-methyl-1napthol hydrochloride, is used as a fungistatic agent, has been used in food preservation, and is
most effective at an acidic pH (Michalek, 1962; Merrifield and Yang, 1965). For health
Vitamin K3
Menadione

concerns, only vitamin K1 and K2 are used as
supplements due to their high biological availability and
natural occurrence compared with the synthetic forms of
vitamin K (Newman and Shearer, 1998; Ferland, 2012).

Vitamin K4

Chemistry of Vitamin K

Acetomenapthone

Vitamin K is a group of lipophilic vitamins from the
class 2-methyl-1,4-napthoquinone derivatives (Ferland,
2012). The differentiation corresponds to different
aliphatic side chains on the third carbon of the common
Vitamin K5
4-amino-2-methyl-1naphthol hydrochloride

methylated naphthoquinone ring (Binkley et al., 1939;
Newman and Shearer, 1998; Lippi and Franchini, 2011).
There are two naturally occurring vitamin K groups, K1,
phylloquinone, (2-methyl-3-phytyl-1-4-naphthoquinone),
and K2, menaquinone, (2-[(2E, 6E, 10E, 14E, 18E, 22E)3,7,11,15,19,23,27-heptamethyloctacosa-2, 6, 10, 14, 18,

Figure 1.2. Vitamin K3, K4, and
K5 2D chemical structures
adapted from the National Center
for Biotechnology Information
(2022).

22, 26-heptaenyl]-3-methylnaphthalene-1,4-dione), that
share the same structure as vitamin K1, however the side
chain at position 3 is substituted with different lengths of
isoprene units (MacCorquodale et al., 1939; Suttie, 1992;
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Newman and Shearer, 1998). There are three synthetic vitamin K groups, K3, menadione, (2methylnaphthoquinone), K4, menadiol (diacetate, 4-acetyloxy-3-methylnapthalen-1-yl acetate),
and K5, (4-amino-2-methyl-1-napthol hydrochloride) (Michalek, 1962; Merrifield and Yang,
1965 Dobrinescu et al., 2012).

Absorption of Vitamin K
Vitamin K1 (phylloquinone) is the most common form of vitamin K, and is fairly heat
stable, making it unique among most vitamins (Dam, 1935a; Dam, 1935b; Lippi and Franchini,
2011). Vitamin K1 is found in greatest quantities in green leafy vegetables, and sparingly in
animal products whereas concentrations of vitamin K2 (menaquinone), specifically MK-4, are
found in greater concentrations in animal products such as liver (Booth et al., 1993; Newman and
Shearer, 1998). Phylloquinone is readily absorbed in the intestine after solubilization into mixed
micelles. These micelles can contain additional solubilized compounds such as vitamin K
analogs (Shearer et al., 1974; Newman and Shearer, 1998). Mixed micelles are composed of bile
salts and pancreatic secretions, such as pancreatic lipase, which are involved in lipolysis and
absorption of lipids. Vitamin K can be absorbed with between 40% to 80% efficiency from
mammalian sources through micellar absorption (Shearer et al., 1974; Newman and Shearer,
1998). Green leafy vegetables yield an absorption rate of about 10% for phylloquinone because
it forms a complex with the thylakoid membrane of chloroplasts, making it difficult to be fully
absorbed (Gijsbers et al., 1996; Newman and Shearer, 1998; Sato et al., 2012).
This poor absorption is partially due to the non-polar nature of phylloquinone where
phylloquinone is commonly partitioned between intestinal emulsion and the micellar phase,
enabling some of the free phylloquinone to escape absorption and move through the digestive
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system unchanged (Shearer et al., 1974; Shearer, 1992). This is exacerbated in individuals with
biliary obstruction or pancreatic malfunction (Shearer et al., 1974). Absorption of phylloquinone
is negligible in the large intestine because the bacterial flora in the intestine are largely unable to
remove the phytyl side chain of phylloquinone for absorption (Shearer et al., 1974; Shearer,
1992). Menadione, however, can be readily absorbed across the epithelium of the large intestine
due to its high polarity, but menadione does not occur naturally and would need to be converted
to menaquinone for activation (Shearer et al., 1974). This absorption of both menadione and
menaquinone in the large intestine occurs via passive diffusion, but is slow and inefficient
(Shearer, 1992). Once absorbed, chylomicrons transport vitamin K to the lymph system and are
metabolized by lipoprotein lipase, removing triglycerides. On high density lipoproteins, lipids
and apolipoproteins are exchanged. This will create small chylomicrons with no triglycerides
forming chylomicron remnants that contain apolipoprotein E (Kohlmeier et al., 1996; Shearer et
al., 1996). The chylomicron remnants then bind with apolipoprotein receptors for absorption
within the capillaries of endothelial cells (Kohlmeier et al., 1996; Newman and Shearer, 1998).
It is through chylomicron remnants that vitamin K is transported to the liver, spleen, and bone
marrow because these tissues have unobstructed access to blood and bind lipoproteins directly
(Kohlmeier et al., 1996; Shearer et al., 1996; Newman and Shearer, 1998).
There are nine menaquinones currently known. These are denoted by the length of
isoprenyl group that synthetic menadiones do not possess. Menaquinones include MK-4, MK-7,
MK-8, MK-9, MK-10, MK-11, MK-12, MK-13, and MK-14 (Newman and Shearer, 1998).
Shorter side chains (MK-4 to MK-6) are more lipophilic than longer side chain menaquinones
(MK-7 to MK-14) (Shearer et al., 1996). Most menaquinones are more lipophilic than
phylloquinone, increasing absorption capacity in both the small and large intestine, despite
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having longer side chain length (Shearer et al., 1974). The most common forms of vitamin K2
are MK-4 and MK-7. MK-7 has a half-life of 72 hours compared to a 1.5-hour half-life of MK4. This enables MK-7 to reach the bones and blood vessel walls more easily because it is in the
blood stream longer than MK-4 and vitamin K1 (Schurgers and Vermeer, 2000; Sato et al.,
2012;). MK-4 is derived from animal products whereas MK-7 is largely consumed from
fermented foods such as cheese, sauerkraut, and natto, or produced by the microflora in the gut
(Gijsbers et al., 1996; Newman and Shearer, 1998; Sato et al., 2012). Vitamin K1 and MK-4 are
both transported in the blood via triglyceride rich lipoprotein fractions such as in chylomicrons,
whereas MK-7, and the other long chain MK-n’s are transported via low density lipoproteins,
similar to the transport mechanism of vitamin E (Shearer et al., 1974; Shearer, 1992). Through
metabolism and transport in the blood, the vitamin K2 derivatives are able to activate osteocalcin
and matrix Gla protein (MGP), which are proteins involved in bone density and the coagulation
cascade (Newman and Shearer, 1998).

Metabolism of Vitamin K
All vitamin K homologues can be converted into MK-4 through normal metabolism.
However, it is noted that not all homologues are actually converted to MK-4 but will remain in
their original conformation (Sato et al., 2012). MK-4 is highly dependent on the presence of
phylloquinone availability (Thijssen and Drittij-Reijnders, 1994; Gijsbers et al., 1996). MK-4 is
found in greatest concentrations in the pancreas and salivary glands but has trace concentrations
in blood plasma, similar to MK-9, 10, 11, 12, and 13, and the liver, where concentrations of MK7 and phylloquinone are elevated (Thijssen and Drittij-Reijnders, 1994; Shearer et al., 1996;
Ferland, 2012). MK-6, MK-7, and MK-8 are found in high concentration in the bone and liver
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(Hodges et al., 1993; Shearer et al., 1996). The elevated concentration of long chain
menaquinones in the liver suggests some intestinal absorption occurs from bacterial production
of vitamin K2 (Shearer et al., 1996). Long chain menaquinones also have a much slower
turnover rate than short chain menaquinones or phylloquinone whereas the latter must be
replaced daily through the diet as 60% to 70% is excreted (Shearer et al., 1996). Both MK-4 and
phylloquinone provide a protective role against insulin resistance in conjunction with undercarboxylated osteocalcin that has been reported to regulate glucose metabolism in mice (Ferland,
2012).
In rats that were supplemented or not supplemented with vitamin K1, those with
deficiency in phylloquinone (K1) had less plasma MK-4 than supplemented rats indicating a
direct correlation between phylloquinone and MK-4 concentrations (Thijssen and DrittijReijnders, 1994). Conversion of phylloquinone to MK-4 proceeds through menadione as an
intermediate where a geranylgeranyl side chain is then introduced to form MK-4 (Thijssen and
Drittij-Reijnders, 1994; Gijsbers et al., 1996). Oral administration of menadione yields MK-9
and MK-10 residues as a result of alkylation from upper intestinal bacteria as opposed to MK-4
(Shearer et al., 1974). When taken as an oral supplement, MK-4 is found in trace amounts in the
blood whereas MK-7 yields elevated concentrations of both MK-4 and MK-7 in the blood (Sato
et al., 2012; Theuwissen et al., 2013). As a result, MK-7 is a better oral supplement to increase
blood concentrations of vitamin K2 residues but is only effective if supplemented daily for at
least a week (Sato et al., 2012; Theuwissen et al., 2013).
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Gla Residues of Vitamin K
K vitamins are used as coenzymes for γ-carboxylation of vitamin K-dependent protein
glutamic acid residues to form γ-carboxyglutamate residues (Gla-residues) (Lippi and Franchini,
2011; Wen et al., 2018). Gla-residues are involved in calcium binding in the blood and bone and
are essential for Gla-proteins to function properly (Vermeer et al., 1995; Lippi and Franchini,
2011). Osteoblasts produce osteocalcin, matrix-Gla protein, and protein S, three proteins of
many that contain a Gla-matrix. However, when these proteins are missing one or more Gla
residues, they are referred to as undercarboxylated or descarboxy proteins (Vermeer et al., 1995).
Vitamin K dependent coagulation factors require γ-carboxyglutamate to enable binding of
calcium and are created through microsomal membrane, vitamin K dependent enzymes called γglutamyl carboxylase and cyclooxygenase (Bristol et al., 1996; Lippi and Franchini, 2011; Wen
et al., 2018). This process is part of a cyclic salvage pathway called the vitamin K epoxide cycle
(Bristol et al., 1996; Lippi and Franchini, 2011; Wen et al., 2018). For this pathway, vitamin K
must produce an active vitamin K cofactor known as vitamin K quinone (Vermeer et al., 1995).
Vitamin K quinone then binds as a cofactor with γ-carboxylase for post-translational
modification of the vitamin K dependent precursor proteins (Vermeer et al., 1995; Lippi and
Franchini, 2011; Walenga, 2020). In the liver, vitamin K quinone is catalyzed by the enzyme
cyclooxygenase to 2,3-epoxide, which is then converted to uniquinone by epoxide reductase
(Vermeer et al., 1995; Bristol et al., 1996; Walenga, 2020). Uniquinone can be reduced back to
hydroquinone, which completes the cycle of vitamin K in the body, enabling vitamin K to be reused indefinitely until excretion (Wen et al., 2018). This is why intakes of vitamin K can remain
low for periods of time without noticeable signs and symptoms of deficiency such as
osteoporosis or hemophilia, since epoxide reductase maintains consistent concentrations of
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biologically active vitamin K from stored sources (Kohlmeier et al., 1996; Card et al., 2014; Wen
et al., 2018). It has been noted that 40 mmoles of Gla and vitamin K are excreted daily;
however, the minimal requirement is 0.2 μmoles so it is evident that vitamin K is recycled
hundreds of times in the body prior to excretion (Kohlmeier et al., 1996). When this cycle is
disrupted, such as by oral doses of dicumarol derivatives, vitamin K is no longer converted to
2,3-epoxide (Lippi and Franchini, 2011). As a result, plasma coagulation factors, which are
proteins induced by vitamin K absence (PIVKA), are produced but are non-functional in the
clotting process (Lippi and Franchini, 2011).

Bone Density and Vitamin K
MK-4 is involved in homeostasis of bone density because it is responsible for apoptosis
of osteoclasts, which inhibits bone resorption (Kameda et al., 1996; Newman and Shearer, 1998).
Phylloquinone does not induce apoptosis, however, geranylgeraniol, a diterpene alcohol, has
been reported to induce apoptosis in myeloid leukemia cells (Kameda et al., 1996). Interestingly,
geranylgeraniol is an intermediate that forms a side chain on vitamin K2 through posttranslational modification (Thijssen and Drittij-Reijnders, 1994; Kameda et al., 1996). This side
chain, found on vitamin K2 residues, is likely the cause of osteoclast apoptosis although vitamin
K2 does not induce apoptosis of other cell types (Kameda et al., 1996). It is through selectivity
for osteoclast apoptosis that the mechanism for bone resorption is different than that of
calcitonin, a hormone that regulates calcium and phosphorus concentrations in the blood
(Kameda et al., 1996). Vitamin K2 reduces the pit area but not the pit number in bones without
toxic effect or cell senescence (Kameda et al., 1996). MK-4 also limits production of
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interleukin-6, a pro-inflammatory cytokine, and prostaglandins that modulate inflammatory
responses (Ferland, 2012).
Vitamin K is necessary for normal function of blood clotting proteins (Lippi and
Franchini, 2011). There are 17 vitamin K dependent proteins, 14 of which have been identified
in the human body (Wen et al., 2018). Coagulation factor prothrombin (II), proconvertin (VII),
antihemophilic factor (IX), Stuart-Prower factor (X), matrix Gla protein (MGP), growth arrestspecific protein 6 (Gas6), anticoagulant protein C, anticoagulant protein S, and anticoagulant
protein Z, osteocalcin (OC), Gla-rich protein (GRP), periostin (isoforms 1-4), periostin-like
factor (PLF), proline-rich Gla protein (PRGP) 1, PRGP 2, and transmembrane Gla protein
(TMG) (2-5) (Wen et al., 2018; Walenga, 2020; Messner et al., 2022). These proteins are part of
the coagulation cascade, a series of coagulation factor activation that will result in a blood clot.

Vitamin K-Dependent Proteins - Coagulation Cascade
Prothrombin (II) is a vitamin K dependent, plasma glycoprotein proenzyme that is
proteolytically cleaved during the first step of the coagulation cascade (Hemker et al., 1963;
Bristol et al., 1996). It maintains vascular integrity during developmental stages in fetal and postnatal life (Hemker et al., 1963; Bristol et al., 1996; Ferland, 2012). Prothrombin encodes for
several entities including a single peptide, a propeptide, γ-carboxyglutamic acid (Gla), a short
aromatic acid stack, two kringle domains, and serine protease (Esmon and Suttie, 1975; Bristol et
al., 1996). Anti-hemophilic factor (IX), a propeptide (-18 to -1), contains the γ-carboxylation
recognition sites for prothrombin, which are similar between all propeptides for vitamin Kdependent proteins (Esmon and Suttie, 1975; Bristol et al., 1996). These sites are important for
direction of carboxylation and binding of prozymogens by propeptides (Bristol et al., 1996). A
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protein precursor of prothrombin, proprothrombin, is converted to prothrombin in the liver,
specifically in the endoplasmic reticulum and the Golgi apparatus (Hemker et al., 1963; Bristol et
al., 1996). It goes through γ-carboxylation before leaving the cell, which confirms that γcarboxylation is a post-translational process (Bristol et al., 1996). Proprothrombin encodes for
furin, a protein that will cleave proprothrombin to form prothrombin and, thus, the coagulation
cycle can progress forward (Bristol et al., 1996). The vitamin K-dependent synthesis of
proprothrombin depends on the blood concentration of prothrombin and will act as a
prothrombin inhibitor when there are excess concentrations of proprothrombin shunted into the
blood from the liver (Hemker et al., 1963).
Prothrombin is similar to proconvertin (VII), a serine protease type enzyme that binds
tissue factor, anti-hemophilic factor (IX), and Stuart-Prower factor (X), to activate them for
continuation of the coagulation cascade (Ferland, 2012; Walenga, 2020). Anti-hemophilic factor
(IX) is a non-recombinant coagulation factor (VIII) that binds to membrane surfaces in the
presence of calcium, only when it is not carboxylated (Bristol et al., 1996; Walenga, 2020).
Stuart-Prower factor (X) is a serine endopeptidase, synthesized in the liver (Wen et al., 2018;
Walenga, 2020). Stuart-Prower factor (X) will ultimately cleave the zymogen, prothrombin, to
thrombin, which will cleave fibrinogen to fibrin to form a clot (Ferland, 2012; Walenga, 2020).
A brief summary of the coagulation cascade is provided in Figure 1.3. Administration of vitamin
K antagonists such as dicumarol or warfarin, cause production of functionally impaired forms of
prothrombin, (X), (IX), and (VII), factors that all contribute to clotting, and deplete vitamin K
stores in the liver, but not in bone (Esmon and Suttie, 1975; Vermeer et al., 1995). Prothrombin
(II), proconvertin (VII), antihemophilic factor (IX), and Stuart-Prower factor (X) are all
dependent on the availability of vitamin K1 in the liver (Wen et al., 2018).
24

Matrix Gla protein (MGP) is dependent on vitamin K2 and has high affinity for binding
calcium in the blood, preventing vascular mineralization, specifically of the aorta and coronary
artery, and increasing bone density (Hodges et al., 1993; Wen et al., 2018). It is secreted from
chondrocytes, arterial medial vascular smooth muscle cells, fibroblasts, and endothelial cells and
is upregulated in bone cells by the presence of vitamin D3 (Wen et al., 2018).

III:VII

X
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XII
Pre-K
HMWK

IX:VIII

X:V

II

Fibrinogen

Thrombin

XIII

Fibrin

Cross-Linked Fibrin

Figure 1.3. Brief overview of the coagulation cascade pathway (modified from Walenga, 2020).
Factor III (tissue factor), a cofactor, activates factor VII, a serine protease. Factor VII activates
factors IX and X, both of which are serine proteases. Factor IXa and VIIIa, active proteases of
factors IX and VIII, also activate factor X. Factor VIII is a cofactor. The factor Xa and Va
complex, and active proteases of factors X and V, activate prothrombin (factor II) which is a
serine protease and inactive zymogen of thrombin. Thrombin, a serine protease, cleaves
fibrinogen (factor I), the inactive zymogen of fibrin, to fibrin. Thrombin also activates factor
XIII, fibrin-stabilizing factor, a transglutaminase, which stabilizes the clot. Thrombin also
activates factors V, VIII, XI, and platelets until the clot is stabilized. This process occurs in a
positive feedback loop. Presence of bacteria and negatively charged cellular membranes
activates Hageman factor (factor XII), Fletcher factor (prekallikrein, or pre-K), and Fitzgerald
factor (high-molecular weight kininogen, or HMWK) of which Hageman and Fletcher factors
are serine proteases and Hageman factor is a cofactor. These three factors then activate factor
XI, a serine protease, which activates factors IX and VIII.
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Undercarboxylated MGP is converted into five γ-carboxylated glutamate residues that provide
binding sites for apoptotic cells, calcium ions, and matrix vesicles, and, thereby, cleans the blood
(Wen et al., 2018). Matrix vesicles provide a microenvironment for the deposition of free
calcium ions that coagulate on vessel walls (Wen et al., 2018). Secondary modification of MGP
to phosphorylated-carboxylated-MGP uses three serine residues, and combines with crystallized
calcium, removing it from the walls of blood vessels (Wen et al., 2018).
Growth arrest-specific protein 6 (Gas6) is a γ-carboxyglutamic acid containing protein
found in the bone, that stimulates cell proliferation, and inhibits vascular calcification by
inhibiting vascular smooth muscle cell apoptosis (Wen et al., 2018). Gas6 shares 44% homology
with plasma anticoagulant protein S, a single chain glycoprotein containing γ-carboxyglutamic
acid (DiScipio and Davie, 1979). Anticoagulant protein C and S work together where protein C
is a proteolytic component of the coagulation cascade and protein S binds protein C to activate
the anticoagulant complex on cell surfaces to enhance fibrinolysis (Ferland, 2012). Thrombin
binds to protein C for activation of protein C, which in turn inhibits coagulation (DiScipio and
Davie, 1979). Anticoagulant protein C inhibits factors (V) and (VIII) (Ferland, 2012). Protein Z
is a cofactor for the inhibition of Stuart-Prower factor (X) using the serpin dependent protease
inhibitor, but does not have enzymatic activity (Ferland, 2012). Anticoagulant proteins C, S, and
Z actively work against the pro-coagulant system and are vitamin K1 dependent (Ferland, 2012).
Osteocalcin (OC), or bone γ-carboxyglutamic acid containing protein, is a calcium
binding protein found in dentin, and it comprises 15% to 20% of non-collagenous bone (Ferland,
2012). It is produced by osteoblasts and odontoblasts and is responsible for negative regulation
of bone formation as well as inhibition of hydroxyapatite formation (Vermeer et al., 1995;
Ferland, 2012;). Osteocalcin is one of the most sensitive proteins to vitamin K deficiency and is
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a reliable blood marker for bone health (Vermeer et al., 1995). Gla-rich protein (GRP) is a
calcification inhibitor within the bone and cardiovascular system that acts as an antiinflammatory agent for chondrocytes, responsible for production of cartilage, and synoviocytes,
responsible for production of synovial fluid between the joints (Ferland, 2012; Wen et al., 2018).
It is imperative that GRP undergo γ-carboxylation for it to fully function as a calcification
inhibitor that will also determine the competence of vascular smooth muscle cell extracellular
vesicles (Wen et al., 2018).
Periostin, or osteoblast-specific factor 2, is an extracellular matrix secreted protein found
in bone and ligament tissue that is lipid soluble (Rani et al., 2009; Wen et al., 2018). It is
secreted by osteoblasts and fibroblasts with expression in the lungs and kidneys in addition to
bone and heart tissue (Rani et al., 2009; Wen et al., 2018). Periostin is involved in fetal heart
development, and binds to cell surface receptors of osteoblasts to promote differentiation,
aggregation, proliferation, and adhesion for increased bone strength (Rani et al., 2009; Wen et
al., 2018). Periostin is also a transcription product of vascular injury, where isoforms 1 through
4 are most prevalent in damaged heart tissue (Wen et al., 2018). Isoform 1 inhibits adhesion of
cardiac fibroblasts and muscle cells, whereas isoform 2 performs the opposite process but also
increases formation of blood vessels (Wen et al., 2018). Periostin-like factor is a γ-carboxylated
protein also found in bone tissue, specifically osteoblasts, osteocytes, and osteoclasts as well as
in the periosteum similar to the locations of periostin (Rani et al., 2009; Wen et al., 2018). Both
periostin and periostin-like factor are not normally expressed in healthy adults (Rani et al.,
2009). Only under mechanical stress, cardiovascular disease, injury, or musculoskeletal repair
are these factors expressed for strength promotion of the bone and heart tissue systems (Rani et
al., 2009). Proline rich Gla proteins 1 and 2, in addition to transmembrane Gla protein 3 and 4
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(isoforms 2-5), are also part of the coagulation cascade; however, the full extent of their function
remains to be explored (Wen et al., 2018). The aspect that makes these factors of the coagulation
cascade vitamin K dependent is within the shared Gla domains that each protein exhibits (Lippi
and Franchini, 2011; Wen et al., 2018). A deficiency in vitamin K, or a malfunction in any of
these factors will cause symptoms similar to that of hemophilia (Newman and Shearer, 1998;
Lippi and Franchini, 2011; Ferland, 2012).

Storage of Vitamin K
Blood concentration of vitamin K1 in a normal, fasting adult is 0.15 μg/L to 1.0 μg/L
(Newman and Shearer, 1998; Lippi and Franchini, 2011). During fasting, half of phylloquinone
is bound to triglyceride rich lipoproteins in the liver whereas the other half is distributed between
low-density lipoproteins and high-density lipoproteins in circulation (Kohlmeier et al., 1996;
Newman and Shearer, 1998). Storage in the liver is approximately 9 μg of which 90% are longchain menaquinones (MK-7 to MK-13) that are distributed similarly to their respective
concentrations within the rest of the body, and the remaining 10% is vitamin K1 (Shearer, 1992;
Newman and Shearer, 1998; Lippi and Franchini, 2011). The brain, kidney, and pancreas store
minute amounts of vitamin K2 (<2 pmol/g), which are synthesized during the metabolism of
vitamin K1 (Lippi and Franchini, 2011; Wen et al., 2018). In bone lipid storage, vitamin K1 is
the primary form; MK-4 to MK-7 are also stored in the bone but in a lesser concentration
(Kohlmeier et al., 1996; Newman and Shearer, 1998). Menaquinones greater than MK-8 cannot
be stored in the bone because their side chains are too long (Kohlmeier et al., 1996; Newman and
Shearer, 1998). Cortical bone contains a similar amount of stored vitamin K as the liver and
both bone and liver tissue contain several times the amount of vitamin K found in the blood
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(Kohlmeier et al., 1996). In circulation, vitamin K must be bound to a lipoprotein and the
greatest concentration of blood vitamin K occurs 2 to 4 hours after consuming a meal (Shearer et
al., 1974; Gijsbers et al., 1996; Kohlmeier et al., 1996).
MK-4 is found in greatest concentrations in the pancreas and salivary glands but is
minimally found in the blood plasma and liver (Thijssen and Drittij-Reijnders, 1994; Shearer et
al., 1996; Ferland, 2012). MK-9 to MK-13 are found mainly in the liver and in trace amounts in
the blood. However, other long chain menaquinones, MK-6 to MK-8 are found in great
concentration in the bone and liver (Hodges et al., 1993; Thijssen and Drittij-Reijnders, 1994;
Shearer et al., 1996). Bioavailability of vitamin K depends on the form of vitamin K in the diet
and the lipid content of the diet, where longer side chain residues such as MK-13 are less
biologically available than MK-4 but are more lipid soluble so they can be absorbed more
efficiently (Newman and Shearer, 1998). When consuming foods containing vitamin K, the
young and elderly tend to be more deficient because consumption of vitamin K sources
decreases. The source of vitamin K is not biologically available due to phylloquinone being
bound to chloroplasts or the microflora in the gut is inadequate to produce enough menaquinones
(Suttie, 1992; Hodges et al., 1993; Newman and Shearer, 1998).

Requirement of Vitamin K
An adult male in the United States is recommended to consume 120 μg of vitamin K1 per
day whereas women are recommended to consume 90 μg/d (Vermeer et al., 1995; Lippi and
Franchini, 2011). European standards suggest consuming 1μg/kg of body weight daily (Vermeer
et al., 1995; Lippi and Franchini, 2011). This is sufficient for prothrombin activity, but for full
carboxylation of bone Gla proteins, more vitamin K is likely required (Vermeer et al., 1995). It
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is unclear quantitatively how much the bacterial flora in the gut contributes to the content of
vitamin K1 in the human (Suttie, 1992). The average adult is estimated to consume 70 μg to 250
μg vitamin K1 per day, however, less than 20% is absorbed in the intestines (Lippi and Franchini,
2011). Approximately 90 μg to 120 μg per day of MK-7 is sufficient to meet the requirement for
vitamin K1 (Suttie, 1992; Vermeer et al., 1995). In contrast, 135,000 μg would be required from
oral supplementation of MK-4 to have the same effect (Suttie, 1992; Vermeer et al., 1995).
Newborns should consume 2 μg/d, babies from 7 to 12 months should consume 2.5 μg/d, 1- to 3year-old children should consume 30 μg/d, and those from 3 to 18 years of age should consume
75 μg/d of vitamin K1 in the diet (Lippi and Franchini, 2011).

Deficiency of Vitamin K
Vitamin K deficiency does not typically occur from the diet, but is linked to intestinal
disorders, renal failure, malabsorption, decreased production by natural gut bacteria, excessive
antibiotic use, biliary obstruction, and other prominent digestive disorders (Shearer et al., 1974;
Shearer, 1992; Suttie, 1992). Those with malabsorption of fat excrete up to 98% of ingested
vitamin K and have poor availability of circulating vitamin K in the blood (Shearer et al., 1974).
Deficiency is more common in neonates because of insufficient intestinal bacteria, poor placental
transport, or poor breast milk quality (Shearer, 1992; Lippi and Franchini, 2011). Breast milk
contains 1 μg/L to 4 μg/L of vitamin K1 and cannot compensate for deficiency from gut flora
(Shearer, 1992; Suttie, 1992; Lippi and Franchini, 2011). Neonates do not have detectable blood
concentrations of vitamin K1 until 12 to 24 hours post-natal, but within 3 to 4 days after birth,
breast fed infants have blood concentrations of vitamin K similar to that of adults (Shearer,
1992).
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Childhood hemostasis is vastly different from adult hemostasis, which is likely due to the
chance of deficiency in vitamin K in neonates, which can lead to differences in the concentration
of coagulation factors between children and adults (Lippi and Franchini, 2011; Card et al., 2014).
The hemostasis system does not mature until 3 to 6 months of age, so it is important to ensure
adequate dietary intake of vitamin K in neonates (Shearer, 1992; Lippi and Franchini, 2011). Up
to 0.03% of ingested vitamin K is excreted in the urine 24 hours after dosing in infants, which
indicates that vitamin K catabolic pathway may not be fully functional in neonates (Card et al.,
2014). Breast milk from mothers taking anticonvulsants, antituberculosis drugs, some
antibiotics, vitamin K antagonists, or who are deficient in vitamin K themselves can cause
deficiency in vitamin K content in the breast milk (Shearer, 1992; Lippi and Franchini, 2011).
This can cause vitamin K deficiency-related bleeding (VKDB) that can be corrected with
supplementation or abnormal clotting proteins known as PIVKA, proteins induced by vitamin K
absence (Shearer, 1992; Lippi and Franchini, 2011). PIVKA occurs when high concentrations of
descarboxy coagulation proteins are found in the plasma that are functionally inviable, causing
excessive bleeding due to a lack of available vitamin K for γ-carboxylation (Shearer, 1992).
Vitamin-K dependent coagulation factor deficiencies (VKCFD) are autosomal recessive diseases
that have mutations on the genes encoding for γ-glutamyl carboxylase (type 1) and vitamin K
epoxide reductase (type 2). VKCFD can be fatal if left untreated (Lippi and Franchini, 2011).
Regardless of dietary intake, VKCFD cannot be remedied with supplementation alone as the
enzymes in the biological cycle of vitamin K through the liver are impaired (Lippi and Franchini,
2011; Card et al., 2014).
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Bacterial Production of Vitamin K
The initial thought that intestinal microflora produced vitamin K residues originated from
the discovery of vitamin K in the feces of chicks and rats (Shearer, 1992). Specifically, the
microflora from the large intestine was believed to produce menaquinones because dietary intake
of known vitamin K rich foods was poor and irregular, but menaquinones were still present in
the feces (Shearer, 1992). Through coprophagic behavior, excreted vitamin K2 can be reclaimed
(Shearer, 1992). Around 10% of the human requirement is estimated to be produced by the
intestinal microflora, which is around 2 mg of vitamin K2 (Suttie, 1992; Lippi and Franchini,
2011). The menaquinones that are produced by the gut flora are mostly MK-7 to MK-13, which
are highly lipophilic, but difficult to absorb because of their long prenyl side chains (Shearer et
al., 1996). Most of the bacterial synthesized vitamin K2 is excreted as a result of low
bioavailability because bile salts are needed to form micelles for absorption across the epithelium
of the large intestine. Instead, they are largely absorbed in the small intestine and do not travel
as far as the large intestine (Shearer, 1992; Lippi and Franchini, 2011; Hartling, 2017). Some
enveloping of vitamin K2 also occurs by bacterial membranes, further reducing the
bioavailability for absorption (Lippi and Franchini, 2011). The remainder of this vitamin K2
functions as a redox reagent in electron transport and oxidative phosphorylation for some
bacteria (Ramotar et al., 1984; Hiratsuka et al., 2008; Hartling, 2017).
Menaquinone and ubiquinone (coenzyme Q) are involved in the electron transport chain
for shuttling electrons between membrane bound proteins in prokaryotes (Ramotar et al., 1984;
Hiratsuka et al., 2008). Gram negative and Gram positive bacteria are both capable of producing
and using menaquinones for electron transport in the mitochondrial matrix. However, Gram
positive bacteria such as Bacillus subtilis must synthesize menaquinones because they do not use
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ubiquinone for this process (Hiratsuka et al., 2008). Mammalian cells use ubiquinone as an
electron transport agent whereas menaquinone is then used for activation of the vitamin Kdependent proteins (Hiratsuka et al., 2008). Bacterial produced MK-4 is a membrane bound
electron carrier that functions as a mitochondrial electron carrier to restore ATP production such
as in the cellular malfunction produced by Parkinson’s disease (Card et al., 2014). The
production of menaquinones varies greatly between bacterial species where some will only
produce menaquinone (MK-8) under anaerobic conditions like Escherichia coli (Hiratsuka et al.,
2008; Hartling, 2017). Gram positive bacteria are able to produce menaquinones by converting
chorismate to menaquinone using a series of seven enzymes (MenA to MenG) (Hiratsuka et al.,
2008; Hartling, 2017). Gram negative bacteria and archaea use a different pathway involving
futalosine (Hiratsuka et al., 2008).
Menaquinones have been recovered from the bacterial groups of Escherichia coli (MK8), Bacteroides fragilis (MK-9, MK-10, MK-11, and MK-12), Streptococcus faecalis (DMK-8
and DMK-9), Staphylococcus (MK-6, MK-7, and MK-8), and Bacillus (MK-7) (Shah and
Collins, 1983; Ramotar et al., 1984; Shearer et al.,1996). Some pathogenic bacteria such as
Helicobacter pylori, Campylobacter jejuni, Klebsiella pneumoniae, and Mycobacterium
tuberculosis also synthesize vitamin K2 (Hiratsuka et al., 2008; Hartling, 2017). Since there are
specific families that produce menaquinones, the menaquinone content of bacteria, specifically
which isoform, is used as a biochemical marker in establishing the taxonomy of certain bacterial
families that would have been difficult to distinguish otherwise (Newman and Shearer, 1998).
Normal intestinal flora that produce menaquinones are Bacteriodes, Veillonella,
Propionibacterium, Eubacterium, and Arachnia, where Eubacterium, Propionibacterium, and
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Arachnia were the only Gram positive, non-spore forming bacteria known to produce
menaquinone (Ramotar et al., 1984).
Food products made by microbial processes such as dairy products contain varying
concentrations of vitamin K2 (Fu et al., 2017). In cheeses, MK-9, MK-10, and MK-11 are most
commonly found followed by moderate amounts of MK-4, MK-7, MK-8, MK-12, and
phylloquinone, and no MK-5, MK-6, and MK-13 (Fu et al., 2017). Fermented cheeses such as
blue cheese or cheeses fermented with Lactococcus bacteria, contained greater concentrations of
all vitamin K2 residues compared with non-fermented cheeses (Fu et al., 2017). Yogurts
contained less vitamin K2 than cheese, but the vitamin K content directly correlated to the
amount of fat in the yogurt with 4% yogurt containing the greatest amount of vitamin K2 (Fu et
al., 2017). In dairy products, MK-9 is the most prominent menaquinone whereas MK-4 is the
most prominent in meat products, specifically chicken breast/leg meat, goose, and goose/hog
liver as well as in egg yolks and butters (Schurgers and Vermeer, 2000). MK-5, MK-6, MK-7,
and MK-8 were most prominent in Japanese natto, a fermented soybean product made by
fermenting soybeans with Bacillus subtilis natto (Schurgers and Vermeer, 2000; Berenjian et al.,
2012). MK-7 production in natto begins as early as 2 hours post inoculation and continues to
increase linearly until 96 hours of fermentation (Schurgers and Vermeer, 2000; Berenjian et al.,
2012). This production of MK-7 is still in the exponential growth phase of B. subtilis natto
(Berenjian et al., 2012). Other common foods such as sauerkraut, green beans, broccoli, spinach,
and kale have high concentrations of phylloquinone although interestingly enough, sauerkraut
has <1 μg/100 mL of any vitamin K2 residue despite being a fermented food (Schurgers and
Vermeer, 2000; Ferland, 2012; Fu et al., 2017). Overall, Japanese natto is the greatest known
source by far of vitamin K1, and K2, containing 34.7 μg/100 mL of K1, 0 μg/100 mL of MK-4,
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7.5 μg/100 mL of MK-5, 13.8 μg/100 mL of MK-6, 998 μg/100 mL of MK-7, and 84.1 μg/100
mL of MK-8 (Schurgers and Vermeer, 2000). Natto and fermented cheeses are two of the few
food groups that contain both vitamin K1, and K2, with multiple isoforms of vitamin K2
(Schurgers and Vermeer, 2000; Berenjian et al., 2012; Fu et al., 2017).
Vitamin K2 production as a functional food component is an emerging topic. Further
research needs to be completed to determine how many species of bacteria produce vitamin K2.
Additionally, research needs to determine at what point bacteria produce vitamin K2 during their
growth cycle to optimize food preparation and the subsequent vitamin K2 content in these
fermented foods. The health benefits of fermented foods, such as Japanese natto, are becoming
well known, but the knowledge gap as to what makes these foods so beneficial beyond singular
products of bacterial fermentation needs a more in-depth analysis. It is clear the vitamin K
family has an important biological role in cardiovascular health, which is why research on
bacterial production of vitamin K2 in functional foods is so important. By researching this issue
further, it may be possible to characterize more bacteria that produce vitamin K2 in the gut and
encourage natural production and absorption of vitamin K. It may be possible to alter growth
cycles of bacteria that produce vitamin K2, in addition to other beneficial substances, and
manipulate these species to improve functional food products globally.

KEFIR

History of Kefir
Fermentation of milk was originally used as a preservation method throughout the Middle
East, the Balkans, Poland, Central Asia, parts of the former Soviet Union, and Mongolia, with
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the most prominent use around the Caucasus Mountain region dating back more than 10,000
years (Tamime and Marshall, 1997; Ahmed et al., 2013; Litopoulou-Tzanetaki and Tzanetaki,
2014; Ozer and Kirmaci, 2014). Portions of existing batches were saved and added to fresh milk
as a starter culture. Less than 100 years ago, the microbes responsible for this fermentation were
isolated (Tamime and Marshall, 1997; Litopoulou-Tzanetaki and Tzanetaki, 2014).
Upon the discovery of food fermentation microbes, milk fermentation processes and
manufacture have progressed over time. There are multiple fermented milk beverages that exist
globally (Tamime and Marshall, 1997; de Oliveira, 2014; Litopoulou-Tzanetaki and Tzanetaki,
2014). Three main categories of fermented milk can be derived: lactic fermentation products,
yeast-lactic fermentation products, and mold lactic fermentation products (Tamime and Marshall,
1997; Ozer and Kirmaci, 2014). Of the three categories, yeast-lactic fermentation products are
the most prominent and have the greatest economic impact in the Caucasus Mountain region and
across the European and Asian continents (Tamime and Marshall, 1997; Ozer and Kirmaci,
2014). The three most popular beverages in the yeast-lactic fermentation category are kefir,
koumiss, and yeast-acidophilus milk, with kefir being the most prominent globally (Tamime and
Marshall, 1997; Ozer and Kirmaci, 2014).
Kefir is made from fermentation of milk using kefir “grains” (Guzel-Seydim et al., 2000;
Guzel-Seydim et al., 2011; Ozer and Kirmaci, 2014). Koumiss is fermented mare’s milk using
cultures Lactobacillus delbrueckii susp. bulgaricus and Kluyveromyces that produce acid and
alcohol end products similar to that of kefir (de Oliveira, 2014). Yeast-acidophilus milk is
produced using Lactobacillus acidophilus for fermentation of cow’s milk, but because of the
strong taste, it is not a popular beverage unless being consumed therapeutically (de Oliveira,
2014). The strong taste likely led to the production of sweet acidophilus milk in the United
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States during the 1970’s, which is non-fermented milk with L. acidophilus culture added prior to
packaging, retaining the natural sweet flavor of milk while providing therapeutic benefits (de
Oliveira, 2014). There are multiple other fermented milk beverages that vary depending on
region, culture, and milk source, but kefir is by far the most prominent fermented milk beverage
across cultures (Lin et al., 1999; Ozer and Kirmaci, 2014).
Kefir is commonly made from cow’s milk (whole or skimmed), but can also be made
with goat, ewe, camel, mare, buffalo, and soy milk (Irigoyen et al., 2005; Litopoulou-Tzanetaki
and Tzanetaki, 2014; Ozer and Kirmaci, 2014). Cow, goat, and ewe milk are the most common
(Irigoyen et al., 2005; Litopoulou-Tzanetaki and Tzanetaki, 2014; Ozer and Kirmaci, 2014).
According to de Oliveira (2014), goat’s milk must be used with caution because it contains
elevated concentrations of β-casein, which forms α-s-casein during fermentation (de Oliveira,
2014). The α-s-casein coagulates poorly, which causes a very soft product (de Oliveira, 2014).
Kefir was originally fermented in animal hide bags, typically goatskin, and was likely produced
accidentally when milk was stored at ambient temperature indoors in the winter, and outdoors
during the summer (Irigoyen et al., 2005; Litopoulou-Tzanetaki and Tzanetaki, 2014; Ozer and
Kirmaci, 2014). It was not until the 19th century that kefir spread across Eastern and Central
Europe as manufacture and production began to rapidly increase (Ozer and Kirmaci, 2014).

Kefir grains
Kefir originated from the Northern Caucasus Mountain region thousands of years ago and
derives its name from the Turkish word “kef”, meaning pleasant taste (Guzel-Seydim et al.,
2000; Yuksekdag et al., 2004). Kefir is unique because it does not use a traditional starter
culture common among yogurt and other fermented foods (Guzel-Seydim et al., 2011; Ozer and
37

Kirmaci, 2014). Kefir instead uses what are referred to as kefir “grains”, which are tiny
gelatinous balls of lactic acid bacteria, yeast, and occasionally acetic acid bacteria in a symbiotic
relationship within the grain (Guzel-Seydim et al., 2000; Guzel-Seydim et al., 2011; Figure 1.4).
The grains are added to milk at a rate of 2 to 3 percent (w/v) and used as the starter (GuzelSeydim et al., 2000). Once fermentation is complete, the grains are sieved out and saved to
produce more kefir, and the resulting drink can be consumed (Guzel-Seydim et al., 2000; GuzelSeydim et al., 2005; Guzel-Seydim et al, 2006). Grains are 0.3 to 3.0 cm in diameter and are
characterized by their irregular folded and uneven surface similar to the shape and color of
cauliflower florets (Lin et al., 1999; Guzel-Seydim et al., 2000; Ahmed et al., 2013; Ozer and
Kirmaci, 2014). The kefir grains are held together in a polysaccharide matrix that forms a semihard granule that increases in biomass and is retrievable post-fermentation, which is uncommon
among most starter cultures (Garrote et al., 1998; Guzel-Seydim et al., 2000; Guzel-Seydim et al,
2011).
There has been debate as to which
microorganisms inhabit kefir grains, but it
is widely known that the composition
varies regionally (Lin et al., 1999; Wang et
al., 2004; Witthuhn et al., 2004; Sarkar,
2007; Guzel-Seydim et al., 2011).
Generally, kefir grains contain lactic acid

Figure 1.4. Kefir grains

bacteria such as, Lactococcus lactis subsp. lactis, Lactococcus lactis subsp. cremoris,
homofermentative and heterofermentative Lactobacilli, Leuconostoc mesenteroides subsp.
dextranicum, and Streptococcus thermophilus, yeasts such as, Saccharomyces, Kluyveromyces,
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Candida, Mycotorula, Torulopsis, Cryptococcus, Torulaspora, and Pichia, and acetic acid
bacteria such as Acetobacter aceti, and Acetobacter racens (Table 1.1) (Guzel-Seydim et al.,
2000; Yuksekdag et al., 2004; Witthuhn et al., 2004; Litopoulou-Tzanetaki and Tzanetaki, 2014;
Guzel-Seydim et al., 2011). Although kefir grains share common characteristics, grains vary in
the exact composition of their microflora where bacteria tend to be found on the outer portion of
the grain while yeasts populate the center (Lin et al., 1999). The quality of the resulting
beverage depends greatly upon the initial composition of the milk, the microflora within the
grain, in addition to heat treatment and homogenization (Narvhus, 2014; Ozer and Kirmaci,
2014). Without heat treatment and/or homogenization, fermented milk tends to separate from
the whey in storage and creates a weak gel that requires straining through cloth to reach the
desired product consistency (Tamime and Marshall, 1997; Narvhus, 2014).

Table 1.1 Microflora found in authentic kefir grains (modified from Guzel-Seydim et al., 2011).
Genus
Species
Lactobacillus kefir
Lactobacillus kefiranofaciens
Lactobacillus kefirgranum
Lactobacillus parakefir
Lactobacillus brevis
Lactobacillus plantarum
Lactobacillus helveticus
Lactobacillus acidophilus
Lactobacilli
Lactobacillus delbrueckii bulgaricus
Lactobacillus rhamnosus
Lactobacillus casei
Lactobacillus paracasei
Lactobacillus fructivorans
Lactobacillus hilgardii
Lactobacillus fermentum
Lactobacillus viridescens
Lactobacillus gasseri
Lactobacillus crispatus
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Table 1.1 (continued) Microflora found in authentic kefir grains( modified from Guzel-Seydim et
al., 2011).
Lactococcus lactis
Lactococci
Lactococcus lactis diacetylactis
Lactococcus lactis cremoris
Streptococcus thermophilus
Streptococcus cremoris
Streptococci
Streptococcus faecalis
Streptococcus durans
Leuconostoc mesenteroides
Acetobacter
Acetic Acid Bacteria
Acetobacter pasteurianus
Acetobacter aceti
Saccharomyces cerevisiae
Saccharomyces delbrueckii
Candida kefir
Kluyveromyces lactis
Issatchenkia orientalis
Saccharomyces unisporus
Saccharomyces exiguous
Saccharomyces humaticus
Yeast
Kluyveromyces marxianus
Saccharomyces turicensis
Pichia fermentas
Torulopsis holmii
Candida holmii
Torulospora delbrueckii
Candida friedricchi
Candida albicans

Kefiran
The dry mass of a kefir grain is 10 to 16 percent of total weight containing
microorganisms and their metabolites, 30 percent protein, and 25 to 50 percent carbohydrates
including exopolysaccharide (Ozer and Kirmaci, 2014). Bacteria within the kefir grain,
specifically Lactobacillus kefiranofaciens, are responsible for producing exopolysaccharide, or
kefiran (Abraham and de Antoni, 1999; Lin et al.,1999; Marquina et al., 2002; Ozer and Kirmaci,
2014). Kefiran is a water soluble hexa- and heptapolysaccharide composed of a combination of
40

repeating units of equimolar amounts of D-glucose, D-galactose, and mannose that is
impenetrable by the autolyzing surface bacteria and yeast (Lin et al., 1999; Santos et al., 2003;
Ahmed et al., 2013; Ozer and Kirmaci, 2014). Other bacteria thought to produce kefiran include
Lactobacillus kefir, Streptococcus mutans, Leuconostoc mesenteroides, and Streptococcus
cremoris (Abraham and de Antoni, 1999; Ozer and Kirmaci, 2014). The thickness of kefiran is
affected by fermentation temperature only, and not fermentation time, but its presence can have
important effects on the end product such as improving texture or mouth feel of the kefir (Ahmed
et al., 2013; Ozer and Kirmaci, 2014). Kefiran improves gel formation rheology and viscoelastic
characteristics of fermented milks (Ahmed et al., 2013). At low temperatures, such as during
refrigeration, kefiran forms a film that has low water permeability, but remains flexible,
providing some protection for product quality (Ahmed et al., 2013). Kefiran provides health
benefits including immunomodulatory, anti-mutagenic, anti-ulceric, anti-allergic, and anti-tumor
effects, and is the main prebiotic component of kefir (Abraham and de Antoni, 1999; Ozer and
Kirmaci, 2014).

Fermentation
Kefir grains added to milk need 20 to 24 hours at 25°C to ferment, with an optimal time
of 22 hours at 25°C compared with some yogurts that require 4 to 8 hours at 40°C to 45°C for
adequate proliferation (Garcia Fontan et al., 2006; Guzel-Seydim, 2011; de Oliveira, 2014).
During fermentation, lactic acid bacteria use lactose as an energy source and ferment it to lactic
acid, decreasing the pH of milk from between pH 6.4 to 6.7 to between pH 3.8 to 4.2 (GuzelSeydim et al., 2000; Gronnevik et al., 2011; de Oliveira, 2014). This family of bacteria cause
coagulation of milk proteins through a decrease in pH as lactic acid accumulates (de Oliveira,
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2014). Homofermentative lactic acid bacteria break down lactose to glucose and galactose,
using 20 to 25 percent of available lactose (Irigoyen et al., 2005). Total lactose concentration is
reduced to 1.4 percent in the first 24 hours (Irigoyen et al., 2005). Total lactose reduction is
dependent on initial inoculation and is inversely correlated to the content of β-galactosidase in
kefir over time (Marquina et al., 2002; Irigoyen et al., 2005). Hydrolysis of lactose to pyruvate is
catalyzed by β-galactosidase, an enzyme that breaks glycosidic bonds via hydrolysis of betagalactosides such as lactose (Gronnevik et al., 2011). Lactic acid production is consistent
between 0 to 10 hours but rapidly increases between 10 and 15 hours of fermentation from 590
μg/g to 3700 μg/g (Guzel-Seydim et al., 2000).
Glucose is metabolized through the Embden-Meyerhoff-Parnas pathway to produce
pyruvate (Guzel-Seydim et al., 2000). Glucose is first detected at 5 hours of fermentation, but
rapidly increases between 15 and 22 hours of fermentation (Guzel-Seydim et al., 2000).
Pyruvate is used as a hydrogen acceptor and 2 mol of lactate are produced for each glucose
molecule (Guzel-Seydim et al., 2000). Galactose is metabolized by the D-tagatose 6-phosphate
pathway to produce lactic acid as an end product (Litopoulou-Tzanetaki and Tzanetaki, 2014).
Galactose is not detected in the kefir product due to its role in forming the kefiran polymer on
kefir grains (Irigoyen et al., 2005).
The heterofermentative lactic acid bacteria also use lactose as a substrate via the
phosphoketolase and Leloir pathways, producing end products such as lactic acid, acetaldehyde,
propionaldehyde, acetone, ethanol, 2-butanone, n-propyl alcohol, diacetyl, and amyl alcohol
(Yuksekdag et al., 2004; Guzel-Seydim et al., 2011; Litopoulou-Tzanetaki and Tzanetaki, 2014).
However, the three main products of heterofermentation are lactic acid, ethanol, and CO2 (GuzelSeydim et al., 2000). These products make heterofermentation the preferential pathway for kefir
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fermentation and incidentally prevents over acidification by lactic acid (Guzel-Seydim et al.,
2000). Excess pyruvate is converted to acetaldehyde and diacetyl, but diacetyl can also be
produced by utilization of citrate by some lactic acid bacteria, which also produce acetoin
(Guzel-Seydim et al., 2000). Acetoin concentration increases between 10 and 15 hours to 25
μg/g (Guzel-Seydim et al., 2000).
Acetaldehyde is first produced at 10 hours of fermentation and increases in concentration
until 15 hours of fermentation to 5 μg/g (Guzel-Seydim et al., 2000; Yuksekdag et al., 2004).
The low concentration is likely because acetaldehyde can be converted to ethanol via alcohol
dehydrogenase (Lin et al.,1999; Guzel-Seydim et a., 2000; Yuksekdag et al., 2004). Ethanol is
also produced up to 0.25 percent by L. kefir and kefir yeast strains (Lin et al., 1999; GuzelSeydim et al., 2000; Yuksekdag et al., 2004). Ethanol is detected at 5 hours of fermentation but
increases between 15 and 22 hours of fermentation to 0.01 to 1.0 percent (Lin et al., 1999;
Guzel-Seydim et al., 2000). Since yeast are the primary ethanol producing agents in kefir,
authentic kefir tends to have a slight yeast flavor as a result (Guzel-Seydim et al., 2000; Irigoyen
et al., 2005).
Yeast that ferment lactose also use the Leloir pathway to produce end products similar to
heterofermentative lactic acid bacteria (Litopoulou-Tzanetaki and Tzanetaki, 2014). Yeast
provide lactic acid bacteria with growth stimulants and metabolize some lactic acid, creating a
protocooperative effect during fermentation (Guzel-Seydim et al., 2000; Litopoulou-Tzanetaki
and Tzanetaki, 2014). Acetic acid can reach concentrations of 0.10 ± 0.01 percent when kefir is
incubated for 48 hours (Garrote et al., 2000). During fermentation, however, hippuric acid is
undetectable after 15 hours of fermentation, which is likely due to lactic acid bacteria using it as
a substrate for benzoic acid synthesis (Guzel-Seydim et al., 2000). In most strains of kefir, acetic
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acid, propionic acid and butyric acid are not detected in the final product, but when present, they
have an effect on product flavor (Guzel-Seydim et al., 2000).

Lactic Acid Isomers
Lactic acid has two isomers, L (+), which is the form metabolized by humans and used by
cells, and D (-), which is the inactive isomer completely excreted in the urine (Lin et al., 1999;
Sarkar, 2007; Litopoulou-Tzanetaki and Tzanetaki, 2014). L (+) lactic acid is produced in the
log phase and is 2.5 times more prevalent than D (-) lactic acid, which is produced in the
stationary phase (Lin et al., 1999; Garcia Fontan et al., 2006). The difference in L (+) and D (-)
lactate quantity is due to the pH and pyruvate concentration, both of which influence lactate
dehydrogenase that alters isomer ratios during their respective growth phases (Lin et al., 1999).
The amount of L (+) lactic acid isomer in kefir depends on the initial microflora. Mesophilic,
homofermentative lactic streptococci produce 10 percent more L (+) lactic acid than D (-) lactic
acid (Tamime and Marshall, 1997; Witthuhn et al., 2004; Sarkar, 2007). L (+) lactic acid reaches
maximal levels at 24 hours and decreases until 48 hours of fermentation and remains constant
(Garcia Fontan et al., 2006). This is likely because L (+) lactate was converted to acetate (Garcia
Fontan et al., 2006). D (-) lactate is produced at 8 hours of fermentation and reaches a
concentration of 0.57 percent up to 168 hours of fermentation (Garcia Fontan et al., 2006). The
decrease in L (+) lactate and increase in D (-) lactate coincide, which could indicate that some
lost L (+) lactate is converted to D (-) lactate during fermentation (Garcia Fontan et al., 2006).
L. mesenteroides produces D (-) lactic acid whereas Kluyveromyces marxianus and
Bifidobacterium produce L (+) lactic acid, despite Bifidobacterium being anaerobic and difficult
to culture in milk (Lin et al., 1999; Sarkar, 2007; Litopoulou-Tzanetaki and Tzanetaki, 2014).
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Bifidokefir, which is kefir with added Bifidobacteria, contains 90 percent L (+) lactic acid,
decreasing the risk of acidosis and making bifidokefir the safer choice when feeding to infants
(Sarkar, 2007; Ahmed et al., 2013). Bifidokefir is more effective at decreasing infection rate in
the small intestine than normal kefir (Ahmed et al., 2013). Acidophilus milk also contains L(+)
lactic acid, but live cultures of L. acidophilus are inhibited by lactic acid around 0.6 percent
(Litopoulou-Tzanetaki and Tzanetaki, 2014). Once acidophilus milk reaches 0.6 percent lactic
acid, the fermentation must be stopped so there are still a minimum of 5 x 108 cfu/mL of active
bacteria present to provide a therapeutic effect (Litopoulou-Tzanetaki and Tzanetaki, 2014). K.
marxianus is one of the few yeast species that can ferment lactose and does so because it
possesses β-galatosidase (Gronnevik et al., 2011). Lactic acid increases gastric secretion as well
as the rate at which gastric contents are transferred to the intestinal tract (Litopoulou-Tzanetaki
and Tzanetaki, 2014). This increases the digestion of proteins while inhibiting undesirable gut
flora (Litopoulou-Tzanetaki and Tzanetaki, 2014). Since kefir contains high concentrations of L
(+) lactic acid, it is a good product for improvement of gut health.

Kefir Composition
Kefir contains 86.3 percent moisture, 4.5 percent protein, 0.03 percent fat, and 1.2
percent ash and 11.7 percent dry matter on average (Liutkevicius and Sarkinas, 2004; Irigoyen,
2005; Sarkar, 2007; Ahmed et al., 2013). Depending on the type of milk used, the components
can range from 89-90 percent moisture, 3.0 percent protein, 0.2 percent fat, 6.0 percent sugar, 0.7
percent ash, 1.0 percent lactic acid, and 1.0 percent alcohol (Sarkar, 2007). Carbon dioxide
content is reported at 1.98 g/L which increases by 201.7 to 277.0 ml/L when additional kefir
grains (10 to 100 g/L) are used during fermentation (Garrote et al., 1998; Beshkova et al., 2002;
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Sarkar, 2007; Ahmed et al., 2013). Kefir contains 1.65 percent potassium, 0.86 percent calcium,
1.45 percent magnesium, 0.30 percent phosphorus, 7.32 mg/kg copper, 92.7 mg/kg zinc, 20.3
mg/kg iron, 13.0 mg/kg manganese, 0.16 mg/kg cobalt, and 0.33 mg/kg molybdenum
(Liutkevicius and Sarkinas, 2004; Sarkar, 2007).
Kefir also contains vitamin B1 (thiamine), vitamin B2 (riboflavin), vitamin B5 (pantothenic
acid), and can contain vitamin B6 (pyridoxine), vitamin B7 (biotin), vitamin B9 (folic acid), and
vitamin B12 (cobalamin) (Khamnaeva et al., 2000; Irigoyen et al., 2005; Sarkar, 2007; Ahmed et
al., 2013). Vitamin B1, vitamin B2, vitamin B5, and vitamin C are influenced by the type of milk
used (i.e. cow, mare, goat, ewe) and the flora in the grain (Khamnaeva et al., 2000; Liutkevicius
and Sarkinas, 2004; Sarkar, 2007). Vitamin content can be manipulated with addition of
microorganisms such as Propionibacterium peterssoni, Propionibacterium pituitosum, and
Propionibacterium freudenreichii subsp. shermanii, which reduce content of vitamin B12 by 30
percent, and increase vitamin B9 by 500 percent, while minutely increasing concentrations of
vitamin B5 and vitamin B6 (Irigoyen et al., 2005; Sarkar, 2007; Ahmed et al., 2013). During
normal fermentation, vitamin B6, B7, B9, and B12 concentrations increase whereas vitamin B1 and
B2 concentrations decrease (Ahmed et al., 2013). Vitamin K and vitamin C are also found in
large concentrations in kefir regardless of the fermentation method (Ahmed et al., 2013).
Protein content of kefir can also be increased when using whey or soy milk in
comparison with cow’s milk (Sarkar, 2007; Ahmed et al., 2013). During fermentation of milk,
amino acid content increases, specifically increasing threonine, serine, alanine, lysine, as well as
ammonia compared with milk (Guzel-Seydim et al., 2003; Sarkar, 2007; Ahmed et al., 2013).
Tryptophan, valine, lysine, methionine, phenylalanine, threonine, and isoleucine have also been
detected in kefir (Liutkevicius and Sarkinas, 2004; Ahmed et al., 2013). In bifidokefir, there is a
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greater concentration of glutamic acid and threonine, which suggests that protein content can be
manipulated depending on the composition of the kefir grain, the milk quality, and the
supplemental bacteria used in fermentation (Ahmed et al., 2013).

Microbial Components
It is estimated that the microflora in kefir grains comprises 0.9 percent of its wet weight
(Abraham and de Antoni, 1999; Sarkar, 2007). The lactic acid bacteria and acetic acid bacteria
comprise 6.4 x 104 to 8.5 x 108 cfu/g whereas yeasts comprise 1.5 x 105 to 3.7 x 108 cfu/g
(Witthuhn et al., 2004; Irigoyen et al., 2005; Garcia Fontan et al., 2006; Sarkar, 2007; Davras et
al., 2018). Lactobacilli and lactococci have populations of 108 cfu/mL, acetic acid bacteria have
populations of 106 cfu/mL, and yeasts have populations of 105 cfu/mL after 24 hours of
fermentation (Irigoyen et al., 2005; Garcia Fontan, 2006; Sarkar, 2007; Ozer and Kirmaci, 2014).
Compared with kefir made from starter culture instead of authentic kefir grains, authenic kefir
had 10.54 log cfu/mL, 5.69 log cfu/mL, 9.55 log cfu/mL, 7.83 log cfu/mL for Lactobacillus spp.,
yeast, L. acidophilus, and Bifidobacterium, respectively (Davras et al., 2018). These values are
compared with non-authentic kefir counts of 8.40 log cfu/mL, 2.5 log cfu/mL, 8.65 log cfu/mL,
and 0.12 log cfu/mL, respectively, which were greatly reduced compared with authentic kefir
(Davras et al., 2018).
Kefir contains five bacterial phyla including Firmicutes, Proteobacteria, Actinobacteria,
Cyanobacteria, and Bacteriodetes (Dertli and Con, 2017). Firmicutes and Proteobacteria are the
two most densely populated phyla in kefir grains (Dertli and Con, 2017). Depending on the
region from which the grains are derived, these two phyla comprised 58 to 67 percent of the total
microbial mass (Dertli and Con, 2017). Actinobacteria were third most dense at 0.87 to 2.9
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percent, and Cyanobacteria and Bacteroides were present but in such low concentration they
were difficult to record (Dertli and Con, 2017). The seven dominant families in kefir include
Enterobacteriaceae and Lactobacillaceae, which are the most dominant at 64.9 percent density
(Dertli and Con, 2017). Moraxellacaea and Pseudomonoadaceae are found in all kefir grains, but
Enterococcaceae and Streptococcaceae vary in their presence (Dertli and Con, 2017).
Acetobacteraceae is found in the least density at 2.81 percent of kefir grains (Dertli and Con,
2017). The common species of bacteria and yeasts found in kefir are represented in Table 1.1
(Guzel-Seydim et al., 2011). Of all species of bacteria present in kefir grains, L. kefiranofaciens
is the most prominent (Dertli and Con, 2017).
The main fungal phyla found in kefir include Ascomycota, Basidiomycota, and
Zygomycota (Dertli and Con, 2017). There are six families found in kefir, Dipodascaceae,
Pichiaceae, Saccharomycetaceae, Malasseziaceae, Trichosporonaceae, and Mucoraceae,
however, Dipodascaceae and Pichiaceae are the most prevalent families in kefir grains (Dertli
and Con, 2017). The most common species of yeast in kefir grains are Issatchenkia orientalis
comprising 38.2 percent of the fungal species and Dipodascus geotrichum as second most
dominant species, which is different from other sources (Ahmed et al., 2013; Dertli and Con,
2017). The major species of yeast found in kefir include Kluyveromyces, Zygosaccharomyces,
Pichia, Torula, Candida, and Saccharomyces (Ahmed et al., 2013). Specifically, Kluyveromyces
lactis, K. marxianus, and Saccharomyces cerevisiae are the most prominent strains of yeast and
Torulaspora delbrueckii, Zygosaccharomyces rouxii, Saccharomyces unisporus, Debaryomyces
hansenii, and Torulaspora delbrus are found in smaller quantities in kefir grains (Ahmed et al.,
2013). Some mold species have been found sparsely in regional kefir grains but are not in great
quantity (Dertli and Con, 2017).
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Flavor
Kefir contains seven different volatile compounds that contribute to the flavor and aroma
of kefir including acids, alcohols, aldehydes, carboxylic acids, esters, ketones, and sulfur
compounds (Dertli and Con, 2017). Carboxylic acids are the most prevalent compounds in kefir,
between 34.95 to 56.60 percent, as they are products of carbohydrate and lipid metabolism
during fermentation (Dertli and Con, 2017). Dertli and Con (2017) reported acetic acid as the
most prominent carboxylic acid in kefir. Carboxylic acids and ketones provide a cheesy flavor
whereas esters provide a fruity flavor and 2-butanone provides the typical yogurt aroma (Dertli
and Con, 2017). As a fermented beverage, kefir contains products of fermentation such as
acetaldehyde, diacetyl, pyruvic acid, hippuric acid, acetic acid, propionic acid, butyric acid,
lactic acid, propionaldehyde, acetone, acetoin, ethanol, 2-butanone, n-propyl alcohol, diacetyl,
amyl alcohol, CO2, and ethanol (Guzel-Seydim et al., 2000; Yuksekdag et al., 2004; Sarkar,
2007; Guzel-Seydim et al., 2011; Narvhus, 2014). Lactic acid, products of proteolytic activity,
acetaldehyde, and diacetyl are major flavor compounds that give kefir its characteristic taste
(Yuksekdag et al., 2004; Narvhus, 2014). Diacetyl is produced by S. lactis, and acetaldehyde is
produced by Leuconostoc sp. (Ahmed et al., 2013). Aromatic alcohols comprise 9.27 to 27.9
percent, esters are 1.63 to 17.14 percent, and ketones are 12.3 to 17.7 percent of kefir whereas
aldehydes were in the lowest concentration at 2.34 to 5.61 percent (Dertli et al., 2017). Ethanol
reaches 890 ± 300 mg/kg. which is less than 0.1 percent that is found in commercial kefir,
providing a slight alcohol taste but not a large alcohol content overall (Gronnevik et al., 2011).
Product Quality & Storage
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Good quality kefir should have a light, foamy, pourable consistency with self-carbonation
(Guzel-Seydim et al., 2000). Viscosity depends upon the initial amount of inoculated kefir and
increases with more inoculum (Irigoyen et al., 2005). Post fermentation, kefir should be
refrigerated at 4°C to increase shelf life (Irigoyen et al., 2005; Ahmed et al., 2013). At two days
of refrigerated storage, lactobacilli counts in kefir remain at 108 cfu/mL and decreased by a total
of 1.5 logs from day 7 to 14 (Irigoyen et al., 2005). Lactococci counts remain at 108 cfu/mL
until around three days of storage and then follow a similar decreasing pattern to that of
lactobacilli (Irigoyen et al., 2005; Garcia Fontan et al., 2006). Yeast concentration, however,
remains constant around 105 cfu/mL over the course of 28 days. Similarly, the concentrations of
acetic acid bacteria remain at approximately 106 cfu/mL over storage time (Irigoyen et al., 2005;
Gronnevik et al., 2011). Fat content of kefir decreases 3.3 to 7.9 percent over the course of 28day storage depending on the initial fat content of the milk (Irigoyen et al., 2005). This is likely
due to lipases naturally present in the kefir that have a greater lipolytic effect, hydrolyzing
butterfat to free fatty acids after 14 days of storage (Guzel-Seydim et al., 2000; Irigoyen et al.,
2005). Glucose concentration is reduced from the original concentration in milk to <60 mg/kg
post fermentation and was completely metabolized after 3 weeks in storage (Gronnevik et al.,
2011).
During storage for 21 days, ethanol concentrations were reduced to 0.08 percent,
acetaldehyde to 11 μg/g, and acetoin to 16 ppm (Guzel-Seydim et al., 2000; Sarkar, 2007).
When stored at 48°C, ethanol, acetaldehyde, and acetoin concentrations were all reduced
(Ahmed et al., 2013). Initial dry matter of kefir made with 5 percent inoculum after 24 hours of
fermentation was 11.7 g/100mL, which was very similar to milk (Irigoyen et al., 2005). Total
dry matter of kefir decreased over the course of a 28-day storage period, but especially decreased
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rapidly after day 14 by a total of 2 percent (Irigoyen et al., 2005). Lactose content and pH tended
to stay constant throughout the storage process due to the decline in lactic acid bacteria and
presence of yeast in the culture (Irigoyen et al., 2005; Gronnevik et al., 2011). Yeast caused
proliferation of lactic acid bacteria to slow in the culture (Irigoyen et al., 2005). One major
concern for product quality in storage was presence of mold after 14 days of storage (Irigoyen et
al., 2005). This reduced palatability and kefir should not be consumed at this point (Irigoyen et
al., 2005). Sensory acceptability of kefir decreased the longer it remained in storage so kefir
should be consumed within 3 days of fermentation (Irigoyen et al., 2005).

Antimicrobial properties
Due to its metabolic end products, kefir maintains certain antimicrobial characteristics
(Santos et al., 2003; Sarkar, 2007). Many of the organic acids provide an inhibitory effect in
their undissociated form (Garrote et al., 1998; Garrote et al., 2000). Lactic acid has the greatest
proportion of its undissociated form in milk and has a sufficient concentration after 48 hours of
fermentation to inhibit Escherichia coli (Garrote et al., 2000; Morgan et al., 2000; Gulmez and
Guven, 2003). Non-pathogenic E. coli can be inhibited by 0.09 percent of undissociated lactic
acid whereas pathogenic E. coli requires at least 0.47 percent of undissociated lactic acid likely
because pathogenic strains tend to be more acid tolerant (Garrote et al., 2000; Morgan et al.,
2000). Kefir has a bacteriostatic effect on Gram negative organisms and a bactericidal effect on
Gram positive organisms (Garrote et al., 2000; Marquina et al., 2002; Sarkar, 2007). It has been
reported that kefir has an antagonistic effect on common pathogenic bacteria such as E. coli,
Listeria monocytogenes, Yersinia enterocolitica, Listeria innocua, and Salmonella enteritidis
(Garrote et al., 2000; Morgan et al., 2000; Marquina et al., 2002; Gulmez, 2003; Santos et al.,
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2003; Sarkar, 2007). Specifically, Lactobacilli extracted from kefir grains are believed to be the
main antagonist of pathogenic bacteria (Morgan et al., 2000; Marquina et al., 2002; Gulmez and
Guven, 2003; Santos et al., 2003; Sarkar, 2007). When Lactobacilli from kefir were tested on 58
strains of each pathogen listed above, the extract was antagonistic against 43 strains of E. coli, 28
strains of L. monocytogenes, 10 strains of Salmonella typhimurim, 22 strains of E. enteriditis, 36
strains of Shigella flexneri, and 47 strains of Y. enterocolitica (Morgan et al., 2000; Marquina et
al., 2002; Gulmez and Guven, 2003; Santos et al., 2003; Sarkar, 2007). Long term, kefir reduces
Gram negative anaerobic bacteria as well as sulfite reducing Clostridia, which is of interest to
those in hospitals with post-operative intra-abdominal septic complications (Marquina et al.,
2002). However, kefir increases the concentration of Enterococci by 10-fold (Marquina et al.,
2002).
Hydrogen peroxide is produced by lactic acid bacteria between 0.04 μg/mL and 0.19
μg/mL and is stable in the acidic kefir matrix (Yuksekdag et al., 2004). Reducing the hydrogen
concentration in kefir, and thus affecting the pH, the presence of hydrogen peroxide inhibits
pathogenic bacteria and spoilage bacteria (Yuksekdag et al., 2004). The acetic acid and yeasts in
kefir grains are thought to produce organic acids, which inhibit pathogens whereas general
products of fermentation such as organic acids, undissociated lactic and acetic acid, or hydrogen
peroxide also contribute to the antimicrobial properties of kefir (Garrote et al., 2000; Morgan et
al., 2000; Gulmez and Guven, 2003; Yuksekdag et al., 2004). Duration of fermentation also
affects antimicrobial activity where 24-hour fermentation has greater populations of E. coli, L.
monocytogenes and Y. enterocolitica compared with 48-hour fermentation only containing
populations of E.coli (Morgan et al., 2000; Gulmez and Guven, 2003; Sarkar 2007).
Probiotics
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Probiotics are live microorganisms that have positive health effects such as improved
digestive health, serum cholesterol reduction, improved lactose tolerance, improved immune
function, cardiovascular benefits, control of irritable bowel symptoms, reduction of pathogenic
bacteria, and anticarcinogenic effects (Marquina et al., 2002; Guzel-Seydim et al., 2011). Over
400 species of bacteria live in the intestinal tract, but it is proposed that there are more, unculturable strains that also make up the intestinal microflora (Marquina et al., 2002). Bacteria
that inhabit the intestinal tract must be able to tolerate low pH, high bile concentrations, and must
be able to adhere to the intestinal surface to be successful (Marquina et al., 2002). From
fermented dairy products, bioactive peptides and proteins provide lymphocyte proliferation,
immunoglobulin production, hypertension reduction, and increased absorption of intestinal
calcium but also have an effect on pathogenic bacteria by producing bacteriocins, hydrogen
peroxide, organic acids, and by competitive adhesion to the epithelial lining of the gut (Marquina
et al., 2002; Guzel-Seydim et al., 2011; Ahmed et al., 2013). Kefir and other fermented dairy
products provide probiotics to the gut and increase overall health when consumed regularly
(Guzel-Seydim et al., 2000; Marquina et al., 2002; Guzel-Seydim et al., 2011).

Intestinal Flora
Beneficial probiotic microorganisms commonly found in food products are
Bifidobacteria species, L. acidophilus, Lactobacillus plantarum, Lactobacillus reuteri,
Lactobacillus rhamnosus, Lactobacillus salivarius, and Saccharomyces boulardii (Abraham and
de Antoni, 1999; Thoreux and Schmucker, 2001; Guzel-Seydim et al., 2011; Ahmed et al.,
2013). Fermented milk products, especially kefir, are capable of replenishing the natural lactic
intestinal flora in both the small and large intestines through competition and inhibition of
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undesirable microbes (Marquina et al., 2002; Santos et al., 2003; Sarkar, 2007). Exact benefit
highly depends on culture activity, temperature, time in storage, and level of contamination
within the intestine (Santos et al., 2003; Sarkar, 2007). Kefir is able to reduce undesirable
concentrations of Clostridia by two logs cfu/g in mice (Marquina et al., 2002; Sarkar, 2007).
Kefir is also able to prevent colonization by Campylobacter jejuni and Salmonella kedougou in
the cecum of chicks and reduce established C. jejuni by 6 to 7 logs cfu/g (Zacconi et al., 2003).
Kefir has the ability to improve the intestinal mucosa in young rats and increase intestinal
mucosal risk of infection in mice (Thoreux and Schmucker, 2001; Liu et al., 2002; Sarkar, 2007).
As animals age, serum IgA concentrations increase; however, mucosal antigenic
responses decrease which has been demonstrated in humans, rats, mice, and rhesus macaques
(Thoreux and Schmucker, 2001; Davras et al., 2018). Kefir provides multiple probiotic effects
and can stimulate gut immunomodulation, increasing IgA, and IgG response to antigens
(Thoreux and Schmucker, 2001; Davras, 2018). When supplemented orally for 7 days, IgG and
IgA increased in the lamina propria of mice (Davras et al., 2018). It increased production of
anti-inflammatory cytokines such as interleukins 4, 6, and 10, and transforming growth factor
beta in addition to reducing incidence of pro-inflammatory cytokines like interleukin-8 (Davras
et al., 2018). Kefir can be supplemented with Bifidobacteria species and is able to inhibit
Salmonella and Shigella in the intestines of infants within 7 to 11 days post infection with
normality after 4.8 ± 0.8 days compared with control infants with 12 to 18 days and 6.6 ± 0.9
days, respectively (Santos et al., 2003; Sarkar, 2007). Bifidokefir with 5 x 107 cfu/mL of
Bifidobacteria improved intestinal flora in humans and balanced the content of Bifidobacteria
compared with Lactobacilli (Sarkar, 2007). Additionally, pathogen populations decreased within
7 to 14 days (Sarkar, 2007).
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Hypocholesterolemia
Elevated cholesterol concentrations in the blood indicate high risk for cardiovascular
disease (Sarkar, 2007). Lactic acid bacteria in kefir are able to bind up to 33.9 percent of
cholesterol, decreasing intestinal content through bacterial flora (Sarkar, 2007). Using ewe’s
milk as a base can increase health benefits because ewe’s milk has greater concentrations of
linoleic and α-linoleic acids (Sarkar, 2007). Culture time and temperature of kefir grains in milk
also has an effect on the cholesterol abatement capacity of the beverage (Sarkar, 2007). Kefir
cultured at 24°C for 24 hours reduced plasma cholesterol content by 28 to 65 percent (Sarkar,
2007). When cultured at 24°C for 48 hours, reduction of plasma cholesterol improved to 41 to
84 percent (Sarkar, 2007).

Anticarcinogenic Properties
Fermented dairy products provide anticarcinogenic effects by binding mutagens and
inhibiting proliferation of tumors (Liu et al., 2002; Sarkar, 2007). Kefir has two characteristics
that encourage tumor suppression: the grain microflora and the kefiran polysaccharide matrix
produced during fermentation (Liu, 2002; Sarkar, 2007). Bacteria within the kefir culture
including Streptococcus, Lactobacillus, Leuconostoc, and Streptococcus lactis subsp. lactis were
all found to be principal mutagen binding bacteria with Lactobacillus species being the most
effective (Hosono et al., 1990; Guzel-Seydim et al., 2003; Sarkar, 2007). In mice, kefir fed at 2
g/kg of body weight for 9 days inhibited tumor growth more than yogurt (Sarkar, 2007). When
mice were dosed orally with 100 to 500 mg/kg of body weight with kefir, immunosuppression
was activated in the spleen and tumor size was drastically reduced (Ahmed et al., 2013). Kefir
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made using soy milk inhibited tumors by 70.9 percent opposed to cow’s milk kefir inhibition at
64.8 percent (Liu et al., 2002; Sarkar, 2007). The bioactive components in kefir have the ability
to suppress tumor growth through inhibition of enzymes that promote the conversion of
procarcinogen to carcinogen (Ahmed et al., 2013). These components are also able to inhibit
cancer initiation by activation of the immune system, which also decreases tumor growth if the
tumor is already established (Ahmed et al., 2013).
Kefir was able to induce apoptotic tumor lysis in mice as well when made from both
cow’s and soy milk and fed for 30 days (Liu et al., 2002). Milk proteins with an elevated
concentration of sulfur containing amino acids are effective as anticarcinogen components and
bacterial isolates have the ability to bind 97 percent of pyrolyzed, carcinogenic amino acids
(Hosono et al., 1990; Guzel-Seydim et al., 2003). Water soluble polysaccharides containing
kefir flora suppress tumors more than those without kefir flora if used after the tumor is
established, which is a result of the fermentation products and not the cells themselves (Sarkar,
2007; Guzel-Seydim et al., 2011; Ahmed et al., 2013). Increased consumption of the
polysaccharides is correlated with tumor suppression (Ahmed et al., 2013). Other components of
kefir such as CLA ([c9, t11], [t10, c12], and [t9, t11]), butyric, palmitic, palmitoleic, and oleic
acids are known to be anticarcinogenic, decreasing components such as methyl methanosulfate,
sodium azide, aflatoxin B1, N-methyl-N-nitro-N-nitrosoguanidine (MNNG), 1,1-diphenyl-2picryl-hydrazyl (DPPH), and 4-nitroquinoline-N-oxide (NQNO) (Guzel-Seydim et al., 2006;
Guzel-Seydim et al., 2011). Both milk and soymilk kefirs reduce mutagenesis of NQNO by 89.3
and 68.8 percent, respectively (Guzel-Seydim et al., 2006).
Conclusion
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Kefir is a fermented milk beverage that has been consumed for thousands of years.
Recently, it has been under intense observation due to its unique grain structure and symbiotic
relationship of probiotic microorganisms. The production of antimicrobial organic compounds
provides a self-preservation method but also a unique, refreshing, and healthy beverage. The
vast array of health benefits provided by kefir are becoming increasingly recognized but a
knowledge gap remains concerning which microflora combination provides the best product.
This diverse beverage is simple to produce and could reinvent the way nutrition is viewed in the
United States. Probiotic effects of this beverage need to be explored further as well as potential
prebiotic effects and diet supplementation. The impact of functional components from kefir on
cardiovascular health are also of interest and should further be explored. There is much work to
be done to improve functional foods globally.

NATTO

History of Natto
Natto, a fermented soybean product, is a common breakfast food in Asian countries
(Ichishima et al., 1982; Shurtleff and Aoyagi, 2012). Not to be confused with miso, natto is not
used in soups but rather eaten with rice (Kiuchi et al., 1976). It is suggested that natto was
discovered by mistake between 1051 and 1083 B. C. in northeastern Japan by Minamoto
Hachimantaro Yoshiie (Shurtleff and Aoyagi, 2012). Natto was not mentioned in the United
States until hundreds of years later in 1896 by scientist Henry Trimble (Shurtleff and Aoyagi,
2012). Historical records report the initial discovery of natto occurred when cooked and
packaged soybeans were transported in a horse saddle bag made of rice straw, where the culture
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remained moist, and the temperature was stable. The contaminating bacteria Bacillus subtilis
natto was able to grow and create what is now called natto (Shurtleff and Aoyagi, 2012). Natto
can also be made using Aspergillus oryzae, but this fermentation creates a different flavor profile
and is less common than fermentation using Bacillus subtilis (Kiuchi et al., 1976).
Characterized by the aroma and production of mucoid strings that appear similar to
strings of melted cheese, natto was mistaken for soy cheese until it was defined as its own dish in
the 1400’s (Shurtleff and Aoyagi, 2012) (Figure 1.5). In 1894, scientist Kikuji Yabe at the
Tokyo University of Japan, was able to isolate bacterial colonies from natto, but was unable to
distinguish the culture responsible for the characteristic fermentation of the soybeans. Later, in
1906, researcher S. Sawamura isolated B. natto (Ichishima et al., 1982; Hosoi and Kiuchi, 2003;
Steinkrauss, 2004; Shurtleff and Aoyagi, 2012). Sawamura used cedar to package the product
instead of the traditional rice straw. It is believed the cedar packaging kept natto pure without
the risk of other bacterial strains from traditional rice straw contaminating the product
(Steinkrauss, 2004). This process was further refined in 1912 by Dr. Sinsuke Muramatsu from
the Morioka College of Agriculture who set the optimal fermentation temperature of Bacillus
No. 1 at 45°C and recommended using this strain as a pure culture (Shurtleff and Aoyagi, 2012).
There are three strains of B. natto that grow naturally on rice straw, the original
packaging material traditionally used for cooked soybeans. One of the strains was selected based
on its superior fermentation characteristics (Steinkrauss, 2004; Shurtleff and Aoyagi, 2012). B.
subtilis and B. subtilis natto are different because B. subtilis does not require biotin for growth
whereas B. subtilis natto does, and growth is greatly enhanced with the addition of biotin to the
culture (Shurtleff and Aoyagi, 2012; Ichishima et al., 1982; Hosoi and Kiuchi, 2003). The genes
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for this difference are found on a plasmid, which is
likely why the strains differentiated (Tanaka et al.,
1977; Shurtleff and Aoyagi, 2012). B. subtilis
natto was, thus, isolated as a pure culture and is the
strain used globally for commercial production
(Tanaka et al., 1977; Shurtleff and Aoyagi, 2012).
Spores are sold either in a water suspension or
lyophilized for home starter cultures (Hosoi and
Kiuchi, 2003).

Figure 1.5. Soybeans fermented with
Bacillus subtilis natto bacteria for 24
hours at 37°C.

Dr. Jun Hanzawa from Hokkaido Imperial University’s Department of Agriculture was
the next contributor to modern natto where between 1919 and 1928, the pure bacillus culture was
commercialized and used consistently to make natto (Hosoi and Kiuchi, 2003; Shurtleff and
Aoyagi, 2012). Hanzawa also implemented thin pine packaging designed for incubation at room
temperature where rooms used for natto fermentation were fitted with a ceiling air vent,
increasing the success rate of natto fermentation and production (Hosoi and Kiuchi, 2003;
Shurtleff and Aoyagi, 2012). Once commercialized, natto expanded its presence in the United
States beginning in 1926 where several manufacturers produced natto in the Los Angeles area
(Shurtleff and Aoyagi, 2012). Strains of Bacillus subtilis natto were officially recognized in
1957 in the 7th ed. of Bergey’s Manual of Determinative Bacteriology (Sulistyo et al., 1988;
Hosoi and Kiuchi, 2003). This specific strain of Bacillus subtilis was officially recommended as
the optimal strain to use for fermentation because it provided the characteristic aroma, wrinkly
layer of bacteria on the soybeans, and the desirable stickiness, which are difficult qualities to
maintain with the starter culture (Sulistyo et al., 1988; Hosoi and Kiuchi, 2003).
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In 1965, Dr. Hiroshi Matsubara described subtilisin, a serine protease produced from
Bacillus subtilis bacteria (Kasper et al., 1965; Matsubara et al., 1965; Schurtlleff, 2012). Dr.
Hiroyuki Sumi at the Chicago University Medical School was the first to mention nattokinase, a
fibrolytic enzyme specific to natto in 1987, which is similar to subtilisin (Sumi et al., 1987;
Shurtleff and Aoyagi, 2012). In 2001, Dr. Masao Kanecki described vitamin K2 content in natto,
specifically menaquinone-7, which is known to be a component of calcium metabolism in the
body (Kanecki, 2001; Shurtleff and Aoyagi, 2012). Similarly, pyrroloquinoline quinone (PQQ) a
vitamin in the B family was discovered in large quantity in natto in 2003, adding to the
functional properties of the product (Kasahara and Kato, 2003; Shurtleff and Aoyagi, 2012)
These four substances, subtilisin, nattokinase, menaquinone-7, and pyrroloquinoline quinone
(PQQ), are all components that give natto its main health benefits to humans, making it a
desirable food for cardiovascular health.

Preparation of Natto
Natto is made by soaking soybeans, lightly boiling them until tender for 60 minutes and
fermenting them with 1 mL per 100 g of soybean at 108 cells/mL B. subtilis natto. The
fermentation conditions used are 40°C for 15 to 24 hours under humid conditions greater than 80
percent humidity (Sulistyo et al., 1988; Hosoi and Kiuchi, 2003; Couto and Sanroman, 2006;
Shurtleff and Aoyagi, 2012). Smaller soybeans are best because of the increased surface area for
contact with the culture. However, if soybeans are too small, substrate agglomeration can occur,
compromising the growth of the culture, and lowering the quality of the end product (Sulistyo et
al., 1988; Hosoi and Kiuchi, 2003; Couto and Sanroman, 2006) There are three popular kinds of
natto in Japan known as Itohiki-natto (1450), Yukiwari-natto (1975), and Hama-natto (1650)
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(Kiuchi et al., 1976; Hosoi and Kiuchi, 2003). While there are many variations of natto, these
three methods are predominant and are the most common forms of natto consumed.
Itohiki-natto is produced by fermenting soybeans for 16 hours at 42°C using Bacillus
subtilis natto and is the most common natto (Kiuchi et al., 1976; Shurtleff and Aoyagi, 2012). It
contains 10 to 20 percent salt, which is used as a deterrent for putrefaction from contaminating
bacteria (Hosoi and Kiuchi, 2003). Yukiwari-natto is made by mixing Itohiki-natto with rice,
salt, and koji, and letting it continue fermenting at 25 to 30°C for 15 days (Kiuchi et al., 1976).
Koji is the surface mold resulting from cooked soybeans being inoculated with Aspergillus
oryzae (Kiuchi et al., 1976). To make Hama-natto, koji is used as an enzymatic source for the
fermentation of cooked soybeans and is fermented for 6 to 12 months at 42°C (Kiuchi et al.,
1976). This method provides free amino acids post fermentation and has elevated levels of lipid
hydrolysis, which contribute to the characteristic taste of Hama-natto, similar to that of miso
(Kiuchi et al., 1976).
Another variation of natto known as Hikiwari-natto, or cracked natto, is made with beans
that are cracked prior to cooking. However, this method is less popular and is used mainly for
sushi (1975) (Kiuchi et al., 1976; Hosoi and Kiuchi, 2003; Shurtleff and Aoyagi, 2012). There
are forms of dry or hard natto; however, these were more popular before Japan’s infrastructure
improved after the Second World War because dried natto had a longer shelf life than fresh natto
(Hosoi and Kiuchi, 2003).
When cultured on nutrient agar at 37°C for 12 hours, the end product from Bacillus
subtilis natto fermentation is of lesser quality than if the inoculating culture is grown on soybean
extract agar under the same conditions (Sulistyo et al., 1988). Using a combination of 1 percent
sucrose, 0.5 percent NaCl, and 2.0 percent agar in soybean extract, the liquid removed after
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soybean steaming is completed, yields natto with better flavor, consistency, and stringiness, as
well as an increase in amino acid content (Sulistyo et al., 1988). Glutamic acids and fructans
determine the stickiness of natto, and glutamic acid production can be increased when Bacillus
subtilis natto is cultured with additional biotin and Mn++ (Sulistyo et al., 1988). Dry matter and
lipid content of Itohiki-natto decreased during the soaking and steaming but increased during
fermentation, whereas these parameters decreased after soaking for Hama-natto and increased
during koji making (Kiuchi et al., 1976). Overall, fermentation does not affect the concentration
of soybean lipids where free fatty acids comprise 5 to 18 percent of total lipid content where the
majority is triglyceride (Kiuchi et al., 1976). The addition of koji increased the free fatty acid
content of natto with each conditioning of koji during fermentation, 13.9 percent increasing to 47
to 60 percent respectively (Kiuchi et al., 1976). Bacillus subtilis natto does not produce lipase,
but when paired with koji, it is suggested that koji produces lipase, causing the observed increase
in free fatty acids in Yukiwari-natto and Hama-natto (Kiuchi et al., 1976).
Bacillus subtilis is also used to ferment other food sources to produce chemicals and
enzymes for human consumption (Krishna and Chandrasekaran, 1996; Couto and Sanroman,
2006). Wheat bran, corn bran, okara (soy pulp), red beans, and other byproducts have been
fermented to produce enzymes such as α-amylase, or antioxidants such as ethanolic extract, in
large quantities, but not many of these substrates are used as a food source for humans (Krishna
and Chandrasekaran, 1996; Chung et al., 2002; Zhu et al., 2010) When using Bacillus subtilis to
ferment 400 μm banana fruit stalk, α-amylase production is optimal (Krishna and
Chandrasekaran, 1996; Couto and Sanroman, 2006). Small particle size for solid state
fermentation using Bacillus subtilis increases the output of bacterial enzymes as observed with
glucoamylases from wheat bran as well as cellulases from coir pith (Krishna and
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Chandrasekaran, 1996; Couto and Sanroman, 2006). Thermostability of the amylases produced
by Bacillus subtilis vary depending on the substrate, moisture content and moistening agent,
temperature of incubation, surfactant presence, and availability of carbon, nitrogen, minerals,
amino acids, and vitamins (Krishna and Chandrasekaran, 1996; Couto and Sanroman, 2006).
The manipulation of these parameters optimizes the production of the desired enzymes when
using Bacillus subtilis as the bacterial inoculant (Krishna and Chandrasekaran, 1996; Couto and
Sanroman, 2006).
Natto has a natural antioxidative capacity that is greater than that of steamed soybeans
(Chung et al., 2002). Many legumes contain phenolic compounds, which are known to have
antioxidative properties, but Bacillus subtilis IMR-NK1 is a bacterium that produces superoxide
dismutase, which separates superoxide into oxygen and hydrogen peroxide (Chung et al., 2002).
Due to the elevated concentration of phenolic compounds in natto, it is likely that spoilage
occurs at a reduced rate because phenolic compounds are known to reduce lipid oxidation
(Chung et al., 2002). It is unknown if legumes other than soybeans can produce a similar,
consumer acceptable product, with equivalent, or greater health benefits compared with soybeans
and red beans.

Flavor Profile of Natto
During the fermentation process, soybeans are penetrated by B. subtilis natto, breaking
down peptides during fermentation to produce viscous strings made of 58% γ-polyglutamic acid
and 40% polysaccharides including fructans synthesized from soybean proteins and sugars
(Kiuchi et al., 1976; Ichishima et al., 1982; Besson et al., 1997). In mammalian nutrition,
glutamic acid is not considered an essential amino acid. However, glutamic acid is used in the
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production of protein within the body, to coagulate milk as a replacement for calf rennin during
cheese making, and also to yield vitamin K after post-translational modification (Kanecki et al.,
2001; Shieh et al., 2009). Glutamic acid causes the natto to have a savory flavor to humans,
contributing to the taste (Besson et al., 1997).
Free fatty acids as well as alkylpyrazines found within the viscous strings also contribute
to the flavor of the natto. The flavor becomes stronger as fermentation time increases (Kiuchi et
al., 1976; Besson et al., 1997). Specifically, 2,5-dimethylpyrazine and tetramethylpyrazine,
common flavoring agents of either Maillard reaction or microbial origin, are used in the food
industry to provide a nutty or roasted flavor (Kosuge et al., 1962; Besson et al., 1997; Couto and
Sanroman, 2006) Both of these compounds are produced during fermentation using Bacillus
subtilis, and Bacillus subtilis natto, and contribute to the strong flavor of natto in addition to
acetoin and 2,3-butanediol (Kosuge et al., 1962; Kanno and Takamatsu, 1987; Besson et al.,
1997; Couto and Sanroman, 2006). Volatile fatty acids found in natto include acetic, propionic,
iso-butyric, 2-methylbutyric, 3-methylbutyric, citric, malic, succinic, lactic, formic,
pyroglutamic, iso-valeric, and n-valeric acids (Kanno and Takamatsu, 1987; Sulistyo et al.,
1988). During fermentation, citric acid content decreased to trace amounts and was converted to
acetic acid (Sulistyo et al., 1988). Between 10 and 12 hours of fermentation, acetic acid
decreased slightly and then increased after 12 hours (Kanno and Takamatsu, 1987). Iso-valeric
and iso-butyric acids increased during the fermentation process as well (Kanno and Takamatsu,
1987; Sulistyo et al., 1988). Acetoin and 2-butanediol increased between 8 and 12 hours of
fermentation to 495 mg/100g and 748 mg/100 g, respectively (Kanno and Takamatsu, 1987).
Propionic acid content increased after 14 hours of fermentation during the maturation
stage to 6.1 mg/100 g and continued to increase during storage in response to the temperature
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(Kanno and Takamatsu, 1987). At 25°C after 15 days, propionic acid reached a maximum
concentration of 65.2 mg/100 g (Kanno and Takamatsu, 1987). Isobutyric, 2-methylbutyric, and
3-methylbutyric acids are all present after 12 hours of fermentation (Kanno and Takamatsu,
1987). When left to mature, maximum concentrations of these branch chain acid include
isobutyric acid up to 85.5 mg/100g, 2-methylbutyric acid at 66.5 mg/100g, and 3-methylbutyric
acid at 25.5 mg/100g (Kanno and Takamatsu, 1987).
Odor compounds also play a role in the acceptability of soybeans in the human diet
(Sugawara et al., 1985). Natto is the only soybean product that does not have the distasteful odor
of regular soybeans (Sugawara et al., 1985). Cooking soybeans for up to 8 hours still provides
the characteristic soybean smell, which is a result of hexanal, 3-methyl-1-butanol, hexanol, and
1-octen-3-ol, the four major soybean odor molecules (Sugawara et al., 1985). There are some
sulfur containing compounds in addition to furfuryl alcohol, which become more prominent as
soaking and cooking times increase (Sugawara et al., 1985). These compounds contribute to the
sweet and roasted flavor of cooked soybeans (Sugawara et al., 1985). The main compounds
responsible for the distasteful flavor and odor of soybeans are 2-pentylfuran, and 1-octen-3-ol,
both of which are heat stable compounds (Sugawara et al., 1985). Hexanal, hexanol, and (E)-2hexanal, however, are not heat stable and concentrations are drastically reduced during the
cooking process (Sugawara et al., 1985). Overall, the main components of natto that provide the
distinct flavor are attributed to the sulfur containing compounds produced during the cooking
step and the pyrazines formed during fermentation in addition to free 2-methylbutyric acid
(Sugawara et al., 1985; Kanno and Takamatsu, 1987). The removal of the hexane compounds
during cooking is likely where the undesirable cooked soybean flavors are lost in the natto
fermentation process (Sugawara et al., 1985).
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Although it is made in small batches and is recommended to be consumed quickly, natto
can be kept up to two weeks until the desired thickness is achieved and, in turn, the desired
flavor from aging of the viscous layer is reached (Kiuchi et al., 1976; Steinkrauss, 2004,). This
process tends to occur between the third and sixth day of aging as B. subtilis natto cells autolyze,
but proteolysis continues, contributing to the flavor of the dish (Tanaka et al., 1977; Besson et
al., 1997). Tetramethylpyrazine is produced in much larger quantities around day 12 whereas
2,5-dimethylpyrazine is produced in higher quantities earlier in incubation (Kosuge et al., 1962;
Besson et al., 1997) The 2,5-dimethylpyrazine is synthesized from L-threonine whereas
tetramethylpyrazine is synthesized from acetoin and free fatty acids. The concentrations of these
components peak at day 2. Therefore, depending on the quality of the soybeans, the flavor may
be subject to change (Kosuge et al., 1962; Besson et al., 1997; Zhang et al., 2014). The smell of
ammonia becomes apparent after two or four days when natto is stored at 25°C or 15°C,
respectively (Kanno and Takamatsu, 1987). Complete deterioration of natto can occur as early
as two or seven days, depending on the storage temperature (Kanno and Takamatsu, 1987).
While natto can still be consumed after up to two weeks in storage, there is precipitation of
tyrosine, and ammonium magnesium phosphate, which have the appearance of white dots on the
beans (Kanno and Takamatsu, 1987). Low storage temperatures are better when storing natto for
long periods of time to maintain the integrity of the product for as long as possible (Kanno and
Takamatsu, 1987).

Health Benefits of Natto
Enzymes and other beneficial substances are also produced during the fermentation
process such as subtilisin, nattokinase, α-amylase, alkaline proteinase, vitamin B12, fibrinolysis
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accelerating substance, menaquinone-7 (vitamin K2), and dipicolinic acid (DPA) (Kiuchi et al.,
1976; Ichishima et al., 1982; Sumi et al., 1995; Matsubara et al., 1998; Sumi et al., 2004; Oshugi
et al., 2005). Vitamin B12 is produced in the rumen of ruminant animals and ruminant meat is
the largest source of mammalian vitamin B12 in the human diet. However, natto is one of the
only plant-based sources of vitamin B12, another being algal B12, for human consumption
(Ichishima et al., 1982; Watanabe et al., 2002; Watanabe, 2007). Vitamin B12 is important for
nerve function and the production of DNA in the human body and has a large impact on red
blood cell replication. For populations of humans who do not consume ruminant products, natto
can be an alternative source of vitamin B12 from the diet.
A natto bacterium on its own is considered a probiotic in the gut (Minikawa, 2003).
When natto is consumed, the low pH of stomach acid drives sporulation of Bacillus subtilis
natto. Typically, these spores do not have enough time in the rest of the digestive tract to
germinate and populate the intestines (Minikawa, 2003). Bacillus subtilis natto in the intestine
has an antibacterial effect on undesirable bacteria and is able to outcompete these organisms
(Minikawa, 2003). When delivered in a capsule, Bacillus subtilis natto is able to colonize the
gut and improve food digestion and absorption, reduce incidence of constipation and diarrhea,
decrease blood pressure, improve symptoms of pancreatitis, reduce effect of carcinogens, and
prevent thrombus formation as well as osteoporosis (Minikawa, 2003). A thrombus is formed
with tight, crosslinked fibrin proteins that is meant to prevent blood loss but can have detrimental
effects if not properly degraded after the wound has healed.
Fibrin, the active form of fibrinogen, is formed when platelets in the blood stream
encounter damaged areas within the vessel and membrane phospholipids are activated to form a
clot. Thereafter, fibrinogen forms tough fibrin threads to block the flow of blood, reducing blood
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loss (Sumi et al., 2004; Kwon et al., 2011; Chapin and Hajjar, 2015). Increased fibrin stabilizes
a clot but also makes it more difficult for the clot to deteriorate, which may block blood flow
elsewhere if the clot detaches prior to degradation (Sumi et al., 1995, Chapin and Hajjar, 2015).
In the case of cardiovascular diseases, this process can lead to death and is the cause of 31% of
deaths worldwide (Fujita et al., 1993; Chapin and Hajjar, 2015; Chen et al., 2018). Subtilisin is a
strong proteolytic enzyme, similar to nattokinase, which breaks peptide bonds within the
legumes, allowing for deeper penetration of the bacteria as fermentation progresses (Fujita et al.,
1993; Matsubara et al., 1998; Shurtleff and Aoyagi, 2012). The proteolytic effect of subtilisin
can decrease the incidence of blood clots; however, nattokinase is much more effective at
reducing the risk of blood clots.
Nattokinase is an alkaline protease of 275 amino acid residues that has fibrinolytic,
antithrombotic, antihypertensive, anti-atherosclerotic, antiplatelet, anticoagulant, lipid lowering,
and neuroprotective properties (Kwon et al., 2011; Chen et al., 2018). Nattokinase is the only
natural substance from plants that has such a resounding positive effect on cardiovascular health
and out-competes any synthetic substance currently on the market (Kwon et al., 2011; Chen et
al., 2018). Nattokinase is four times more potent than plasmin in degradation of thrombi and has
high efficacy especially for an oral supplement (Fujita et al., 1993; Sumi et al., 2004; Chen et al.,
2018). When compared to commercial blood thinners, nattokinase has greater potency with
fewer side effects such as inhibition of platelet aggregation, which enables it to slow the
progression of plaque formation while reversing atherosclerosis (Fujita et al., 1993; Okamoto et
al., 1995; Chen et al., 2018).
Nattokinase decreases hypertension by inhibiting angiotensin-converting enzyme, which
is responsible for production of angiotensin, a hormone that raises blood pressure (Okamoto et
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al., 1995; Chen et al., 2018). It is also capable of degrading amyloid fibrils, which play a role in
progression of Alzheimer’s disease (Sumi et al., 1995; Chen et al., 2018). Nattokinase has many
beneficial characteristics related to human cardiovascular health, which is why consuming natto
is useful to more than just the digestive system (Fujita et al., 1993; Sumi et al., 2004; Chen et al.,
2018). Dipicolinic acid (DPA) also has an anticoagulant effect and inhibits formation of fibrin
(Ichishima et al., 1982; Oshugi et al., 2005). B. subtilis natto produces DPA because it is a spore
forming bacterium. DPA binds tightly to calcium and water molecules within the core,
dehydrating the spore, thus protecting DNA from degradation during excessive heating, enabling
survival through extreme temperatures such as cooking and low pH such as when entering the
digestive system (Oshugi et al., 2005). Sporulation also allows habitation of the small intestine,
which increases weight gain, feed efficiency and fecal flora composition in poultry and humans
(Terada et al., 1999; Samanya and Yamauchi, 2002; Hong et al., 2009). Combined with the
effects of nattokinase, DPA increases the cardiovascular health benefits of consuming natto.
Vitamin K is also an important component of the cardiovascular system and bone
structure. Vitamin K acts as a posttranslational cofactor for modification of glutamic acid
residues to form γ-carboxyglutamic acid residues, which are important in binding and retaining
free calcium (Kanecki et al., 2001; Schurgers et al., 2007). The liver, kidney, spleen and
placental tissues also require the presence of vitamin K and its derivatives for normal function
(Kanecki et al., 2001; Schurgers et al., 2007). Vitamin K1, or phylloquinone, is a blood
coagulation factor found in leafy green vegetables. Vitamin K2, menaquinone-n, is a bone
density factor created by two different sources, animal metabolism or bacterial fermentation
(Kanecki et al., 2001, Schurgers et al., 2007). Menaquinone-4 is produced by animal tissues,
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whereas menaquinone-7 (MK-7) is only produced by bacterial fermentation and is abundant in
natto (Kanecki et al., 2001; Schurgers et al., 2007; Berenjian et al., 2012).
In natto, glutamic acid is produced in the mucoid strings. Glutamic acid is a precursor for
the beneficial γ-carboxyglutamic acid residues needed in the body that not only bind free
calcium, but are also involved with osteocalcin, a protein that drives calcium into bones
(Schurgers et al., 2007; Berenjian et al., 2012). This process helps prevent osteoporosis and
maintains bone health, providing strength against fractures specifically in the neck and hip
regions where older individuals are likely to have impact fractures (Schurgers et al., 2007).
Natto is currently the most vitamin K2 dense food available (Kanecki et al., 2001; Schurgers et
al., 2007; Berenjian et al., 2012). Therapeutically, MK-7 can be used to alleviate symptoms of
bone and cardiovascular diseases (Schurgers et al., 2007; Berenjian et al., 2012).
Menaquinone containing isoprene side chains and a quinone skeleton (1,4naphthoquinone) rely on rapidly metabolizable carbon sources such as glucose, fructose, and
glycerol during fermentation (Berenjian et al., 2012). Glycerol requires the least additional
enzymes in order for it to be used by Bacillus subtilis during fermentation, which enables MK-7
to be produced large scale (Berenjian et al., 2012). By adding glycerol at 48 hours of
fermentation as a carbon source to the natto culture, MK-7 production increases by eight percent,
providing increased health benefits from a single food source (Kanecki et al., 2001; Schurgers et
al., 2007; Berenjian et al., 2012). It was determined that two percent glycerol was the optimal
level for increasing output of MK-7 (Berenjian et al., 2012). Glycerol addition increases the total
growth of the bacteria and reduces viscosity of the solution, which increases oxygen flow and is
likely a cause in the increased growth of bacteria and production of MK-7 (Berenjian et al.,
2012).
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Soybeans fermented with B. subtilis natto are a great source of enzymes and proteins that
benefit the human digestive and cardiovascular system greatly. The question remains, however,
if fermented soybeans are the only legume capable of creating such vast amounts of these
substances. While there are other substrates that have been fermented by B. subtilis natto to
create different enzymes or antioxidants, it is unknown if natto made from soybeans is the only
legume that is both acceptable to the consumer as well as beneficial to the health of humans,
specifically with attention to cardiovascular health. Beginning with chickpeas and lentils, two
common legumes in the American diet, it will be necessary to ferment these substrates using B.
subtilis natto to determine if the same products will be present, and in what quantity. If
traditional Japanese natto can be made with a variety of legumes, there may be an entirely new
market available in the American food industry.

BORON

History of Boron
Boron use was first recorded in approximately 1900 B.C. by the Babylonians (Woods,
1994). Imports of boron from the Far East were used as flux to work gold and in other
metallurgic processes, or as ingredients for medicinal remedies or mummification (Woods, 1994;
Messner et al., 2022). In the 12th century, use of boron as a flux for goldsmithing spread to
Europe (Woods, 1994).
In the 8th century, boron trading was reported in Mecca, Medina, and China originating
from Arabic traders selling mineral borax, known as tinkar, for medicinal purposes (Travis and
Cocks, 1984; Woods, 1994; Messner et al., 2022). Boric acid was used as a mild antiseptic and
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eye wash and was also used as a preservative for meat and dairy foods for a period of time until
it was thought to be toxic (Messner et al., 2022). Tibetan lakes are credited with being the
earliest source of borax, or sodium borate, which was transported across the Himalayan
Mountains toward India in bags carried by sheep (Travis and Cocks, 1984; Woods, 1994).
Boron was not recognized as an element until 1808 when Sir Humphry Davy reported
findings on boric acid reduction and isolation by potassium addition, which he originally named
boracium (Davy, 1809; Woods, 1994; Bedasso, 2015). Joseph Luis Gay-Lussac and Louis
Jacques Thenard are also credited with the discovery of boron, using iron to reduce and air to
oxidize boron to boric acid, a weak acid also known as hydrogen borate (Gay-Lussac and
Thenard, 1808; Weeks, 1932; Bedasso, 2015). The product discovered by Davy, Gay-Lussac,
and Thenard was not pure elemental boron; elemental boron was not isolated until nearly a
century later (Weeks, 1932; Bedasso, 2015). In 1824 boron was recognized as an element,
resulting from the work of Jons Jacob Berzelius, but the isolation of pure boron is credited to
Ezekiel Weintraub in 1909 (Bedasso, 2015). Boron does not occur in its purified form in nature,
which caused determination of the atomic mass to span several decades (Baxter and Scott, 1921;
Woods, 1994; Marschall and Foster, 2018; Bialek et al., 2019). Instead, the volatility of boron
allows the element to complex with steam, carbon, and other elements to form borate, boric acid,
calcium fructoborate, or borax compounds (Bolanos et al., 2004; Bialek et al., 2019) (Figure
1.6).
Deposits of boron compounds are found mostly in basalts (5 mg B/kg), shales (100 mg
B/kg), and the ocean (4.5 mg B/kg; Bolanos, et al., 2004; Bialek et al., 2019). These boron rich
deposits in the Earth’s crust are not distributed evenly across the Earth’s surface but instead,
boron is most predominantly found in Turkey, Russia, and parts of the United States, but can
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also be found in China, Chile, Argentina, Peru, Iraq, Bolivia, Syria, Egypt, Libya, and Morocco
(Woods, 1994; Bhaskar et al., 2015; Bialek et al., 2019). Since 1865, Turkey has produced over
70% of the world’s raw boron compounds providing mainly calcium borate pandermite, tincal,
ulexite, colemanite, refined borax decahydrate, borax pentahydrate, anhydrous borax, and boric
acid (Woods, 1994; Bhaskar et al., 2015; Turkbay et al., 2022). In 1913 in the United States,
California and Nevada first produced ulexite and colemanite (Woods, 1994). In 1925 and 1926,
tincal ore and rasorite were discovered, and supported American boron production for the next
50 years, which would later include borax pentahydrate and decahydrate as well as anhydrous
borax and boric acid (Woods, 1994). Currently, Turkey (73.4%), Russia (7.8%), and the United
States (6.2%) produce the world’s supply of boron of which are mainly in the forms of tincal,
colemanite, and ulexite (Turkbay et al., 2022).

Figure 1.6. Borate, boric acid, and calcium fructoborate 2D chemical structures
adapted from the National Center for Biotechnology Information (2022).

73

Demand for boron and boron compounds has increased over time due to its wide variety
of uses and improved development of industrial technology (Turkbay et al., 2022). Industries
such as the glass industry use boron to improve the quality of glass (Turkbay et al., 2002).
Boron improves resistance to vibration, thermal fluctuations, and chemical use, it increases
durability and decreases thermal expansion (Devirian and Volpe, 2003; Turkbay et al., 2022).
The ceramic industry has similar uses for boron compounds including an increase in resistance to
chemicals and thermal stressors (Devirian and Volpe, 2003; Turkbay et al., 2022). Boron has
been used in the home since the 1900’s mainly in laundry detergents because of its affinity for
binding calcium ions found in hard water (Devirian and Volpe, 2003; Turkbay et al., 2022).
Boron is also added to agricultural fertilizers to improve yield of fruit and seed production as
many plants, especially those for human or animal consumption, have a nutritional requirement
for boron (Bolanos et al., 2002; Bolanos et al., 2004; Bialek et al., 2019; Turkbay et al., 2022).

Boron Chemistry
The origin of elemental boron was derived from Big Bang nucleosynthesis, similar to
elements such as lithium and beryllium (Bolanos et al., 2004). Boron is a d-orbital subshell
transition element with three valence electrons, an empty p-orbital, and an atomic weight of
10.81 in the metalloid and semiconductor groups of the periodic table (Devirian and Volpe,
2003; Bhaskar et al., 2015; Fernandes et al., 2019; Legare et al., 2019). Boron’s properties fall
between the metals and non-metals in group IIIA as a strong, electrophilic, Lewis-acid
(Braunschweig et al., 2006; Bhaskar et al., 2015; Fernandes et al., 2019). The d-orbital subshell
can carry 10 electrons total; however, elemental boron contains only three valence electrons
making it possible for boron to interact with smaller molecules and form unique bonding patterns
74

because of fluctuations in electron density and deficiency (Braunschweig et al., 2006; Legare et
al., 2019).
Similar to carbon and silicon, boron transition metal complexes are electron-precise twocenter, two-electron metal-boron bonds (Braunschweig et al., 2006). These complexes are more
commonly found in the electron deficient state in metalloboranes and transition-metal borides
(Braunschweig et al., 2006). Boron, like silicon, is electropositive, meaning it is capable of
reacting with other electropositive metals (Braunschweig et al., 2006; Legare et al., 2019).
Reactivity can occur in one of three main ways for boron including formation of stable electron deficient complexes with low lying vacant boron-centered orbitals able to react with H2 and C-H
bonds, B-B single and multiple bonds able to bind CO, alkynes, and H2, and hypovalent boron
species which are able to bind CO, H2, and N2 (Braunschweig et al., 2006; Legare et al., 2019).
Biologically, the empty p-orbital allows for dative bonds with biological nucleophiles (Fernandes
et al., 2019). In enzymes, carbohydrates, and nucleic acids, boron complexes with hydroxyl and
amine groups and can be converted from a trigonal planar sp2 to tetrahedral sp3 hybridization
dependent upon physiological conditions in the body (Devirian and Volpe, 2003; Hunt, 2012;
Fernandes et al., 2019). Due to its unique chemistry and low risk of toxicity, it is possible boron
has a greater impact on physiology than previously recognized (Devirian and Volpe, 2003;
Legare et al., 2019; Lewis, 2019; Turkbay et al., 2022).

Boron Mechanics
It has been well documented that boron is a necessary component in plant, diatom, and
certain species of algal development (Bolanos et al., 2002; Bolanos et al., 2004). To be
considered essential, an element must follow three main criteria; a deficiency causes life cycle
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failure, the deficiency is specific to that element and substitution from another element is not
possible, and it must have direct action in the nutrition of the organism (Arnon and Stout, 1939;
Lewis, 2019). In the early 1920’s, boron was determined to be an essential micronutrient for
plant growth, cell wall structure, membranes, membrane-associated reactions, pollen tube
growth, nitrogen fixation and germination (Bolanos et al., 2002; Devirian and Volpe, 2003;
Bolanos et al., 2004; Lewis, 2019). The claim that boron is essential, however, has not been
confirmed biochemically (Bialek et al., 2019; Lewis, 2019). While multiple reports have been
made of the positive impact boron has on plant growth and health, there is no consensus about
the primary role boron has concerning mechanisms by which the independent chemical and
biological functions occur (Bolanos et al., 2004; Lewis, 2019). Boron chemistry is not yet well
understood especially in biochemical and physiological settings (Bolanos et al., 2004). Although
boron is believed to be an essential micronutrient, this fact has not been officially established. It
has been widely accepted among plant researchers that boron is in fact an essential micronutrient
for plant growth and reproduction due to the deficiency of boron leading to rapid degradation of
biochemical, physiological, and anatomical functions in plants (Devirian and Volpe, 2003;
Bialek et al., 2019; Lewis, 2019). The primary functions of boron in the plant and animal is
largely unknown (Bolanos et al., 2004; Lewis, 2019).
In microorganisms, however, some bacteria have been reported to also require boron for
proper growth and reproduction (Bonilla et al., 1990; Bolanos et al., 2002; Bolanos et al., 2004).
Heterocystous cyanobacteria, an ancient family of bacteria, Frankia, Actinomycetes,
Azotobacter, Nostoc muscorum, Calothrix parietina, and Anabaena cylindrica have a boron
requirement for cell envelope stability specifically for protection against nitrogenase-poisoning
oxygen species when grown under N2 fixing conditions, all of which are involved in nitrogen
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fixation in some regard (Bonilla et al., 1990; Berry et al., 1991; Bolanos et al., 2002; Bolanos et
al., 2004). While bacteria are not known to require boron, species such as Rhizobium involved in
legume root nodule growth also require boron to maintain symbiosis and growth (Bonilla et al.,
1990; Berry et al., 1991; Bolanos et al., 2002). The commonality between these bacteria is the
multilaminate vesicle wall containing glycolipids and neutral lipids with long-chain polyhydroxy
fatty acids or alcohols, which function as free diol groups that complex well with borate found in
the soil (Berry et al., 1991; Bolanos et al., 2002; Bolanos et al., 2004). Without boron,
glycoproteins are able to attach to rhizobial cell surfaces, drastically reducing the interaction
capacity those bacteria have with plant cell walls ultimately decreasing nitrogen fixation (Berry
et al., 1991; Bolanos et al., 2004). When exposed to calcium, however, nodules in boron
deficient pea plants are able to re-establish and develop under salt-stress (Bolanos et al., 2004).
The impact of calcium on boron deficiency is suggested to be a result of calcium stabilizing
boron complexes within the plant (Bolanos et al., 2004). When a plant is intentionally deprived
of boron, calcium concentrations in bacteria, cell envelopes, membrane bound calcium, and
boron cross-linkage with calcium in roots drastically decreases (Bolanos et al., 2004). It is also
suggested these linkages between boron and calcium have an important role in signaling events
within plants as can be reported by the impact of boron on the relationship between Rhizobium
and root nodules (Bolanos et al., 2004). Other signaling molecules which boron complexes
include nucleic acids, nucleotides, adenylates, guanylates, oxidized nicotinamides, and others
(Bolanos et al., 2004; Fernandes et al., 2019). Boron compounds (boric acid and borate)
complex with some vitamins such as pyridoxine, riboflavin, and dehydroascorbic acid, as well as
a variety of sugars and compounds containing a cis-hydroxyl group such as polysaccharides,
phosphoinositides, glycoproteins, apiose and glycolipids, all of which have a role in structural
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stability of plant cells (Devirian and Volpe, 2003; Bolanos et al., 2004; Hunt, 2012).
Rhamnogalacturonan-II-boron (RG-II-B) is a prime example of boron complexing with pectin to
create strength in cell walls of plants (Bolanos et al., 2004; Hunter et al., 2019).
Boron also binds strongly with furanoid cis-diols such as erythritan and ribose, which can
impact metabolic pathways in times of deficiency because ribose is a key component of
nicotinamide adenine dinucleotide (NAD+) and nicotinamide adenine dinucleotide phosphate
(NADP) (Devirian and Volpe, 2003). It has been suggested that one way boron influences
metabolism is by binding to substrates and cofactors, inhibiting activity by creating transition
state analogs (Hunt, 1998; Devirian and Volpe, 2003). Borate complexes tend to have a lower
pKa than free boric acid (9.25) in the body (Hunt, 1998). This has an impact on enzymatic
mechanisms in the sense that boron complexes directly impact and change the pH of the system
actively inhibiting enzymatic function (Hunt, 1998). Phosphoglucomutase, γ-glutamyl
transpeptidase, glyceraldehyde-3-phosphate dehydrogenase (GPD), glucose-6-phosphate
dehydrogenase, and glycolytic enzymes are all inhibited by the presence of boron (Devirian and
Volpe, 2003). GPD and glucose-6-phosphate dehydrogenase inhibition directly impacts the
Pentose Phosphate Pathway (PPP) reducing available NADPH, in turn reducing oxygen
requirements in the body (Devirian and Volpe, 2003). Reduction in γ-glutamyl transpeptidase
activity from boron addition also increases glutathione concentrations, increasing antioxidative
success in the body (Devirian and Volpe, 2003). Although boron does not directly act as an
antioxidant, it has an indirect impact on the removal of radical oxygen species from cellular
tissues of plants and animals (Devirian and Volpe, 2003).
Boron is involved in mineral metabolism of Ca, P, Al, Mg, and in metabolism of
triglycerides, glucose, amino acids, reactive oxygen and nitrogen species, vitamin D3, estrogen,
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testosterone, and some enzyme and antioxidant mechanisms (Devirian and Volpe, 2003;
Rogoveanu et al., 2015; Bialek et al., 2019; Hunter et al., 2019). Normal biological conditions
have an almost neutral pH at which boron is present as boric acid (B(OH)3) at a 96%
concentration (Devirian and Volpe, 2003; Bolanos et al., 2004; Smoum et al., 2012). Small
amounts of the borate anion (B(OH)4-) are also present under normal conditions at smaller
concentrations (Devirian and Volpe, 2003; Bolanos et al., 2004). Due to the high solubility of
borates, boron is present in plant and animal tissue as borate complexes and is in larger quantities
in plant than animal tissues (Devirian and Volpe, 2003). On average, it is estimated that boron
concentrations fall in plants and animals between 30 to 50 ppm (Devirian and Volpe, 2003).
Plants are only able to absorb organic forms of boron from the soil where availability varies
depending on soil type, pH, fertilizers, temperature, and microflora, which can alter the
concentration of boron in plant tissue (Devirian and Volpe, 2003; Bialek et al., 2019). Fruits,
vegetables, tubers, and legumes have greater amounts of boron than grasses such as corn, rice,
and wheat (Devirian and Volpe, 2003; Bialek et al., 2019).
Nearly 100% of inorganic boron is absorbed when consumed by animals as compared
with organic forms of boron (Devirian and Volpe, 2003). Boron is readily absorbed across the
gastrointestinal epithelia and across mucous membranes in animals (Devirian and Volpe, 2003).
Concentration of boron in animal tissues varies, suggesting tissue requirements and storage of
boron vary (Devirian and Volpe, 2003). It appears boron compound intake from animal sources
could require less daily consumption compared with plant sources, despite plant sources having a
greater concentration of boron (0.1 to 0.6 mg B/100g vs. 0.01 to 0.06 mg B/100g, respectively)
because the bioavailability from animal sources could be greater (Devirian and Volpe, 2003;
Hunter et al., 2019; Kome et al., 2019). In human blood, total boron concentrations are 15.3 to
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79.5 ng/g with 98.4% being boric acid and 1.6% present as borate anion (Devirian and Volpe,
2003; Hunt, 2012). Human plasma has similar concentrations of boron compared with rats,
chicks, cows, lambs, pigs, and horses (Hunt, 2012). The greatest concentration of boron in the
human body is present in bone, fingernails, toenails, and hair (4.3 to 17.9 ppm) compared to
whole blood serum (0.02 ppm) and urine (0.75 ppm) (Devirian and Volpe, 2003; Hunt, 2012).
Soft tissues such as liver, spleen, lung, kidney, muscle, and brain tissue contain < 3 ppm of boron
each whereas heart (28 ppm) and rib tissue (10.2 ppm) contained greater concentrations
(Devirian and Volpe, 2003). Human liver content of boron is similar to that of chicks and cows
(Hunt, 2012). Soft tissues in the body do not accumulate boron and will plateau at 15 ppm
because excess boron is excreted when consumed in excessive amounts greater than 18 to 20
mg/d (Devirian and Volpe, 2003). Death does not occur from over consumption of boron but
rather renal damage or circulatory shock with symptoms including induced riboflavin deficiency
(Devirian and Volpe, 2003). When one or more of these systems is compromised, it is possible
to achieve toxicity through lack of excretion of boric acids in the urine (Bialek et al., 2019).
Intakes of >84 mg B/kg daily can cause neurological, gastrointestinal, cardiovascular, hepatic,
and nephritic damage in humans (Bialek et al., 2019). However, bone tissue will continuously
store boron when supplemented beyond normal daily intake and will increase beyond 47 ppm
indefinitely, indicating that boron could have a major role in bone health and metabolism
(Devirian and Volpe, 2003; U.S. Department of Health and Human Services, 2010; Uluisik et al.,
2018).
In a study on boron requirements, it was reported that chicks require 1 ppm/d of dietary
boron for normal homeostatic function (Nielsen, 1988; Devirian and Volpe, 2003). Intakes of
0.3 to 0.4 mg/d had a significant positive impact on bone mineral metabolism (Nielsen, 1988;
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Devirian and Volpe, 2003). Speculation from a study determining the boron requirements of
chicks indicated that humans require at least 0.2 mg/d of boron intake with the benchmark
requirement falling between 1 to 2 mg/d of boron intake (Nielsen, 1988; Devirian and Volpe,
2003; Messner et al., 2022). Currently, the World Health Organization recommends a dietary
intake of 0.4 mg B/kg of body weight in adult humans (Messner et al., 2022). Boron deficiency
has non-specific symptoms so when deprived of boron, growth in animals is stunted along with
abnormalities in bone development and increased urinary calcium excretion. Boron deficiency
exacerbates vitamin D3 and magnesium deficiency and causes enlarged kidney and spleen tissue
as well as common bone diseases such as arthritis, bone density loss, and osteoporosis (Devirian
and Volpe, 2003; Mogosanu et al., 2016). In plants, these symptoms are mirrored in depressed
growth in roots, buds, flowers, and leaves as well as causing deformities in vegetative parts
(Bialek et al., 2019; Nielsen and Eckhertt, 2020). Borates and boric acid bonds cannot be
degraded in the body due to the large amount of energy needed (523 kJ/Mol) to break the bonds
between boron and oxygen (Bialek et al., 2019). However, when borates complex with
biological molecules, these bonds are reversible and tend to be between thiols, amino, and
hydroxyl groups such as the hydroxyl group in estrogen, testosterone, and vitamin D3 (Bialek et
al., 2019).
Supplemental dietary boron was reported to ameliorate vitamin D3 deficiency in chicks
(Hunt and Nielsen, 1988; Devirian and Volpe, 2003). Supplementation of 1 to 3 mg/kg/d of
boron increased growth rate by 38%, plasma calcium, glucose, triglyceride, β-hydroxybutyrate,
triiodothyronine, cholesterol, and plasma alkaline phosphatase concentrations in chicks (Hunt
and Nielsen, 1981; Hunt and Nielsen, 1988; Elliot and Edwards, 1992). With adequate vitamin
D3, boron supplementation had only an 11% growth rate increase, but rachitic bone (brittle bone)
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incidence decreased (Hunt and Nielsen, 1981; Devirian and Volpe, 2003). When deficient in
magnesium, supplemental boron has a similar effect in reduction of growth abnormalities and
cartilage calcification and increased plasma calcium and magnesium concentrations in chicks
and rats (Hunt and Nielsen, 1988; Devirian and Volpe, 2003). When deficient in magnesium and
boron, these symptoms are exacerbated and abnormalities associated with magnesium deficiency
are more severe (Hunt and Nielsen, 1988; Devirian and Volpe, 2003). In post-menopausal
women supplemented with 3 mg/d of boron, there was a decrease in urinary calcium and
magnesium excretion, especially in magnesium deficient women (Nielsen et al., 1987; Devirian
and Volpe, 2003). Magnesium influences the efficacy of dietary boron in humans which has an
impact on bone mineralization and health (Nielsen et al., 1987; Naghii, 1999; Devirian and
Volpe, 2003; Mogosanu et al., 2016).
Vitamin D3, Se, Ca, P, F, Al, Mo, n-3PUFA, and protein amino groups also impact the
efficacy of supplemented boron and have an indirect impact on its biological activity in the body
(Elliot and Edwards, 1991; Bialek et al., 2019). Boron supplementation increases plasma
calcium concentrations and reduces calcium lost in urine in humans (Nielsen et al., 1987;
Devirian and Volpe, 2003). Boron impacts metabolism of calcium and magnesium so it is
postulated that boron supplementation during vitamin D3 deficiency improves micromineral
content of bone and normalizes energy substrate utilization (Hunt and Nielsen, 1981; Elliot and
Edwards, 1991; Devirian and Volpe, 2003). Indirectly, vitamin D3 is impacted by the effect
boron has on calcium, phosphorus, and magnesium metabolism (Elliot and Edwards, 1991). In
women with sufficient calcium, magnesium, and vitamin D3 concentrations, boron does not have
a large impact on bone mineralization and health. However, when one or more components are
deficient, boron has a drastic impact on the improvement of bone health, which is likely
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influenced by boron’s impact on cell membrane
activity (Naghii, 1999; Devirian and Volpe, 2003).
It is important to note that supplemented boron in the
form of boric acid had a positive impact on growth
in broiler chicks with vitamin D3 deficiency but
decreased growth rate in chicks fed adequate vitamin
D3 (Elliot and Edwards, 1992; Devirian and Volpe,
2003). Vitamin D3 contains a hydroxyl group, which
is one of the chemical structures’ boron compounds
complex within the body (Naghii and Samman,
1997; Hunt, 2012) (Figure 1.7). When fed adequate
vitamin D3, boron compounds should complex with
vitamin D3, increasing the efficacy of vitamin D3 in
the body and improving bone metabolism and
strength (Naghii and Samman, 1997; Devirian and
Volpe, 2003). When supplemented with dietary
Figure 1.7. Chemical structures of
Vitamin D3, estrogen, and testosterone
adapted from the National Center for
Biotechnology Information (2022).

boron, plasma concentrations of vitamin D3 increase
indicating enhancement of steroid ring hydroxylation
in compounds containing steroid rings such as

estrogen, testosterone, and vitamin D3 (Naghii and Samman, 1997; Devirian and Volpe, 2003).
This property also allows for boron to form corticosteroids which reduce incidence and intensity
of rheumatoid arthritis and improves bone health (Devirian and Volpe, 2003). Vitamin D3,
estrogen, and calcium are involved in the mechanism for turnover of bone tissue in the body
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(Rondanelli et al., 2020; Boyacioglu et al., 2018; Bialek et al., 2019). It is hypothesized that
boron increases the rate of hydroxylation of steroid hormones, increasing plasma concentrations
of estrogen in humans and estrogen and testosterone in animals (Naghii, 1999). Due to its effect
on vitamin D3 and the steroidal hormones estrogen and testosterone, it can be concluded that
boron does impact the homeostatic regulation of hydroxy-ring containing steroids (Naghii,1999;
Bialek et al., 2019). Specifically, sugar-borate esters have been known to impact the mineral
calcium metabolism of bone as well as the concentration of estrogen and testosterone in blood
(Soriano-Ursua et al., 2014; Bialek et al., 2019).
Sugar-borate-esters are the most common source of soluble borate consumed in the
animal diet from fruits, vegetables, and some nuts and legumes in the form of calcium
fructoborate (Pietrzkowski et al., 2014; Mogosanu et al., 2016; Bialek et al., 2019). Plants can
metabolize inorganic sources of boron for growth. However, in natural plant foods, humans and
animals rely on consumption of mono- or di-sugar-borate esters (Bialek et al., 2019; Hunter et
al., 2019; Nielsen and Eckhertt, 2020). Sugar-borate-esters cannot be made by animal
metabolism and are a key component of homeostasis of bone mineral requirements (SorianoUrsua et al., 2014; Bialek et al., 2019). Calcium fructoborate is present as a bis-fructose ester,
which is a complex between boric acid, fructose, and calcium carbonate (Soriano-Ursua et al.,
2014; Mogosanu et al., 2016). It is estimated that humans consume 1.05 to 2.25 mg of boron in
this form daily which is naturally absorbed by animal cells (Mogosanu et al., 2016). At normal
cellular pH (7.4), boron is present as boric acid (pKa 9.24) complexed with fructose opposed to
anionic borate present elsewhere in the body as discussed previously due to the pKa of 4.16 for
fructoborates (Mogosanu et al., 2016). This allows for fructoborates to complex more easily
with cellular membrane proteins such as glycoproteins compared with free boric acid (Mogosanu
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et al., 2016). Boric acid compounds are found within the cell whereas, the mono- and diester
fructoborate compounds are present in the extracellular matrix. However, transport of these
compounds across the cellular membrane still remains unclear (Mogosanu et al., 2016). It is
postulated that the fructoborates crystallize in a hexagonal system opposed to the triclinic system
in which free boric acid crystallizes. This may be why toxicity is not an issue (Mogosanu et al.,
2016). Calcium fructoborate specifically is the most abundant and potent sugar-borate ester and
has been reported to have anti-inflammatory, antioxidant, antiosteoporosis, antitumor, improved
vitamin D3 retention, reduced joint degeneration, improved arthritis symptoms, and many other
beneficial functions in humans and animals (Pietrzkowski et al., 2014; Hunter et al., 2019; Bialek
et al., 2019).

Boron and Serine Proteases
Boron is also thought to bind substrate compounds, such as NAD+, which inhibits
pathways that need serine proteases or oxidoreductases (Hunt, 1998; Devirian and Volpe, 2003).
Serine proteases are proteolytic enzymes categorized either in the trypsin-like, chymotrypsinlike, thrombin-like, elastase-like, or subtilisin-like family with a nucleophilic active site
containing serine (Smoum et al., 2012; Walenga, 2020). Serine proteases are present as
zymogens until activated by the action of another peptide cleaving protease (Walenga, 2020).
Thrombin is a serine protease involved in the coagulation cascade, a pathway where one factor is
activated then it activates the next factor in the sequence. In this case, thrombin converts
fibrinogen to fibrin during the final steps in the formation of a blood clot (Smoum et al., 2012;
Weber and Czarniecki, 2018; Walenga, 2020). Thrombin also activates factor XIII, a
transglutaminase, which is involved in stabilizing the clot once it is formed (Tanaka et al., 2009;
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Weber and Czarniecki, 2018; Walenga, 2020). Briefly, the coagulation cascade begins with
tissue factor (TF), which activates factor VII, another serine protease (Tanaka et al., 2009;
Walenga, 2020). Factor VII then activates factor IX (Christmas factor) and factor X (StuartPrower factor) both of which are serine proteases (Walenga, 2020). Factor IXa:VIIIa (Christmas
factor a and Antihemophilic factor a), a cofactor, also activate factor X, which will complex to
form Xa:Va (Stuart-Prower factor and a cofactor) (Tanaka et al., 2009; Walenga, 2020). The
Xa:Va complex then activates factor II (prothrombin) another serine protease (Tanaka et al.,
2009; Walenga, 2020). Prothrombin is cleaved to form thrombin, which activates factors V, VIII,
and XI and platelets in a positive feedback loop, which is catalyzed mainly by factor XI (Tanaka
et al., 2009; Walenga, 2020). Contact factors XII (Hageman factor), prekallikrein (pre-K, or
Fletcher factor), and high molecular weight kininogen (HMWK, or Fitzgerald factor), are only
activated in the presence of negatively charged surfaces such as those found on bacterial cell
walls and negatively charged phospholipids (Walenga, 2020). Ionized calcium is required in this
step for proper binding of serine proteases, specifically the phosphatidylserine group, to
negatively charged surfaces in clot formation (Walenga, 2020). Factors XII and pre-K are also
serine proteases whereas HMWK is a cofactor (Tanaka et al., 2009; Walenga, 2020). These
factors also activate factor XI (Tanaka et al., 2009; Walenga, 2020). The main function of
thrombin is to cleave fibrinogen to fibrin which is then activated by factor XIII (fibrin-stabilizing
factor) to form cross-linked fibrin which changes the solubility of the fibrin protein in
preparation to create an insoluble clot (Tanaka et al., 2009; Walenga, 2020). The now insoluble
fibrin complexes over the platelets that form the initial portion of the clot to stabilize and
strengthen the closure with further stabilization added from factor XIII (Tanaka et al., 2009;
Negrier et al., 2019; Walenga, 2020).
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Within a serine protease, serine195, histidine57, and aspartic acid102 are the three side
chain molecules not located together in primary sequence but are in close proximity to one
another by protein folding, creating what is known as the catalytic triad of the active site of a
serine protease (Smoum et al., 2012; Weber and Czarniecki, 2018). Upon binding of a substrate
in the active site S1 pocket found on the backbone of the enzymatic structure, a slight
conformation change shifts aspartic acid closer to histidine, causing proton sharing between
aspartic acid and histidine. The bound substrate is known as a Michaelis complex which allows
for exposure of the amide bond (Smoum et al., 2012; Weber and Czarniecki, 2018). This shift in
electrons allows for the nitrogen group in the imidazole side chain of histidine to bind a proton
from the hydroxyl group of serine, creating an alkoxide ion, or negatively charged oxygen ion
(Philipp and Bender, 1971; Smoum et al., 2012). The alkoxide ion makes a nucleophilic attack
on the carbonyl group of protein creating an unstable tetrahedral intermediate that will bind the
extra proton from the imidazole ring and stabilize with Gly193, creating the oxyanion hole
within the serine protease molecule (Philipp and Bender, 1971; Smoum et al., 2012). This
concludes the rapid step of catalysis as the nitrogenous fragment of the initial substrate breaks
away upon donation of a proton from histidine to the amine of the tetrahedral intermediate
(Smoum et al., 2012). In the slow step of catalysis, water is introduced to the acyl-enzyme
complex between serine and the carbonyl group of the peptide to break the covalent bond and
release the carboxyl fragment and ultimately regenerate serine (Smoum et al., 2012). The
nitrogen from the imidazole ring in histidine must bind a proton from water, creating a
nucleophile of the oxygen molecule that will bind the carbonyl carbon (Philipp and Bender,
1971; Smoum et al., 2012). This creates another tetrahedral intermediate, cleaving the nitrogen
bound hydrogen, releasing the carboxyl fragment completing the breakage of the peptide bond
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(Smoum et al., 2012). With so many serine proteases involved in the coagulation cascade, it is
pertinent to explore the inhibition of serine proteases by boron compounds.
Boronic acid compounds are able to inhibit serine proteases if they contain the correct
peptide sequence required to bind in the active site of the protease (Dembitsky et al., 2004;
Smoum et al., 2012). Boronic acid is an organoborane which is either an alkyl- or arylsubstituted boric acid (Dembitsky et al., 2004). Due to the valence structure of boron, it is easily
converted to the anionic sp3 hybridization, allowing it to be a better transition state analog than
an aldehyde-based inhibitor, in turn, allowing these boron molecules to inhibit the serine
protease mechanisms (Smoum et al., 2012). Many boronic acid-based enzyme inhibitors exist
currently either naturally or through design and synthesis for drug therapies such as arginineboronate esters, polyhedral boranes, benzoxaboroles, diazaborines peptidic boronic acids, and
cyclic boronic acid β-lactamase inhibitors (Smoum et al., 2012; Weber and Czarniecki, 2018;
Messner et al., 2022). Mechanistically, these boronic-acid enzyme inhibitors commonly inhibit
the function of serine proteases by forming a tetracoordinate boronate complex with the active
serine hydroxyl side chain (Tsilikounas et al., 1993; Smoun et al., 2012). This tetracoordinate
boronate complex is similar to that of the normal tetrahedral structure of amidolysis (Tsilikounas
et al., 1993; Smoum et al., 2012; Weber and Czarniecki, 2018). Other inhibitory mechanisms
include the formation of a covalent bond between the active site histidine residues (Tsilikounas
et al., 1993; Smoum et al., 2012). While healthy individuals should have no reason to dissuade
normal clotting functions or serine protease activity, those with underlying conditions such as
history of myocardial infarction, cardiac arrest, deep vein thrombosis, or other cardiovascular
diseases may benefit from a thrombin inhibitor to reduce the risk of unwanted clot formation
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(Weber and Czarniecki, 2018). Other maladies have also been reported to respond positively to
boron containing drug therapies (Messner et al., 2022).

Therapeutic Agents Containing Boron
Boron has recently been used as a therapeutic agent for treatment of infectious disease
and cancer (Fernandes et al., 2019; Ali et al., 2020; Messner et al., 2022). Specifically,
bioactivity of boronic acid containing compounds has been reported to inhibit proteasomes, thus
having an anti-cancer effect (Fernandes et al., 2019; Ali et al., 2020; Messner et al., 2022).
These proteasome targeting moieties have specific anti-cancer mechanisms such as downregulation of selective estrogen receptors, inhibition of topoisomerase I, inhibition of tyrosine
kinase DYRK1A, and inhibition of β-lactamase (Fernandes et al., 2019; Ali et al., 2020; Messner
et al., 2022). The use of boron neutron capture theory has been developing since the 1960’s for
effective treatment of various cancers (Ali et al., 2020; Messner et al., 2022). Not only do
boronic acid compounds have anti-cancer functionality, but they are also able to disrupt normal
function of Escherichia coli, Klebsiella pneumoniae, Acinetobacter, Salmonella, Proteus,
Enterobacter, Neisseria gonorrhea, and methicillin-resistant Staphylococcus aureus in addition
to providing anti-viral effects on diseases such as Hepatitis C, Influenza, Dengue, West Nile, and
Zika viruses via viral protease inhibition (Bialek et al., 2019; Fernandes et al., 2019; Messner et
al., 2022). Chronic inflammation resulting from dysregulation of chemokine receptors is
reduced when using boronic acid compound antagonists for treatment targeting human
neutrophils (Fernandes et al., 2019). Other diseases such as dyslipidemia, chronic inflammation,
and amyloidogenic diseases have also been treated by boronic acid containing compounds to
inhibit certain pathways pertaining to the disease (Fernandes et al., 2019; Messner et al., 2022).
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Benzoxaboroles are boron-carbon compounds with increased hydrolytic resistance that inhibit
protein synthesis pathways in microbial cells, particularly fungi (Fernandes et al., 2019; Messner
et al., 2022). Organisms such as Mycobacterium tuberculosis, Cryptosporidium parvum,
Toxoplasmosis gondii, Plasmodium falciparum, Plasmodium berghei, Trichomonas vaginalis,
and fungi and parasites from the kinetoplastidae family such as Trypanosoma brucei,
Trypanosoma congolense, and Trypanosoma vivax are all susceptible to protein synthesis
inhibition by benzoxaborole compounds (Fernandes et al., 2019; Messner et al., 2022).
Benzoxaborole compounds also have efficacy against animal ectoparasites such as Dermacentor
variabilis, or dog ticks, and Chlamydophila felis, or cat fleas, when dosed orally (Fernandes et
al., 2019; Messner et al., 2022). Diseases such as psoriasis, cancer, inflammation, dermatitis,
and sickle cell disease have all responded positively to treatment with benzoxaborole compounds
(Fernandes et al., 2019). Other boron containing compounds used therapeutically include cyclic
boronic acids, boronic esters, diazaborines, oxazaborines, boranophosphates, and borohydrides
(Bialek et al., 2019; Fernandes et al., 2019; Messner et al., 2022). Of these boron containing
compounds, boronic acid moieties and benzoxaboroles are the most potent and widely used
boron treatments currently in human and animal medicine (Fernandes et al., 2019; Messner et al.,
2022). Boronic acid compounds have also been explored as transport vessels following the
boron neutron capture theory for targeted drug therapy and release because of their ability to
reversibly bind with 1,2 and 1,3 diols found in carbohydrates (Ali et al., 2020; Messner et al.,
2022). They have also been explored as nanocarriers for transport within the body for targeted
drug therapy against cancerous tumors (Messner et al., 2022). Using surface conjugation,
nanoparticles of boron containing compounds can be bound to the liposome for micellar
transport of boron-containing drugs to the tumor (Messner et al., 2022). Carborane containing
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molecules such as boron complexed carbohydrates, amino acids, nucleosides, nucleic acids and
bases, lipids, DNA groove binders, and porphyrins have all been explored using boron neutron
theory as effective cancer treatment compounds (Ali et al., 2020; Messner et al., 2022). Boron
drug therapy is not a new field of study; however, effective transport and delivery of boroncontaining drugs is a rapidly emerging field (Messner et al., 2022). As anti-cancer, antimicrobial, anti-inflammatory etc. compounds, boron containing compounds could have a
positive impact on health in the future (Messner et al., 2022).

Conclusion
The primary role and function of boron in the animal is not well understood despite
recent efforts to further explore the role of this element in animal species (Bolanos et al., 2004).
Boron, although seemingly non-essential for years, has proven necessary for many seemingly
unrelated biological functions (Bolanos et al., 2004). Such variety in biological response to
deprivation of boron indicates boron is much more complex than originally thought in the plant
and animal model (Bolanos et al., 2004). This element raises the question about how well the
metabolism of other seemingly unimportant micronutrients is understood and if the oversight of
their importance could have a major impact on both plant and animal health. Homeostatic
functions regarding the metabolism of minerals such as calcium and magnesium, steroids such as
vitamin D3, and inhibition of common pathways such as the coagulation cascade and the impact
on cardiovascular health need further exploration. Research is needed to determine the exact
effect boron actually has on the regulation of clotting, bone mineralization, and normal
biological function in humans and animals. Despite not being accepted as an essential
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micronutrient, it is obvious that boron has a larger impact on a multitude of biological pathways
that are of great importance in the body and should be reconsidered in the near future.
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CHAPTER TWO
MICROBIAL AND CHEMICAL CHARACTERISTICS OF KEFIR GRAINS OBTAINED IN
THE U.S. MARKET

ABSTRACT

Authentic kefir is made from kefir grains and is renowned for its probiotic and health
benefits. However, obtaining quality kefir grains is difficult in the United States as there are no
commercial vendors producing and selling kefir grains under regulated sanitary conditions.
Consequently, consumers seeking kefir grains only have a choice of purchasing them online
from a very few private individuals who grow kefir grains in their home kitchens. Sanitary
conditions and microbial quality of these kefir grains is unknown. This study sought to
understand the quality of kefir grains obtained in the United States via online sales. Eleven
different kefir brands were purchased in duplicate on separate days (n=22). Grains were shipped
in a variety of containers ranging from lip balm containers to plastic bags to baby food jars to
condiment containers. Although shipped during hot summer months, only one sample out of 22
obtained was shipped with an ice pack which was melted and warm upon arrival. The grains
were inoculated into UHT milk and incubated at 25°C for 22 hours. Day 0 and Day 1 samples
were plated on standard plate count, MRS, M17, PDA, VRBA, Pseudomonas and MSA media.
Results indicated lactobacilli, lactococci and yeast in all samples. Six out of 11 samples
contained coliform, and all samples contained pseudomonal and staphylococcal species. Using
targeted genome sequencing (16S) of kefir grain samples 1, 2, and 3 revealed that lactobacilli
were the predominant genera of bacteria. ITS sequencing revealed grain 1 was predominantly
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Kluyveromyces, grain 2 was a mixture of several fungal species, and grain 3 was predominantly
Saccharomyces. All pH values decreased during fermentation (Table 2.5). Day 1 pH readings
were significantly different (P = 0.0009). On day 1, grain 11 (4.51), grain 7 (4.38), and grain 3
(4.09) had the lowest pH value post-fermentation whereas grain 9 (5.66), grain 10 (5.62), and
grain 2 (5.60) had the greatest pH post-fermentation. Samples were analyzed for vitamin K1,
MK-4, and MK-7 using UPLC-MS/MS. Results indicated potential presence of MK-4 and MK7 in kefir products; further study is needed to quantify vitamin K in kefir samples. In conclusion,
kefir grains available for online purchase in the United States were contaminated and there was
variability across grains in bacterial and fungal species which had an impact on the resultant
kefir products.

INTRODUCTION

Kefir is a fermented milk product originating from the Caucasus Mountain region dating
back more than 10,000 years (Tamime and Marshall, 1997; Ahmed et al., 2013; Litopoulou and
Tzanetakis, 2014; Ozer and Kirmaci, 2014). Authentic kefir is made from kefir grains which are
placed into milk and sieved out to use as a starter culture for the next batch of kefir (GuzelSeydim et al., 2000; Guzel-Seydim et al., 2011; Ozer and Kirmaci, 2014). These grains can be
found globally and are passed down from family to family. Kefir is made primarily with cow’s
milk but kefir grains can ferment multiple different substrates (Irigoyen et al., 2005; Litopoulou
and Tzanetakis, 2014; Ozer and Kirmaci, 2014). Kefir grains are a symbiotic relationship of
bacteria and yeast in a small, gelatinous ball with an uneven surface similar to that of a
cauliflower floret (Lin et al., 1999; Guzel-Seydim et al., 2000; Ahmed et al., 2013). Each kefir
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grain is a unique, living set of organisms in which a variety of bacteria and yeast species inhabit
(Lin et al., 1999; Wang et al., 2004; Witthuhn et al., 2004; Sarkar, 2007; Guzel-Seydim et al.,
2011). Kefir grains contain lactic acid bacteria, yeast, and acetobacter along with other smaller
groups of microorganisms that may be present (Guzel-Seydim et al., 2000; Yuksekdag et al.,
2004; Witthuhn et al., 2004; Litopoulou and Tzanetakis, 2014; Guzel-Seydim et al., 2011).
Predominantly, kefir grains contain lactic acid bacteria of which the primary substrate is lactose
in milk (Guzel-Seydim et al., 2000; Yuksekdag et al., 2004; Witthuhn et al., 2004; Litopoulou
and Tzanetakis, 2014; Guzel-Seydim et al., 2011). The microflora of kefir grains is variable
from grain to grain (Marsh et al., 2013; Korsak et al., 2015). Since grains are passed among
family members, purchased online, and sourced globally, variation in microflora is inevitable.
Since sanitary conditions in the home environment can be variable and since many consumers do
not have a thorough understanding of microbiology and sterile technique, it is possible that kefir
grains could become contaminated. In the United States, there are no quality control parameters
enforced for private sales between individuals. As a result, it is impossible for the consumer to
know what they are purchasing when they obtain kefir grains from online private vendors.
Since people are becoming more aware of the benefits of probiotics, they are seeking
healthy probiotic sources such as authentic kefir made from kefir grains. To our knowledge,
there is no commercial, sanitary inspected kefir grains sold in the U.S. market. Authentic kefir is
not only a probiotic, but also a functional food meaning it has more than one health benefit
beyond the nutritional effect on the body when consumed. Authentic kefir is known to have
anti-cancer, anti-ulceric, and immunomodulatory effects as well as a reduction in plasma
cholesterol and cardiovascular disease symptoms among other benefits (Hosono et al., 1990;
Abraham and Antoni, 1999; Thoreux and Schmucker, 2001; Liu et al., 2002; Guzel-Seydim et
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al., 2003; Santos et al., 2003; Sarkar, 2007; Ozer and Kirmaci, 2014; Davras et al., 2018). This
study aimed to examine the microbiota present in kefir grains available to the U.S. consumer in
addition to measuring functional components produced by these grains upon fermentation in
bovine milk. The objectives of this study were to determine the level of contamination of kefir
grains obtained in the U.S. market, to determine the microbial populations present in these
grains, and to determine the presence of vitamin K in the resulting kefir produced by these kefir
grains.

MATERIALS AND METHODS

Fermentation and Plate Count
Kefir grains were purchased from 11 different private vendors in two separate lots. Upon
arrival, grains were weighed and added at a rate of 2 g/100 mL of ultrahigh temperature (UHT)
pasteurized, shelf-stable milk (Parmalat, Etobicoke, ON M9C 5J1, Canada) and were fermented
for 22 hours at 25°C in a 90-rpm shaking water bath (Precision Scientific Group, Chicago, IL)
(Guzel-Seydim et al., 2011). Grains were sieved using a sterile, stainless-steel sieve, and passed
through fresh UHT milk three times for reactivation. Uninoculated UHT milk was collected as a
control. For day 0 fermentation, grains were sieved and added to fresh UHT milk at a rate of 2
g/100 mL; a 15 mL sample of the milk which was inoculated with the kefir grains was collected
as the day 0 control. From this sample, 1 mL was serially diluted and plated on each of the
following microbial media: SPC, MRS, M17, PDA, VRBA, Pseudomonas, and MSA as a day 0
post-inoculation, pre-fermentation plate count sample. SPC enumerates total aerobic, mesophilic
bacterial species, MRS is selective for lactobacilli, M17 is selective for lactococci, PDA is
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selective for yeast species, VRBA is selective for coliforms, Pseudomonas agar is selective for
pseudomonas species, and MSA is selective for staphylococcal species. After fermentation for 22
hours at 25°C in a 90-rpm shaking water bath, a 15 mL day 1 post-fermentation sample was
collected, serially diluted, and plated on the same types of agars. The pH was recorded for the
uninoculated milk, the day 0, and the day 1 samples at the time of sampling. Each media type
was incubated according to the standard procedures (Zimbro and Power, 2003). Colony forming
units (CFU) were determined based on the standard 30-300 colonies per countable plate and by
multiplying the CFU by the inverse of the overall dilution on that plate and converting to the log
value.

DNA Analysis
Kefir Grain Preparation
Kefir grains were ranked based on plate count data, level of contamination, and kefir pH.
The top, middle, and lowest ranked grains were selected for DNA evaluation. Grains were
reactivated in 100 mL of UHT pasteurized, shelf-stable milk (Parmalat, Etobicoke, ON M9C
5J1, Canada) and were fermented for 22 hours at 25°C in a 90-rpm shaking water bath (Precision
Scientific Group, Chicago, IL). Kefir grains were passed through 100 mL of fresh UHT milk
every 24 hours for two weeks. Grains were then sieved from the kefir and 0.2 g were weighed for
DNA extraction with 5 replicates per grain.

DNA Extraction
DNA was extracted using the ZymoBIOMICS DNA Miniprep Kit (Zymo Research,
Irvine, CA). Kefir grains (0.2 g) were weighed and added to ZR BashingBead™ lysis tubes (0.1
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and 0.5 mm beads) with 750 µL of ZR DNA/RNA Shield, which replaced the ZymoBIOMICS™
Lysis Solution in the kit protocol. This modification was done to ensure complete lysis of the
kefir grains. BashingBead™ tubes were then fitted in a 2 mL tube holder on a bead beating
assembly of a mini 120V vortexer (Fisher Scientific, CAT No: 02215365 SN: 150915064
Waltham, MA) and were vortexed for 15 minutes on the highest setting. Tubes were centrifuged
in an Eppendorf Centrifuge 5417R (No:5407 14034 Hamburg, Germany) at 10,000 × g for 1
minute. The supernatant (400 µL) was transferred to a Zymo-Spin™ III-F filter and centrifuged
again at 8,000 × g for 1 minute. Flow through fluid was captured and 1,200 µL of
ZymoBIOMICS™ DNA Binding Buffer was added and mixed, then transferred to a ZymoSpin™ IICR Column and centrifuged at 10,000 × g for 1 minute. ZymoBIOMICS™ DNA Wash
Buffer 1 (400 µL) was added to the Zymo-Spin™ IICR column and centrifuged at 10,000 × g for
1 minute. ZymoBIOMICS™ DNA Wash Buffer 2 (200µL) was then added to the Zymo-Spin™
IICR Column and was centrifuged at 10,000 × g for 1 minute. DNA free water (100 µL) was
then added to the Zymo-Spin™ IICR Column and the column was incubated for 1 minute to
elute the DNA. Eluted DNA was then transferred to a prepared Zymo-Spin™ III-HRC Filter and
was centrifuged at 16,000 × g for 3 minutes. DNA was then aliquoted (60 µL) for storage and
concentration analysis. DNA concentration was analyzed using a NanoDrop 2000 (Thermo
Scientific, Waltham, MA) as well as an Invitrogen™ Qubit 4 Fluorometer (Thermo Fisher
Scientific, Waltham, MA). Using the NanoDrop, 2 µL of extracted DNA was measured in
triplicate for each sample (ng/µL)(A260/280). Samples also were analyzed using the Qubit 4
Fluorometer. Samples were prepared using the Invitrogen™ Qubit dsDNA HS and BR Assay Kit
(Lot# 2069593; Ref# Q32856; Fisher Scientific, Waltham, MA). Sample DNA (2 µL) was
combined with 198 µL of Qubit buffer and dye and was incubated for 3 minutes in the dark, and
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then analyzed on the Qubit 4 Fluorometer (ng/µL). DNA was then examined by electrophoresis
on an agarose gel using 5 µL of DNA mixed with 1 µL of acridine orange dye. Gels were run for
45 minutes at 75V, then removed and stained with TBE buffer and ethylene bromide for 15
minutes, and then rinsed for 10 minutes in nanopure water. Gels were fluoresced using a
Spectroline UV Transilluminator (Select Series Model TC-312E Fisher Scientific, Waltham,
MA). DNA was sent to Zymo Research (Irvine, CA) for analysis.

DNA Analysis
Samples were processed and analyzed by the ZymoBIOMICS® service, Targeted
Metagenomic Sequencing (Zymo Research, Irvine, CA). The DNA samples were prepared for
targeted sequencing with the Quick-16S™ NGS Library Prep Kit (Zymo Research, Irvine, CA).
Zymo Research custom designed the primers in order to have the best coverage and the highest
sensitivity. The primer sets used in this project were Quick-16S™ Primer Set V3-V4 (Zymo
Research, Irvine, CA), and ZymoBIOMICS® Services ITS2 Primer Set (Zymo Research, Irvine,
CA).
The sequencing library was prepared using real-time PCR machines to control cycles and
limit PCR chimera formation. The final PCR products were quantified with qPCR fluorescence
readings and pooled together based on equal molarity. The final pooled library was optimized
with the Select-a-Size DNA Clean & Concentrator™ (Zymo Research, Irvine, CA), then
quantified with TapeStation® (Agilent Technologies, Santa Clara, CA) and Qubit® (Thermo
Fisher Scientific, Waltham, WA). A positive DNA extraction control (ZymoBIOMICS®
Microbial Community Standard, Zymo Research, Irvine, CA) was used to ensure full lysis of
kefir microbial species and as a positive control for each targeted library preparation. In order to
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assess the level of bioburden introduced by laboratory processes, a blank library control was
used. The final library was sequenced using a v3 reagent kit on an Illumina® MiSeq™ (600
cycles). A spike (10% PhiX) was added during sequencing. Using the Dada2 pipeline and by
removing chimeric sequences, unique amplicon sequences were identified from the raw reads
(Callahan et al., 2016). Using Uclust (Qiime v.1.9.1) and the Zymo Research Database,
taxonomy was assigned. The Zymo Research Database is a 16S database which the company
has created and maintains. Composition visualization, alpha-diversity, and beta-diversity
analyses were performed with Qiime v.1.9.1 (Caporaso et al., 2010). Using default settings of
LEfSe, taxonomic groups with high abundance were identified (Segata et al., 2011). To
determine absolute abundance, a quantitative real-time PCR was set up with a standard curve.
The standard curve was made using plasmid DNA containing one copy of the 16S gene and one
copy of the fungal ITS2 region prepared in 10-fold serial dilutions. The primers used were the
same as those used in Targeted Library Preparation. Heat maps, PCoA plots, and relative
abundance figures were created using R version 4.1.3 (R Core Team, 2020).
The equation generated by the plasmid DNA standard curve was used to calculate the
number of gene copies in the reaction for each sample. The PCR input volume (2 µL) was used
to calculate the number of gene copies per microliter in each DNA sample. The number of
genome copies per microliter DNA sample was calculated by dividing the gene copy number by
an assumed number of gene copies per genome. The value used for 16S copies per genome was
4. The value used for ITS copies per genome was 200. For 16S samples, the amount of DNA
per microliter DNA sample was calculated using an assumed genome size of 4.64 × 106 bp
which is the genome size of Escherichia coli. For ITS samples, an assumed genome size of 1.20
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× 107 genome size of Saccharomyces cerevisiae was used. The calculation of total DNA is
calculation is shown below.

Calculated Total DNA =
𝐶𝑎𝑙𝑐. 𝑇𝑜𝑡𝑎𝑙 𝐺𝑒𝑛𝑜𝑚𝑒 𝐶𝑜𝑝𝑖𝑒𝑠 × 𝐴𝑠𝑠𝑢𝑚𝑒𝑑 𝐺𝑒𝑛𝑜𝑚𝑒 𝑆𝑖𝑧𝑒 × 𝐴𝑣𝑔. 𝑀𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑊𝑒𝑖𝑔ℎ𝑡 𝐷𝑁𝐴 𝑏𝑝
𝐴𝑣𝑜𝑔𝑎𝑑𝑟𝑜′ 𝑠 𝑁𝑢𝑚𝑏𝑒𝑟

Vitamin Analysis
Chemicals
MS grade ammonium hydroxide, ammonium formate, acetonitrile, hexane, and 2propanol were purchased from ThermoFisher Scientific (Waltham, MA). Phylloquinone (K1)
(≥99% purity), menaquinone MK-4 (≥95% purity), menaquinone MK-7 (≥99% purity), and MS
grade formic acid were purchased from Sigma Aldrich (St. Louis, MO). MS grade methanol was
purchased from VWR Laboratories (Radnor, PA). Stock solutions were prepared in methanol
for K1, MK-4, and MK-7. Standards were stored at -20°C in opaque vials to prevent
photochemical degradation and were diluted at 8 intervals to create a standard curve.

Extraction of Fat-Soluble Vitamins
Four kefir product samples were selected (1, 2, 3, 4) and were compared with milk and a
commercially available product labeled as “kefir” but manufactured by addition of individual
cultures, many of which are not typical kefir microorganisms. Each kefir sample (10 mL) was
placed into a polypropylene tube wrapped with aluminum foil to prevent photochemical
degradation and combined with 10 mL of ddH2O (Koivu-Tikkanen, 2001; Manoury et al., 2013).
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Samples were shaken vigorously for 30 seconds then were combined with 100.1 µL each of
phylloquinone, menaquinone-4 (MK4), and menaquinone-7 (MK7) in methanol (2.5×10-7 mol/L)
as an internal standard (Koivu-Tikkanen, 2001; Manoury et al., 2013). Lipase (0.5 g) from
Candida rugosa and PBS (10 mL; pH 7.70) were added to the sample and incubated for 90
minutes at 45°C (Koivu-Tikkanen, 2001; Manoury et al., 2013). Isopropyl alcohol (10 mL) and
hexane (4 mL) were added then samples were shaken and centrifuged at 3,700 × g for 10 minutes
at room temperature (Koivu-Tikkanen, 2001; Manoury et al., 2013). The supernatant was
filtered through a 0.45 µm PVDF filter into an amber autosampler vial for analysis (KoivuTikkanen, 2001; Manoury et al., 2013). The remaining sample was then processed through the
same extraction procedure three additional times independently.

UPLC-MS/MS
Samples were analyzed on a Waters Acquity H class ultra-performance liquid chromatography
(UPLC) machine with a Xevo TQ-S quadrupole mass spectrometer coupled with electrospray
ionization (ESI) (Waters, Milford, MA). The autosampler was a Waters Acquity H Class UPLC
Quaternary Solvent Manager. Data was acquired using MassLynx Software v. 4.2. Optimized
multiple reaction monitoring (MRM) acquisition methods were developed using Intellistart
Technology for all vitamin standards (Table 2.1; Table 2.2). Three MRM transitions were
optimized for each vitamin standard using the first transition for quantification and the second for
qualification and confirmation of the compound. Dwell times were automatically optimized to
provide a minimum of 12 inflection points across each chromatographic peak for reproducible
quantification. Linearity of the UPLC-ESI-MS/MS method was evaluated by injecting mixtures
of the K1, MK-4, and MK-7 compounds which covered the range of 5×10-9 to 1×10-6 ng/mL with
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an R2 value of ≥0.99 for each standard (Table 2.3). Calibration standards were newly run on the
same day with each run of kefir samples and blank samples were analyzed first and between
samples to prevent carryover. A Waters Acquity UPLC BEH C18 column (2.1 × 100 mm, 1.7 µm
particle size) was used for separation of vitamin K compounds. The mobile phase A was methanol
with 0.1% formic acid (pH 4.11) and the mobile phase B was ultrapure water with 0.1% formic
acid (pH 3.16). The flow rate was 0.8 mL/minute with an initial composition of 55% A (Table
2.4).

Table 2.1. The ion transitions and corresponding MS parameters used for vitamin K standards.
Vitamin K1

Vitamin K2

Vitamin K2

(Phylloquinone)

(Menaquinone-4)

(Menaquinone-7)

451.22

445.160

648.50

105.01

81.00

81.06

128.17

95.08

95.07

187.04

187.04

187.1

Quantification Ion (m/z)

187.04

187.04

187.1

Cone Voltage (V)

5

70

50

54

26

40

66

24

30

26

18

34

Dwell Time (s)

0.033

0.033

0.033

Retention Time

2..40

2.81

3.96

Item

Precursor Ion (m/z)

Product Qualifier Ions (m/z)

Collision Energy (V)
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Table 2.2. Tandem quadrupole mass spectrometer conditions for vitamin K separation.
Item
Polarity

ESI+

Capillary (kV)

3.70

Source Temperature (°C)

10

Desolvation Temperature (°C)

600

Cone Gas Flow (L/hr)

450

Desolvation Gas Flow (L/hr)

1000

Collision Gas Flow (mL/min)

0.16
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Table 2.3. UPLC standard curve calibration and recovery of vitamin K standards in kefir product
samples made from kefir grains purchased in the U.S. market.

Vitamin

1

Calibration Curve

LOD

LOQ

MQL

Recovery

(ng/mL)1

(ng/mL)1

(ng/g)2

(%)3

R2

K1

Y = 3 × 106x + 8882

0.99

2.25 × 10-3

0.4507

27.68

MK-4

Y = 223899x + 870.54

0.99

2.22 × 10-3

0.4447

1182.08

MK-7

Y = 583894x + 3555.2

0.99

3.25 × 10-3

0.649

28.38

Limits of detection (LOD) and quantification LOQ were determined by injecting dilution series

of vitamin K compounds in duplicate. Signal to noise ratio of 3 was determined to be the LOD
and S/N of 10 the LOQ.
2

Estimated method quantification limit (MQL) as ng/mL sample taking into account the

recovery of sample preparation.
3

Recovery was determined by spiking kefir samples (n=24) with 100.1 µg each of standard

solutions at 2.5×10-7 concentration.
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Table 2.4. UPLC gradient profile analysisa of vitamin K.

a

Time (min)

Mobile Phase Ab, %

Mobile Phase Bc, %

Flow Rate (mL/min)

Initial

45.0

55.0

0.8

0.25

45.0

55.0

0.8

3.50

95.0

5.0

0.8

4.50

95.0

5.0

0.8

4.51

45.0

55.0

0.8

5.50

45.0

55.0

0.8

The sample manager was held at a constant 10°C and column temperature at 85°C. Prior to each

sample run, the needle was washed with a weak (water) and strong (5% ammonium carbonate,
95% acetonitrile, pH 10.10) wash. The seals were also washed with 20% methanol.
b

c

Mobile phase A = methanol with 0.1% formic acid adjusted to a pH of 3.18.

Mobile phase B = water with 0.1% formic acid adjusted to a pH of 4.18.

Limits of detection (LOD) and limits of quantification (LOQ) were established as signal to
noise ratios. LOD was considered three times the background noise signal adjacent to the
corresponding peak and LOQ was considered 10 times the background noise signal. These values
were calculated from duplicated sample analysis.

Spiked samples were used to determine

extraction method efficiency, effect of matrix, and recovery of spiked standards. Quantification
calculations were completed based on the standard curve and the internal standard vitamin K1
levels in kefir samples. Standard curves were plotted to determine the concentration of integrated
peak area where the x-axis represented concentration (ng/mL) and the y-axis represented area
under the curve for each vitamin standard. Linearity was used to calculate sample concentrations
106

using the slope and intercept for each standard. Trace amounts of vitamin MK-4 were present in
control milk.

Statistics
Data were analyzed using ANOVA based on a randomized complete block design with a
factorial structure, followed by Fisher’s protected least significant difference test to separate
means when the ANOVA indicated a treatment effect. All statistical calculations were
performed using JMP Pro 16 (Cary, NC). P-values less than 0.05 were considered evidence of
statistical significance.

RESULTS

Fermentation and Plate Count
SPC media is used for the total mesophilic aerobic plate count. Day 0 post-inoculation,
pre-fermentation microbial counts were significantly different among brands of kefir (P =
0.0009). Mean log standard plate count for grain 3 was 7.42 cfu/mL, for grain 11 was 6.29
cfu/mL, and for grain 8 was 5.75 cfu/mL. These were greater than the day 0 growth of grain 6 at
2.71 cfu/mL, grain 9 at 1.19 cfu/mL, and grain 10 at 0.46 cfu/mL (Figure 2.1). Day 1 postfermentation microbial counts were significantly different (P = 0.0173). Microbial counts for
grain 1 at 4.71 cfu/mL and grain 9 at 3.80 cfu/mL were significantly lower than all other brands
on day 1 (Figure 2.1). Growth patterns on SPC were not different for kefir grains in milk from
day 0 to day 1 across all brands of kefir (P = 0.1296).
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Figure 2.1. Mean log cfu/mL standard plate count of kefir made from kefir grains purchased in
the U.S. market. Values within a day not connected by the same letter are statistically different.
(Day 0, P = 0.0014; Day 1, P = 0.010).

MRS media is used for the enumeration of lactobacilli bacterial species. Day 0 postinoculation, pre-fermentation microbial counts of lactobacilli species were significantly different
(P = 0.0037). Mean log MRS plate counts for grain 3 (8.03 cfu/mL), grain 1 (6.96 cfu/mL), and
grain 7 (6.75 cfu/mL) were greater on day 0 as compared to grain 2 (5.04 cfu/mL), grain 9 (4.63
cfu/mL), and grain 10 (4.61 cfu/mL) (Figure 2.2). Day 1 post-fermentation, microbial counts of
lactobacilli microbes were not different across brands of kefir (P = 0.5038). Growth patterns on
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MRS were not different for kefir grains in milk from day 0 to day 1 across all brands of kefir (P
= 0.2044).

Figure 2.2 Mean log cfu/mL MRS lactobacilli plate count of kefir made from kefir grains
purchased in the U.S. market. Values within a day not connected by the same letter are
statistically different. (Day 0, P = 0.0019; Day 1, P = 0.6040).

M17 media is used for the enumeration of lactococci bacterial species. Day 0 postinoculation, pre-fermentation microbial counts of lactococci species were significantly different
(P = 0.0017). Mean log M17 plate counts for grain 3 (8.01 cfu/mL), grain 1 (6.76 cfu/mL), and
grain 11 (6.30 cfu/mL) were greater on day 0 compared to grain 10 (2.36 cfu/mL), grain 9 (0.30
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cfu/mL), and grain 6 (0.00 cfu/mL) (Figure 2.3). Day 1 post-fermentation microbial counts of
lactococci were significantly different (P = 0.0196) with grain 8 (5.33 cfu/mL) and grain 9 (2.50
cfu/mL) having lower plate counts than all other brands of kefir grains (Figure 2.3). Growth of
lactococci species from day 0 to day 1 was different across brands (P = 0.0048). Grain 6 (9.68
cfu/mL) had the greatest increase in lactococci counts throughout fermentation. Grain 11 (1.29
cfu/mL), grain 8 (0.88 cfu/mL), and grain 3 (0.83 cfu/mL) had the lowest lactococci growth
increase during fermentation on M17 agar (Figure 2.3).

Figure 2.3. Mean log cfu/mL M17 lactococci plate count of kefir made from kefir grains
purchased in the U.S. market. Values within a day not connected by the same letter are
statistically different. (Day 0, P = 0.0012; Day 1, P=0.0120).
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PDA media is used for the enumeration of yeast and mold species. Day 0 postinoculation, pre-fermentation microbial counts of yeast species were significantly different (P =
0.0005). Mean log PDA plate counts for grain 3 (7.44 cfu/mL) and grain 1 (6.50 cfu/mL) were
greater than grain 10 (1.44 cfu/mL) and grain 9 (0.00 cfu/mL) (Figure 2.4). Day 1 postfermentation microbial counts of microbes were significantly different (P = 0.0007). Mean log
PDA plate counts for grain 3 (8.70 cfu/mL), grain 8 (8.31 cfu/mL), and grain 7 (8.10 cfu/mL)
had greater counts of yeast species than grain 10 (6.56 cfu/mL) and grain 9 (5.20 cfu/mL; Figure
2.4). Amount of microbial growth between Day 0 and Day 1 was significantly different among
kefir grains (P = 0.0487). Grain 9 (5.20 cfu/mL), grain 10 (5.12 cfu/mL), and grain 6 (3.85
cfu/mL) had the greatest increase in yeast growth during the fermentation process. Grain 11
(1.39 cfu/mL), grain 3 (1.26 cfu/mL), and grain 4 (0.53 cfu/mL) had the lowest increase in yeast
counts during fermentation on PDA (Figure 2.4).
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Figure 2.4. Mean log cfu/mL PDA yeast and mold plate count of kefir made from kefir grains
purchased in the U.S. market. Values within a day not connected by the same letter are
statistically different. (Day 0, P = 0.0006; Day 1, P = 0.0443).

VRBA media is a selective media for enumeration of lactose-fermenting coliform
microbes. Mean log VRBA plate counts for day 0 post-inoculation, pre-fermentation of coliform
species were not different (P = 0.5000; Figure 2.5). Sample grain 1 (0.51 log cfu/mL) was the
only sample in which coliform was detected on day 0 (Figure 2.5). Mean log VRBA plate counts
for day 1 post-fermentation indicated presence of coliforms in some samples, although, there
were no statistical differences across samples (P = 0.1995). Samples grain 11 (2.63 cfu/mL),
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grain 1 (1.20 cfu/mL), grain 2 (0.99 cfu/mL), grain 5 (0.68 cfu/mL), grain 8 (0.56 cfu/mL), and
grain 7 (0.46 cfu/mL) contained coliform bacteria. Growth patterns on VRBA were not different
for kefir grains in milk from day 0 to day 1 across all brands of kefir (P = 0.1296; Figure 2.5).

Figure 2.5. Mean log cfu/mL VRBA coliform plate count of kefir made from kefir grains
purchased in the U.S. market. Values within a day not connected by the same letter are
statistically different. (Day 0, P = 0.4960; Day 1, P = 0.1810).

Pseudomonas media is used for enumeration of pseudomonal species. Day 0 postinoculation, pre-fermentation mean log microbial counts of pseudomonal species were not
different (P = 0.1069); all brands except grain 9 had colony growth (Figure 2.6). Day 1 post113

fermentation mean log microbial counts were not different (P = 0.5000). Every brand of kefir
grain had presence of non-pathogenic Pseudomonas growth (Figure 2.6). Growth patterns on
pseudomonas media were not different for kefir grains in milk from day 0 to day 1 across all
brands of kefir (P = 0.5000).

Figure 2.6. Percent positive or negative results of spread plating kefir made from kefir grains
purchased in the U.S. market, on pseudomonas agar out of four replicates. Values within a day
not connected by the same letter are statistically different. (Day 0, P = 0.1053; Day 1, P =
0.7091).
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Mannitol Salt Agar (MSA) media is used for enumeration of staphylococcal microbes.
Day 0 post-inoculation, pre-fermentation mean log microbial counts of staphylococcal species
were not different among brands of kefir (P = 0.6589). However, all brands were positive for
non-pathogenic staphylococcal species except for grain 8 and grain 6 (Figure 2.7). Day 1 postfermentation log values of microbes were not different (P = 0.5219) where sample grain 7 was
the only sample without staphylococcal growth (Figure 2.7). Growth patterns on MSA were not
different for kefir grains in milk from day 0 to day 1 across all brands of kefir (P = 0.8765).

Figure 2.7. Percent positive or negative results of spread plating kefir made from kefir grains
purchased in the U.S. market, on mannitol salt agar out of four replicates. Values within a day
not connected by the same letter are statistically different. (Day 0, P = 0.6398; Day 1, P = 4778).
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pH Analysis
A pH measurement was recorded on uninoculated control milk, on day 0 postinoculation, pre-fermentation, and on day 1 post-fermentation. The pH of the milk control was
6.8. The day 0 pH readings were not different across brands of kefir (P = 0.1130; Table 2.5). Day
1 pH readings were significantly different (P = 0.0009). On day 1, samples grain 11 (4.51), grain
7 (4.38), and grain 3 (4.09) had the lowest pH value post-fermentation whereas grain 9 (5.66),
grain 10 (5.62), and grain 2 (5.60) had the greatest pH post-fermentation (Table 2.5). There were
no differences in the amount of change in pH from pre- to post-fermentation in each brand (P =
0.2101). All pH values decreased during fermentation (Table 2.5).
Of the 11 kefir brands, only 5 kefir products (grain 10, grain 5, grain 11, grain 3, grain 7)
coagulated. Grain 10, grain 5, and grain 11 were frothy from obvious gas production. Grain 7
and grain 3 had smooth, thick consistency. The remaining products were of thin consistency
indicating poor to no coagulation. Grain size was variable among brand and replicates of brands.
Grain 2 had small, shattered grains with a light yellowish color and mucoid strings across grains.
Grain 9 had large, intact grains and had a strong yeast smell. Grain 8 had small, shattered grains
with a brown discoloration of the grains. Grain 10 had medium sized grains with no notable
color or smell. Grain 11 had small, shattered grains with a putrid smell and yellow/brown
discoloration. Grain 1 had a variety of grain sizes with some large and small grains and yellow
discoloration. Grain 7 grains were small and shattered and dry with a putrid smell. Grain 4 had
small, shattered grains that were dry with no notable smell. Grain 6 had large grains with
brownish discoloration and a putrid smell. Grain 5 had large grains with shattered grains stuck
between crevices in the grain and were in excess liquid with a putrid smell. Grain 3 had medium
sized grains with no notable color or smell.
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Table 2.5. Mean pH of duplicate kefir product at day 0 and day 1 of kefir made from kefir grains
purchased in the U.S. market. Values within a day not connected by the same letter are
statistically different. (Day 0, P = 0.1130; Day 1, P = 0.0009).
Kefir Grain

Mean pH day 0

Mean pH day 1

Standard Error

Coagulation (Y/N)

1

5.91a

4.66DEF

1.088

No

2

6.25a

5.60AB

0.3889

No

3

4.99a

4.10F

0.1131

Yes

4

6.56a

5.47ABC

0.3394

No

5

6.04a

4.96CDE

0.3464

Yes

6

6.56a

5.42ABC

0.0141

No

7

6.46a

4.38EF

0.2404

Yes

8

6.19a

5.07BCD

0.1979

No

9

6.42a

5.67A

0.6858

No

10

6.30a

5.63AB

0.4879

Yes

11

6.41a

4.52DEF

0.3959

Yes

DNA Analysis
Principal Coordinate Analysis (PCoA) plots were created to represent inter-grain
(dis)similarity using a (dis)similarity matrix as the input for the graphical representation. These
PCoA plots represent the (dis)similarity among kefir grain bacterial and fungal communities
within and between kefir grains using orthogonal axes (Figure 2.8). Raw sequences were
analyzed using Dada2 Pipeline where any reads on microbial DNA that did not meet a minimum
quality score of 25, had a sequence length less than 150 bps for 16S, and 200 bps for ITS
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amplicon reads were removed from the dataset. Dada2 was also used to create PCoA plots based
on Bray-Curtis distances matrices. Statistical differences between kefir grains for both 16S and
ITS were determined using Spearman’s correlation. Bacterial alpha-diversity was low among
kefir grains in this study. Predominantly, Lactobacillus species were the dominant family in each
grain (Figure 2.9). Bacterial beta-diversity was dissimilar among kefir grains. Grain 1 exhibited
clustering within its replicates, however, there was no clustering within grains 2 and 3 (Figure
2.8). Between grains, there was no clustering, indicating dissimilarity across grains (Figure 2.8).
Fungal alpha-diversity was low in kefir grains 1 and 3. Grain 1 was predominantly
Kluyveromyces, grain 3 was predominantly Saccharomyces, and grain 2 was a mixture of several
fungal species (Figure 2.9). Fungal beta-diversity was dissimilar among kefir grains. Grains 1
and 3 exhibited clustering within grain replicates. However, there was no clustering between
kefir grains, indicating low similarity in fungal beta-diversity.
Relative abundance of bacterial and yeast species is presented in Figure 2.9. Two main
bacterial families were detected in kefir grains 1, 2, and 3. Lactobacillus was the dominant genus
present in all grains with prevalence of Acetobacter in grains 2 and 3, but not in grain 1 (Figure
2.9). Bacterial species grouped in the “Other” family were miscellaneous families with <1%
abundance in each grain. The range of bacterial species present include Lactobacillus
kefiranofaciens, Lactobacillus kefiri-otakiensis-sunkii, Lactobacillus parakefiri, Lactococcus
lactis, Leuconostoc mesenteroides, Lactobacillus helveticus, Acetobacter ambici-okinawensis,
Acetobacter orientalis, Streptococcus salivarius-thermophilus, Acetobacter fabarum,
Bifidobacterium longum, Lactobacillus delbrueckii, and Acetobacter cerevisiae-malorum. Nonkefir organisms present at <1% of the total population include Bacillus cereus-pseudomycoides-
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Figure 2.8. Principal Coordinate Analysis (PCoA) plots of kefir grains 1, 2, and 3 based on distance matrices depicting the diversity
within bacterial (left) and fungal (right) population within each grain.
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Figure 2.9. Bar chart representing the relative abundance of bacterial species using 16S targeted metagenomic sequencing (left) and
fungal species using ITS targeted metagenomic sequencing (right) of kefir grains 1, 2, and 3 with five replications each.
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-toyonensis, Enterococcus, Enterococcus faecalis, Bacillus, Bacillus cereus, Anaerostipes
hadrus, and Escherichia-shigella coli.
Fungal organisms present included Kazachstania, Pichia pichia membranifaciens,
Kazachstania kazachstania exigua, and Cryptococcus cryptococcus neoformans. In grain 1,
Kazachstania was the dominant and only genus present. In grain 3, Saccharomyces was the
dominant genus with some presence of Kluyveromyces in all replicates and a small percentage of
Kazachstania in one replicate. In grain 2, however, there were multiple fungal species present
including Saccharoymyces, Pichia membranifaciens, and Kazachstania exigua. Kazachstania
was the dominant genus in grain 3 including Kazachstania exigua and other unidentified
Kazachstania species. Of the three grains analyzed, grain 2 had the most diversity among fungal
species.

Vitamin Analysis
Kefir product and milk samples analyzed for vitamin K from control milk, a commercial
kefir, and kefir grains 1, 2, 3, and 4 are represented in Table 2.6 and Table 2.7. Vitamin K1, MK4, and MK-7 values are the percent recovered of spiked samples compared with blank samples.
The blank samples were each of the products that did not contain spiked vitamins. Milk had no
presence of K1 or MK-7 but there were trace amounts of MK-4 in the blank sample. Commercial
kefir had no presence of K1 or MK-7 in the blank sample but there were high concentrations of
MK-4 in the blank. Grains 1, 2, and 4 had no presence of vitamin K1 in the blank sample. Grain
3 had minimal amounts of vitamin K1 in the blank sample in replicate 1 but not in replicate 2,
which is likely an error. Grains 1, 3, and 4 had no presence of vitamin MK-7 in the blank sample.
However, grain 2 in the first replicate had some presence of vitamin MK-7 but not in the second
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replicate which is likely an error. For all values of MK-4, the percent recovery was drastically
over the limit of quantification set by the standard curve for MK-4. These values for MK-4 were
not consistent across spiked or blank samples and were all extremely high compared to the
amount of MK-4 that was used to spike the samples. The data cannot be extrapolated due to the
limitations of the standard curve in this dataset.

Table 2.6. Percent recovery of vitamin K1, MK-4, and MK-7 in kefir product samples made from
kefir grains purchased in the U.S. market, milk, and a commercially available kefir.
Kefir Product

Blank/Spike

K1 % Recovered

MK-4 %

MK-7 %

Recovered

Recovered

Blank

0 ± 0.00

7.74 ± 0.14

0 ± 0.00

Spike

18.93 ± 0.06

1228.81 ± 5.44

15.58 ± 0.24

Blank

0 ± 0.00

1191.13 ± 3.40

0 ± 0.00

Spike

40.88 ± 0.20

1187.21 ± 3.07

29.99 ± 0.26

Blank

0 ± 0.00

1024. 18 ± 2.95

0 ± 0.00

Spike

30.32 ± 0.41

999.22 ± 9.49

29.13 ± 0.59

Blank

0 ± 0.00

1141.12 ± 2.46

0 ± 0.00

Spike

37.98 ± 0.09

1122.14 ± 6.25

44.05 ± 0.46

Blank

0 ± 0.00

1125.56 ± 3.33

5.76 ± 0.02

Spike

28.89 ± 0.21

1113.4 ± 13.77

29.01 ± 0.32

Blank

0 ± 0.00

1269.3 ± 1.54

0 ± 0.00

Spike

19.36 ± 0.14

1198.37 ± 9.51

24.76 ± 0.12

Milk

Commercial

Grain 1 - 1

Grain 1 - 2

Grain 2 -1

Grain 2 - 2
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Blank

1.05 ± 0.06

1157.56 ± 1.30

0 ± 0.00

Spike

20.35 ± 0.87

1180.52 ± 13.18

16.20 ± 1.10

Blank

0 ± 0.00

1219.71 ± 4.08

0 ± 0.00

Spike

35.63 ± 0.44

1281.09 ± 5.01

34.96 ± 0.67

Blank

0 ± 0.00

1108.85 ± 2.98

0 ± 0.00

Spike

26.89 ± 0.63

1238.94 ± 2.80

33.40 ± 0.82

Blank

0 ± 0.00

1234.1 ± 3.27

0 ± 0.00

Spike

49.20 ± 0.45

1295.6 ± 11.85

55.10 ± 0.72

Grain 3 - 1

Grain 3 – 2

Grain 4 - 1

Grain 4 - 2
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Table 2.7. Mean ng/mL of vitamin K1, MK-4, and MK-7 in milk, commercial kefir product, and
kefir products from kefir grains 1, 2, 3, and 4.
Mean ng/mL
Kefir Product

Blank/Spike
K1

MK-4

MK-7

Blank

-6.64E-04

8.86E-01

-2.44E-03

Spike

7.27E-03

1.41E+02

1.01E-02

Blank

-5.68E-04

1.36E+02

-2.03E-03

Spike

1.57E-02

1.36E+02

1.95E-02

Blank

-8.28E-04

1.17E+02

-2.44E-03

Spike

1.16E-02

1.14E+02

1.89E-02

Blank

-8.83E-04

1.31E+02

-2.44E-03

Spike

1.46E-02

1.28E+02

2.86E-02

Blank

-7.88E-04

1.29E+02

3.74E-03

Spike

9.18E-03

1.27E+02

1.88E-02

Blank

-7.90E-04

1.45E+02

-5.38E-04

Spike

7.43E-03

1.37E+02

1.61E-02

Blank

4.04E-04

1.33E+02

-1.94E-03

Spike

7.82E-03

1.35E+02

1.05E-02

Blank

-9.98E-04

1.40E+02

-2.44E-03

Spike

1.37E-02

1.47E+02

2.27E-02

Blank

-3.09E-04

1.27E+02

-2.19E-03

Spike

1.03E-02

1.42E+02

2.17E-02

Milk

Commercial

Grain 1 - 1

Grain 1 - 2

Grain 2 -1

Grain 2 - 2

Grain 3 - 1

Grain 3 – 2

Grain 4 - 1
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Blank

-5.95E-04

1.41E+02

-2.44E-03

Spike

1.89E-02

1.48E+02

3.58E-02

Grain 4 - 2

DISCUSSION
Across all media types, there was variation between brands of kefir grains for SPC, MRS,
M17, PDA, and VRBA mean log plate count. More than half of the kefir samples (6 of 11) were
contaminated with coliform bacteria (Figure 2.5). All grains were contaminated with nonpathogenic pseudomonas and staphylococcal species (Figure2. 6; Figure 2.7). Consumers
purchasing kefir grains in the U.S. market are unaware of the contamination in their prospective
kefir grains. The kefir grains purchased in this study were obtained through online sales services
apparently sourced from home kitchens. Samples were shipped in a variety of packaging
materials ranging from sealed plastic bags to lip balm containers, condiment containers, baby
food jars, and unsealed sandwich bags. These samples were purchased during summer months
and only one out of 22 received samples (11 different sample brands with two replicates of each)
was shipped with an ice pack, which was thawed and warm upon arrival. Some of the samples
were received in a black mailbox in full sun where samples remained for an undetermined period
of time during a very warm summer month. There were no options for rush shipping or
refrigerated shipping to protect the integrity of this living culture. In some of the advertisements,
photographic evidence showed unsanitary conditions for a cultured food product such as
photographs of kefir grains being held in bare, ungloved hands. Plastic kitchen utensils cannot
be heat-sterilized and were frequently observed in a variety of the kitchen photographs. The
substrate in which these grains were previously grown is also a concern. While it is standard
practice to use pasteurized milk for the culturing of kefir from kefir grains, at least one vendor
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advertised use of raw milk as the substrate of choice. While alternative substrates such as whey
or soy milk have been used to grow and change the composition of kefir, use of raw milk
introduces a variety of concerns due to the unsanitary nature of raw milk and the possibility of
pathogens being sold to unknowing consumers (Sarkar, 2007; Ahmed et al., 2013). Private
vendors are not subject to enforcement of quality control or regulation. Therefore, consumers
who are seeking an at home source of healthy probiotic kefir are potentially purchasing
contaminated grains from which they will produce contaminated kefir. Consumption of this
contaminated product could cause mild to serious illnesses in adults and children.
Authentic kefir is kefir cultured from kefir grains. Authentic kefir is known to have
significant health benefits including immunomodulatory, probiotic, anti-mutagenic, anti-ulceric,
anti-allergic, anti-tumor effects, decreased plasma cholesterol, reduced cardiovascular disease,
and many others (Hosono et al., 1990; Abraham and Antoni, 1999; Thoreux and Schmucker,
2001; Liu et al., 2002; Guzel-Seydim et al., 2003; Santos et al., 2003; Sarkar, 2007; Ozer and
Kirmaci, 2014; Davras et al., 2018). As a probiotic, kefir is commonly consumed in Middle
Eastern culture and is gaining popularity in the United States; however, authentic kefir has yet to
be commercially introduced in the United States. Currently in the United States, a cultured dairy
product exists that is allowed to be sold under the name of “kefir”. These products are not
authentic kefir but instead are made by addition of lactic acid bacteria, yeast, and others to
pasteurized milk. However, the lactic acid bacteria are not the bacteria specific to and necessary
to culture authentic kefir from milk. Bacteria that are specific to authentic kefir include
Lactobacillus kefir, Lactobacillus kefiranofaciens, Lactobacillus kefiri-otakiensis-sunkii,
Lactobacillus parakefiri, and Lactobacillus kefirgranum (Abraham and Antoni, 1999; Lin et al.,
1999; Marquina et al., 2002; Guzel-Seydim et al., 2011 Ozer and Kirmaci, 2014). Each grain
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must have at least one or more of the lactobacillus “kefir” species to be considered authentic
kefir. However, the bacterial strains specific to authentic kefir have not yet been isolated and
cultured successfully on their own. Therefore, it is currently impossible to make a kefir product
similar to authentic kefir by adding isolated strains. As a result, authentic kefir can only be made
by addition of kefir grains to the milk-based substrate of choice.
Plate counts of lactobacilli on MRS media were in the range of 7 to 8 log cfu/mL for kefir
product samples 1, 2, and 3 (Figure 2.2). Similarly, lactococci counts on M17 media were also
in the range of 7 to 8 log cfu/mL for kefir product samples (Figure 2.3). However, when
performing 16S analysis of kefir grains 1, 2, and 3, the ratio of lactobacilli to lactococci was
notably different (Figure 2.9). Lactobacilli dominated the kefir grain composition. Comparison
of the product to the grain composition could be a result of inability to culture lactobacilli on
synthetic media. Another explanation could be a lower growth rate of lactobacilli in the milk
during kefir production resulting in fewer lactobacilli in the kefir product compared with the
kefir grain. The 16S analysis allows observation of the bacterial populations using targeted
genome sequencing. From the sequencing data of grains 1, 2, and 3, it was observed that the
dominant genus in each kefir grain was Lactobacillus, indicating that plating data alone was not
sufficient to draw conclusions about bacterial populations within a kefir grain (Figure 2.9). This
data indicates the importance of determining bacterial populations in kefir grains using targeted
genome sequencing. Further, metagenomic analysis would provide a more complete
understanding of the microbial populations in the kefir grain. In this study, metagenomic
analysis was not conducted, but is recommended for future studies. As can be observed in the
three grains measured in this study, there is large variation between grains and within grain
replicates. Similar data was reported by Korsak et al. (2015) where many of the grains measured
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in their study were dominated by Lactobacillus whereas one sample was dominated by
Lactococcus (Korsak et al., 2015). Korsak et al. (2015) evaluated the variation in microbial
growth in milk cultured with kefir grains and reported similar bacteria including Lactobacillus
kefiranofaciens, Lactobacillus kefiri, and Lactobacillus parakefiri in their cultured product,
further supporting the hypothesis that lactobacilli content in kefir grains may not be accurately
reflected in the kefir product using plating methods.
Yeast content of kefir grains 1, 2, and 3 was similar according to plate counts on PDA
media (Figure 2.4). However, when examined using ITS targeted genome sequencing, it was
apparent that the three grains were vastly different in dominant yeast species. Since PDA does
not distinguish between different genera of yeast and mold, it is impossible to determine the
specific yeast content of the kefir grain in question. As with the bacteria, it is important to use
targeted metagenomic sequencing to provide information about yeast content. Such variability
in yeast can impact the kefir quality, organoleptic, and functional qualities of the kefir product.
There is not enough data available to know which yeast genera are the most important for kefir
product development and desirable functional properties within the kefir product. Further
research is needed to understand the symbiotic relationships among bacterial and yeast
components of quality kefir grains for optimal production of desirable kefir products with
functional properties. For bacterial and yeast genera that may be currently unculturable,
genomic analysis is an important tool providing deeper insight into the intricate network and
relationship among the microbes within a kefir grain.
Contaminants were detected in all kefir grains examined in this study by both plating
methods and by genomic analysis. The three contaminants of interest in this study were coliform
bacteria, pseudomonads, and staphylococcal species. Quality standards for dairy food products
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have zero tolerance for presence of coliform bacteria indicating many of the kefir grains
purchased in the U. S. market would not meet food safety standards (Feng et al., 2020).
Coliform contamination is considered to be fecal contamination. Pseudomonads are common
psychrophilic food spoilage organisms which may damage the flavor of dairy products (Raposo
et al., 2016). Pseudomonal contamination can come from a wide variety of sources including
contaminated water and soil (Raposo et al., 2016). Staphylococcal species have a wide variety of
pathogenicity ranging from non-pathogenic starter organisms to coagulase positive and
methicillin resistant strains (Kadariya et al., 2014). Some advertisements for kefir grains
purchased in this study included photographs of grains being held in ungloved hands.
Staphylococcus is commonly found in the normal flora of human skin. As a result, this prompted
the investigation for staphylococcal contamination in this study.
During kefir fermentation, the lactic acid bacteria in the grains convert lactose to lactic
acid and decrease the pH of the milk to the range of 3.8 to 4.2 (Guzel-Seydim et al., 2000;
Gronnevik, 2011; de Oliveira, 2014). Casein coagulation occurs at a pH of less than 4.7 in dairy
products and becomes insoluble at a pH of less than 3.0, which provides a thickened consistency
to the kefir product (Le Graet and Gaucheron, 1999; Guzel-Seydim et al., 2000; Gronnevik,
2011; de Oliveira, 2014). Out of the 11 brands examined, only three brands reduced the pH to
the acceptable range within the fermentation period (Table 2.5). Non-heat-treated and/or nonhomogenized milk tends to separate from whey protein in storage, reducing the thickness of the
kefir product along with consumer desirability (Tamime and Marshall, 1997; Narvhus, 2014).
Solubilization of phosphorus occurs at pH 5.2 and solubilization of calcium occurs at pH 4.6 (Le
Graet and Gaucheron, 1999). Grain 9, grain 2, and grain 10 had final pH measurements of 5.6 or
greater indicating low conversion of lactose to lactic acid. However, the product could contain
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solubilized phosphorus which was not measured in this study (Le Graet and Gaucheron, 1999).
Only those products with a pH less than 4.6 would contain solubilized calcium (Le Graet and
Gaucheron, 1999). Bacterial plate counts indicated no significant difference in lactobacilli levels
across all samples (Figure 2.2). Observed pH levels did not appear to be linked to lactobacilli
content. Grain 8 and grain 9 had significantly lower levels of lactococci on M17 media (Figure
2.3). However, grain 8 and grain 9 had a mid-range pH of the kefir product compared to the rest
of the brands. Lactobacilli, specifically, Lactobacillus kefiranofaciens, are also responsible for
kefiran production, which thickens the kefir and provides a prebiotic effect (Abraham and
Antoni, 1999; Lin et al., 1999; Marquina, 2002; Ozer and Kirmaci, 2014). Kefiran is a unique
exopolysaccharide that also contributes to the health benefits kefir provides such as providing
anti-mutagenic, anti-ulceric, and anti-tumor effects (Abraham and Antoni, 1999; Ozer and
Kirmaci, 2014). Kefiran was not measured in this study but is an important feature of kefir and
is one of the functional properties of kefir.
When analyzing the growth patterns of lactic acid bacteria, some brands of kefir grains
had high proliferation in the day 0, pre-fermentation period for both lactobacilli and lactococci
plate counts such as grain 1, grain 3, grain 5, grain 7, and grain 11. However, some brands of
kefir grains such as grain 4, grain 10, and grain 2 had low proliferation during this same time
period. At day 1, post-fermentation plate counts were not different across lactobacilli counts on
MRS media, and it was noted that kefir grains that had a high day 0 count did not have as much
growth as bacteria that began the fermentation period with a lower plate count. On M17 media,
however, grain 6, grain 8, and grain 9 had low microbial plate counts on day 0 and were still low
in comparison to other grains on day 1 (Figure 2.3). This could be because the grains were not
as proliferative as the other grains purchased, or the bacterial populations were primarily
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lactobacilli and not lactocci. Another potential explanation is the decrease in pH as fermentation
progressed. A decrease in pH can inhibit the growth of organisms as fermentation progresses. In
grain 9 and grain 10 specifically, the pH only decreased from 6.4 to 5.6, which should not have
had an inhibitory effect whereas grain 1 had a drastic decrease in pH which coincided with
decreased log cfu/mL microbial counts from day 0 to day 1 of the yeast species in that sample
(Table 2.5).
The kefir microbiota is also known to produce a variety of vitamins including thiamine,
riboflavin, pantothenic acid, pyridoxine, biotin, folic acid, and cobalamin (Khamnaeva et al.,
2000; Irigoyen et al., 2005; Sarkar, 2007; Ahmed et al., 2013). While water-soluble vitamins
have been measured in kefir products, fat soluble vitamins have not yet been fully documented
(Ahmed et al., 2013). Certain bacteria such as Propionibacterium peterssoni, Propionibacterium
pituitosum, and Propionibacterium freudenreichii subsp. shermanii are reported to alter the B
vitamin content of kefir product (Irigoyen et al., 2005; Sarkar, 2007; Ahmed et al., 2013;
Kesenkas et al., 2017). The milk substrate has also been reported to alter the B vitamin content
of kefir under normal fermentation conditions (Khamnaeva et al., 2000; Liutkevicius and
Sarkinas, 2004; Sarkar, 2007; Kesenkas, et al., 2017). The microflora of each individual grain
also has an impact on the type and amount of vitamins produced in kefir product (Khamnaeva et
al., 2000; Liutkevicius and Sarkinas, 2004; Sarkar, 2007; Kesenkas et al., 2017). Vitamin K is
known to be present in kefir, but vitamin K2 to our knowledge had not been quantified across
kefir grains with different microbial composition (Ahmed et al., 2013; Buelens et al., 2013;
Kesenkas et al., 2017). Vitamin K2 is a vitamer of vitamin K produced by microbial
fermentation. Menaquinones -4 and -7 are two common forms of vitamin K2 of which MK-4 can
be converted from K1 in animal tissues (Kesenkas et al., 2017; Buelens, et al., 2013; Sungur et
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al., 2021). Lactic acid bacteria are known to produce vitamin K2 where specifically Lactococcus
lactis ssp. lactis, and Lactococcus lactis ssp. cremoris are known to produce MK-8 and MK-9
(Buelens et al., 2013). Other bacteria known to produce vitamin K2 include Bacteroides fragilis
(MK-10, MK-11, MK-12), Eubacterium lentum, (MK-6), and propionibacteria (MK-9). In
general, kefir grains contain five bacterial phyla, Firmicutes, Proteobacteria, Actinobacteria,
Cyanobacteria, and Bacteriodetes of which Firmicutes and Proteobacteria are the most dominant
families (Dertli and Con, 2017). Bacteroides is the lowest concentration in kefir grains making
them difficult to record, likely because they are intestinal bacteria and cannot be easily quantified
by plate counting. Bacteroides could produce MK-10, MK-11, and MK-12 in kefir, but it is
likely the quantities are so minute that these compounds may be difficult to detect (Dertli and
Con, 2017). In these kefir grains, Lactococcus lactis was present in each grain analyzed. This
indicates that some amount of vitamin K2 likely is present in these kefir samples. The data
collected on MK-4 and MK-7 indicate that there is presence of MK-7 in these kefir grains,
however, the concentration is low. MK-4 values are beyond the limit of quantification and
exceed the values listed on the standard curve. Although MK-4 is likely present in these
samples, it cannot be confirmed due to the inability to identify the true concentrations of MK-4
on the standard curve. The drastic excess of MK-4 could be due to calculation errors in the
spiking process of sample extraction, or inefficiency in the extraction procedure. To fully
quantify the presence of MK-4 in these kefir product samples, a new extraction protocol is
recommended in addition to an adjustment to internal standard values.
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CONCLUSION
In conclusion, authentic kefir made from kefir grains is a multi-faceted product with
numerous functional properties. In this study, it was determined that kefir grains purchased from
private online vendors were contaminated with contaminants such as coliform, pseudomonal,
and staphylococcal bacterial species which could compromise the integrity of the kefir product
and potentially cause illness. Due to the variation among kefir grains purchased from various
vendors in the United States, it is apparent that no two kefir grains share the same microbial
composition, which indicates that each kefir product will also vary in quality. As a result of such
variation in microflora within and across kefir grains, functional properties also vary. Vitamin
K2 profile is variable across kefir grains and is difficult to accurately measure. Further
optimization needs to be conducted on vitamin K2 extraction and analysis of kefir products.
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CHAPTER THREE
SOLID-STATE FERMENTATION OF WHOLE AND GROUND SOYBEANS, CHICKPEAS,
AND LENTILS WITH BACILLUS SUBTILIS NATTO

ABSTRACT

Natto is a Bacillus subtilis natto fermented soybean product which is commonly
consumed as a breakfast food in Asia. Natto contains several functional food components
including the enzyme nattokinase which is capable of degrading blood clots, reducing
hypertension, and degrading amyloid fibrils associated with Alzheimer’s disease. Natto is also
an important source of Vitamin K2. This study examined the fermentation of other legumes to
determine if B. subtilis natto would ferment chickpeas and lentils with production of similar
functional components as fermented soybean natto. Bacillus subtilis natto was grown aerobically
in TGY broth (pH 7.0) at 37°C for 24 hours and used to inoculate cooked whole and ground
soybeans, chickpeas and lentils. Samples were collected for uninoculated and inoculated day 0
controls. After incubation, inoculated legume samples were collected. All samples were plated
in duplicate on standard plate count agar (tryptone glucose yeast [TGY]). Day 1 postfermentation microbial counts were significantly different (P <0.0001) across legumes. Soybeans
(9.03 cfu/g), ground chickpeas (8.99 cfu/g) and chickpeas (8.93 cfu/g) were greater than other
legumes but were not different from one another. Whole soybeans and whole chickpeas were
similar (P = 0.1153); however, whole lentils had lower bacterial counts (P <0.0001). Ground
chickpeas (P <0.0001) had the greatest log cfu/g enumeration of bacteria followed by ground
lentils and finally by ground soybeans (P <0.0001). Whole chickpeas were not different from
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ground chickpeas (P = 0.3498). Whole lentils and ground lentils were significantly different (P
<0.0001). Dry matter (DM) was different across legumes (P <0.0001). Whole soybeans had the
greatest percent DM followed by whole chickpeas, whole lentils, ground chickpeas, ground
lentils, and ground soybeans. Results indicated fermentation of chickpeas and lentils both
yielded the ability to dissolve blood clots comparable to soybean natto. Using casein agar,
results indicated similar proteolytic activity for soybean natto and B. subtilis natto fermented
chickpeas and lentils. Analysis of natto validated presence of vitamin K1 and K2 (MK-4 and
MK-7); however, internal standards need to be verified for quantification.

INTRODUCTION

Natto, a fermented soybean product, is a common breakfast food in Asian countries
(Shurtleff and Aoyagi, 2012; Ichishima et al., 1982). It is suggested that natto was discovered by
mistake between 1051 and 1083 B. C. Historical records report the initial discovery of natto
occurred when cooked and packaged soybeans were transported in a horse saddle bag where the
culture remained moist, and the temperature was stable. The contaminating bacteria Bacillus
subtilis natto was able to grow and create what is now called natto (Shurtleff and Aoyagi, 2012).
Characterized by the aroma and production of mucoid strings that appear similar to strings of
melted cheese, natto was mistaken for soy cheese until it was defined as its own dish in the
1400’s (Shurtleff and Aoyagi, 2012). In 1894, scientist Kikuji Yabe at the Tokyo University of
Japan, was able to isolate bacterial colonies from natto, but was unable to distinguish the culture
responsible for the characteristic fermentation of the soybeans. Later, in 1906, researcher S.
Sawamura isolated B. natto (Shurtleff and Aoyagi, 2012; Ichishima et al., 1982; Steinkrauss,
135

2004). Sawamura used cedar to package the product instead of the traditional rice straw. It is
believed the cedar packaging kept natto pure without the risk of other bacterial strains from
traditional rice straw contaminating the product (Steinkrauss, 2004). There are three strains of B.
natto that grow naturally on rice straw, the original packaging material traditionally used for
cooked soybeans. One of the strains was selected based on its superior fermentation
characteristics (Shurtleff and Aoyagi, 2012; Steinkrauss, 2004; Tanaka et al., 1977). B. subtilis
and B. subtilis natto are different because B. subtilis does not require biotin for growth whereas
B. subtilis natto does (Shurtleff and Aoyagi, 2012; Ichishima et al., 1982). The genes for this
difference are found on a plasmid, which is likely why the strains differentiated (Shurtleff and
Aoyagi, 2012; Tanaka et al., 1977). B. subtilis natto was thus isolated as a pure culture, and is
the strain used globally for commercial production (Shurtleff and Aoyagi, 2012; Tanaka et al.,
1977).
Natto is made by soaking soybeans, lightly boiling them until tender, and fermenting
them with B. subtilis natto at 104°F for 15 to 24 hours under humid conditions (Shurtleff and
Aoyagi, 2012; Couto and Sanroman, 2006). Smaller soybeans are best because of the increased
surface area for contact with the culture. However, if soybeans are too small, substrate
agglomeration can occur, compromising the growth of the culture (Couto and Sanroman, 2006)
There are two popular kinds of natto in Japan known as Itohiki-natto (unsalted), and Hama-natto
(salted). Another variation of natto known as cracked natto is made with beans that are cracked
prior to cooking (Shurtleff and Aoyagi, 2012; Kiuchi et al., 1976). During the fermentation
process, soybeans are penetrated by B. subtilis natto, breaking down peptides during
fermentation to produce viscous strings made of 58% γ-polyglutamic acid and 40%
polysaccharides including fructans synthesized from soybean proteins and sugars (Ichishima et
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al., 1982; Kiuchi et al., 1976; Besson et al., 1997). In mammalian nutrition, glutamic acid is not
considered an essential amino acid. However, glutamic acid is used in the production of protein
within the body, to coagulate milk as a replacement for calf rennin during cheese making, and
also to yield vitamin K after post-translational modification (Kanecki et al., 2001; Shieh et al.,
2009). Glutamic acid causes the natto to have a savory flavor to humans, contributing to the
taste (Besson et al., 1997).
Free fatty acids as well as alkylpyrazines found within the viscous strings also contribute
to the flavor of the natto. The flavor becomes stronger as fermentation time increases (Kiuchi et
al., 1976; Besson et al., 1997). Specifically, 2,5-dimethylpyrazine and tetramethylpyrazine,
common flavoring agents of either Maillard reaction or microbial origin are used in the food
industry to provide a nutty or roasted flavor (Besson et al., 1997; Kosuge et al., 1962) Both of
these compounds are produced during fermentation and contribute to the strong flavor of natto
(Besson et al., 1997; Kosuge et al., 1962). Although it is made in small batches and is
recommended to be consumed quickly, natto can be kept up to two weeks until the desired
thickness is achieved and in turn, the desired flavor from aging of the viscous layer, is reached
(Steinkrauss, 2004; Kiuchi et al., 1976). This process tends to occur between the 3rd and 6th day
of aging as B. subtilis natto cells autolyze, but proteolysis continues, contributing to the flavor of
the dish (Tanaka et al., 1977; Besson et al., 1997). Tetramethylpyrazine is produced in much
larger quantities around day 12 whereas 2,5-dimethylpyrazine is produced in higher quantities
earlier in incubation (Besson et al., 1997; Kosuge et al., 1962) The 2,5-dimethylpyrazine is
synthesized from L-threonine whereas tetramethylpyrazine is synthesized from acetoin and free
fatty acids. The concentrations of these components peak at day 2. Therefore, depending on the
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quality of the soybeans, the flavor may be subject to change (Besson et al., 1997; Kosuge et al.,
1962; Zhang et al., 2014).
Enzymes and other beneficial substances are also produced during the fermentation
process such as subtilisin, nattokinase, α-amylase, alkaline proteinase, vitamin B12, fibrinolysis
accelerating substance, menaquinone-7 (vitamin K2), and dipicolinic acid (DPA) (Ichishima et
al., 1982; Kiuchi et al., 1976; Matsubara, et al., 1998; Oshugi et al., 2005; Sumi et al., 1995;
Sumi et al., 2004). Vitamin B12 is produced in the rumen of ruminant animals and ruminant meat
is the largest source of mammalian vitamin B12 in the human diet. However, natto is one of the
only plant-based sources of vitamin B12 for human consumption (Ichishima et al., 1982).
Subtilisin is a strong proteolytic enzyme, similar to nattokinase, which breaks peptide bonds
within the legumes, allowing for deeper penetration of the bacteria as fermentation progresses
(Shurtleff and Aoyagi, 2012; Matsubara, et al., 1998; Fujita et al., 1993). Nattokinase is an
alkaline protease of 275 amino acid residues that has fibrolytic, antithrombotic, antihypertensive,
anti-atherosclerotic, antiplatelet, anticoagulant, lipid lowering, and neuroprotective properties
(Kwon et al., 2011; Chen et al., 2018). Nattokinase is a natural substance that has a resounding
positive effect on cardiovascular health and out-competes any synthetic substance currently on
the market (Kwon et al., 2011; Chen et al., 2018).
Fibrin is formed when platelets in the blood stream encounter damaged areas within the
vessel and membrane phospholipids are activated to form a clot. Thereafter, fibrinogen forms
tough fibrin threads to block the flow of blood, reducing blood loss (Sumi et al., 2004; Kwon et
al., 2011; Chapin and Hajjar, 2015). Increased fibrin stabilizes a clot but also makes it more
difficult for the clot to deteriorate, which may block blood flow elsewhere if the clot detaches
prior to degradation (Sumi et al., 2004; Chapin and Hajjar, 2015) In the case of cardiovascular
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diseases, this process can lead to death, and is the cause of 31% of deaths worldwide (Fujita et
al., 1993; Chapin and Hajjar, 2015; Chen et al., 2018). Nattokinase is four times more potent
than plasmin in degradation of thrombi and has high efficacy especially for an oral supplement
(Fujita et al., 1993; Sumi et al., 2004; Chen et al., 2018). When compared to commercial blood
thinners, nattokinase has greater potency with fewer side effects such as inhibition of platelet
aggregation, which enables it to slow the progression of plaque formation while reversing
atherosclerosis (Fujita et al., 1993; Okamoto et al., 1995; Chen et al., 2018). Nattokinase also
decreases hypertension by inhibiting angiotensin-converting enzyme, which is responsible for
production of angiotensin, a hormone that raises blood pressure (Okamoto et al., 1995; Chen et
al., 2018). It is also capable of degradation of amyloid fibrils, which play a role in progression of
Alzheimer’s disease (Sumi et al., 1995; Chen et al., 2018). Nattokinase has many beneficial
characteristics related to human cardiovascular health, which is why consuming natto is
beneficial to more than just the digestive system (Fujita et al., 1993; Sumi et al., 2004; Chen et
al., 2018). Dipicolinic acid (DPA) also has an anticoagulant effect and inhibits formation of
fibrin (Ichishima et al., 1982; Oshugi et al., 2005). B. subtilis natto produces DPA because it is a
spore forming bacterium. DPA binds tightly to calcium and water molecules within the core,
dehydrating the spore, thus protecting DNA from degradation during excessive heating, enabling
survival through extreme temperatures such as cooking (Oshugi et al., 2005). Sporulation also
allows habitation of the small intestine which increases weight gain, feed efficiency and fecal
flora composition in poultry and humans (Terado et al., 1999; Samanya and Yamauchi, 2002;
Hong et al., 2009). Combined with the effects of nattokinase, DPA increases the cardiovascular
health benefits of consuming natto.
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Vitamin K is also an important component of the cardiovascular system and bone
structure. Vitamin K acts as a posttranslational cofactor for modification of glutamic acid
residues to form γ-carboxyglutamic acid residues, which are important in binding and retaining
free calcium (Kanecki et al., 2001; Schurgers et al., 2007). The liver, kidney, spleen and
placental tissues also require the presence of vitamin K and its derivatives for normal function
(Kanecki et al., 2001; Schurgers et al., 2007). Vitamin K1, or phylloquinone, is a blood
coagulation factor found in leafy green vegetables. Vitamin K2, menaquinone-n, is a bone
density factor created by two different sources which are animal metabolism and bacterial
fermentation (Schurgers and Vermeer, 2000; Kanecki et al., 2001; Schurgers et al., 2007).
Menaquinone-4 (MK-4) is produced by animal tissues, whereas menaquinone-7 (MK-7) is only
produced by bacterial fermentation and is abundant in natto (Kanecki et al., 2001; Schurgers et
al., 2007). In natto, glutamic acid is produced in the mucoid strings. Glutamic acid is a
precursor for the beneficial γ-carboxyglutamic acid residues needed in the body that not only
bind free calcium, but are also involved with osteocalcin, a protein that drives calcium into bones
(Schurgers et al., 2007; Berenjian et al, 2012). This process helps prevent osteoporosis and
maintains bone health, providing strength against fractures specifically in the neck and hip
regions where older individuals are likely to have impact fractures (Schurgers et al., 2007).
Natto is currently the most vitamin K2 dense food available and by adding glycerol to the natto
culture, MK-7 production increases, providing increased health benefits from a single food
source (Kanecki et al., 2001; Schurgers et al., 2007; Berenjian et al, 2012).
Soybeans fermented with B. subtilis natto are a great source of enzymes and proteins that
benefit the human digestive and cardiovascular system. The question remains, however, if
fermented soybeans are the only legume capable of creating such vast amounts of these
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substances. The objective of this study was to determine if other legumes, such as chickpeas and
lentils, could be fermented with B. subtilis natto to make natto. It was hypothesized that if natto
can be made using different legumes, then production of the vitamins and enzymes related to
cardiovascular and bone health may also be produced in new food products.

MATERIALS AND METHODS

Fermentation and Plate Count
Reagents
Class O dilution buffers were mixed according to the procedure described by Marshall,
1992 (Marshall, 1992). Stock solutions of magnesium chloride (38 g/L ddH2O), and potassium
dihydrogen phosphate (34 g/ 500 mL ddH2O) were prepared separately. The potassium
dihydrogen phosphate solution was adjusted to a pH of 7.2 using 1N sodium hydroxide. Class O
buffers contained 1.25 mL/L of the phosphate solution and 5 mL/L of the magnesium chloride.
Dilution bottles were filled with 102 mL each to account for evaporation in the autoclave; the
resulting volume in each was 99 mL. Dilution bottles were sterilized in the autoclave at 121°C
for 20 minutes. Trypticase Soy Broth (TGY) and Standard Plate Count (SPC) (Becton
Dickinson and Co. Sparks, MD) were prepared according to the label instructions using ddH2O.
Media was autoclaved at 121°C for 20 minutes.

Legumes
Chickpeas (Palouse Brand, Palouse, WA), soybeans (Soymerica, IA), and lentils (Food to
Live, Brooklyn, NY) were ground to 2 mm using a Wiley Mill and 2 mm stainless-steel sieve
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(Thomas Scientific, Swedesboro, NJ). Legumes, both whole and ground, were weighed (100 g
dry weight) and soaked in 1,000 mL ddH2O in a 1L flask overnight at 25°C (Raghuvanshi and
Bisht, 2010). At 100°C, soybeans absorb water equal to their weight between 15 minutes to 2
hours (Raghuvanshi and Bisht, 2010). Therefore, all legumes were combined with 1L of
additional ddH2O and were boiled at 100°C for two hours in a stainless-steel pot until tender
(Raghuvanshi and Bisht, 2010). Whole and ground legumes were boiled simultaneously to
ensure each ground legume was boiled for the same duration as its whole bean counterpart.
Legumes, ground and whole, were sieved using a sterile, stainless-steel sieve and transferred to
two sterile, 9 inch, disposable aluminum pie pans. Each legume was spread evenly in the pan
using a sterile spatula and the resultant legumes were approximately 2 cm thick in each pan.
Pans were covered with sterile aluminum foil.

Culture
NattomottoTM starter culture (Yuzo Takahashi Laboratory, Japan) (1 g) was added to 3
mL of sterile TGY broth (pH 7.0) for rehydration and was aseptically streaked for isolation on
five agar plates for colony isolation (Wang et al., 2009). Plates and broth culture were incubated
overnight at 37°C aerobically (Wang et al., 2009). Plates were examined at 18 hours of
incubation and isolated colonies were Gram stained for strain confirmation. A single, isolated
colony of Bacillus subtilis natto was selected to inoculate a 1L flask of TGY broth (pH 7.0) and
was incubated at 37°C aerobically for 24 hours (Wang et al., 2009). The flask was vigorously
shaken for 30 seconds and 1 mL of culture was transferred to 1L of fresh TGY broth and
incubated for 24 hours in preparation for inoculation.
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Solid-State Fermentation
Each sterile pan of whole and ground legumes was inoculated with 1 mL/100g of the
cultured broth (6.68 log cfu/g), which was spread and stirred to evenly distribute in each pan of
legumes. Using sterile spatulas for each, the samples were thoroughly mixed and covered for
aerobic incubation at 37°C for 24 hours. A time 0 hr and 24 hr, a sample was collected
aseptically from each tray (10 g) and was stored at 4°C in the refrigerator until plating. An
additional sample was taken at time 0 hr and 24 hr (50 g) for enzyme and vitamin analysis.
Legume samples were then processed with a Stomacher (400 Tekmar Company, Cincinnati, OH)
in a Whirlpack™ bag (Nasco, Fort Atkinson, WI) for 1 minute, and 1 g was transferred to 99 mL
of dilution buffer for both 0 hr and 24 hr plating samples. Samples were then plated in duplicate.
Each 1 mL transfer to a new dilution bottle was thoroughly mixed by shaking dilution bottles for
30 seconds in a 1-foot arc (Marshall, 1992). SPC was poured over the plated sample and Petri
dishes were swirled until the surface of the plate was fully covered and the sample was mixed
throughout the Petri dish. After solidification, plates were incubated at 37°C for 24 hours.
Media and dilution blank controls were plated to ensure sterility.

Enzyme Analysis
Nattokinase Extraction and Purification
Fermented legumes (10 g) were processed in sterile bags with a Stomacher (400 Tekmar
Company, Cincinnati, OH) for 2 minutes at room temperature and mixed with 25 mL of 0.9%
sterile saline (Fujita et al., 1993; Sumi et al., 2004; Zu et al., 2010; Yang, 2015). Samples were
shaken for 40 minutes at 90 rpm in a shaking water bath at room temperature (Precision
Scientific Group, Chicago, IL) then combined with 95% ethanol at a ratio of 3:4 ethanol to saline
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(Fujita et al., 1993; Zu et al., 2010). Samples were centrifuged at 8,000 rpm at 4°C for 30
minutes then filtered through a stainless-steel sieve and combined with 30 g of (NH4)2SO4 to salt
out the crude nattokinase (Wang et al., 2009; Zu et al., 2010; Hmood and Aziz, 2016). The
solution was then centrifuged for 30 minutes at 12,000 rpm (Sumi et al., 2004; Zu et al., 2010).
The supernatant was removed and filtered through Whatman No. 1 filter paper (Cytiva,
Marlborough, MA) and used for determination of fibrinolytic activity via casein and fibrin
degradation (Sumi et al., 2004).

Casein Degradation Method
Sterile casein agar was made using 50 g of non-fat dry milk and 10 g of agar dissolved in
1L of ddH2O after being autoclaved at 121°C for 20 minutes (Mishra et al., 1980; McGinnis et
al., 1982; Murray et al., 2007). Agar was poured into 150 mm × 15 mm petri dishes to set before
six 2 mm wells were cut aseptically in the agar (Mishra et al., 1980; McGinnis et al., 1982;
Murray et al., 2007). Extracted nattokinase sample (1 mL) was added to each well in triplicate
and was left at room temperature for 24 hours for the initial evaluation and two weeks for the
final evaluation (Mishra et al., 1980; McGinnis et al., 1982; Murray et al., 2007). A positive test
was defined as clearing of casein around and/or under microbial growth indicating full
hydrolysis (Mishra et al., 1980; McGinnis et al., 1982; Murray et al., 2007). A negative test was
defined as growth with no clearing of the medium (Mishra et al., 1980; McGinnis et al., 1982;
Murray et al., 2007) (Figure 3.1).
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Positive Control

Negative Control

Figure 3.1. Casein degradation by purchased nattokinase (left) compared with
saline solution (right).
Fibrin Degradation Method
Bovine blood was collected by an IACUC approved protocol in serum tubes
(Vacutainer™ tube without a clotting agent; red cap). Degradation of the clot was determined on
a scale of 1 to 5 where 1 was no clot degradation and 5 was complete liquefaction of the clot
(Figure 3.2). The scale was created by dissolving a commercially available nattokinase
supplement (2000 FU/100 mg) in 5 mL of 0.9% saline and distributing in a scale of plates 5, 4, 3,
and 2. Plate 1 received a saline blank. Clots were incubated for 4 hours to allow for clot
degradation prior to being photographed to create the scale of degradation. Blood was transferred
aseptically to 1 mL aliquots and allowed to clot for one hour. Extracted nattokinase samples
(inoculated and uninoculated,1 mL) were added to each blood clot, shaken vigorously, and
incubated at 37°C for 12 hours (Zu et al., 2010; Minh et al., 2022). Clots were evaluated for
degradation at 4, 6, 8, and 12 hours.
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2

3

4

5

Figure 3.2. Fibrin degradation scale based on degradation by purchased nattokinase.
A score of 1 (left) is no clot degradation whereas a score of 5 (right) is full enzymatic
degradation of the clot.

Vitamin Analysis
Chemicals
MS grade ammonium hydroxide, ammonium formate, acetonitrile, hexane, and 2propanol were purchased from ThermoFisher Scientific (Waltham, MA). Phylloquinone (K1)
(≥99% purity), menaquinone MK-4 (≥95% purity), menaquinone MK-7 (≥99% purity), and MS
grade formic acid were purchased from Sigma Aldrich (St. Louis, MO). MS grade methanol was
purchased from VWR Laboratories (Radnor, PA). Stock solutions were prepared in methanol
for K1, MK-4, and MK-7. Standards were stored at -20°C in opaque vials to prevent
photochemical degradation and were diluted at 8 intervals to create a standard curve.

Extraction of Fat-Soluble Vitamins
Legume samples (3 g) were processed using a sterile bag in a Stomacher (400 Tekmar
Company, Cincinnati, OH) for 2 minutes at room temperature and then were placed in a sterile
polypropylene tube wrapped in aluminum foil to prevent photochemical degradation of the
vitamins. Samples were then combined with 200.25 µL of phylloquinone, menaquinone-4 (MK146

4), and menaquinone-7 (MK-7) in methanol (2.5 × 10-7 mol/L) as an internal standard (KoivuTikkanen, 2001). Isopropyl alcohol (15 mL) was added, and samples were digested in a boiling
water bath for 10 minutes after which they were cooled to room temperature (Koivu-Tikkanen,
2001). An additional 10 mL of isopropyl alcohol was added to the sample and samples were
vigorously mixed for 2 minutes. Hexane (10 mL) and ddH2O (10 mL) were added and samples
were vigorously mixed again for 2 minutes then were shaken at 90 rpm in a shaking water bath at
room temperature (Precision Scientific Group, Chicago, IL) (Koivu-Tikkanen, 2001). Samples
were centrifuged at 1500 × g for 5 minutes (Koivu-Tikkanen, 2001). The organic layer was
removed and evaporated under nitrogen to dryness and reconstituted in methanol for UPLC-MS
analysis (Koivu-Tikkanen, 2001).

UPLC-MS/MS
Samples were analyzed on a Waters Acquity H class ultra-performance liquid chromatography
(UPLC) machine (Waters, Milford, MA) with a Xevo TQ-S quadrupole mass spectrometer
coupled with electrospray ionization (ESI). The autosampler was a Waters Acquity H Class UPLC
Quaternary Solvent Manager. Data was acquired using MassLynx Software v. 4.2. Optimized
multiple reaction monitoring (MRM) acquisition methods were developed using Intellistart
Technology for all vitamin standards (Table 3.1; Table 3.2). Three MRM transitions were
optimized for each vitamin standard using the first transition for quantification and the second for
qualification and confirmation of the compound. Dwell times were automatically optimized to
provide a minimum of 12 inflection points across each chromatographic peak for reproducible
quantification. Linearity of the UPLC-ESI-MS/MS method was evaluated by injecting mixtures
of the K1, MK-4, and MK-7 compounds which covered the range of 5×10-9 to 1×10-6 ng/mL with
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an R2 value of ≥0.99 for each standard. Calibration standards were newly run on the same day with
each run of kefir samples; blank samples were analyzed first and between samples to prevent
carryover. A Waters Acquity UPLC BEH C18 column (2.1 × 100 mm, 1.7 µm particle size) was
used for separation of vitamin K compounds. The mobile phase A was MeOH with 0.1% formic
acid (pH 4.11) and the mobile phase B was water with 0.1% formic acid (pH 3.16). The flow rate
was 0.8 mL/minute with an initial composition of 55% A (Table 3.3).
Limits of detection (LOD) and limits of quantification (LOQ) were established as signal to
noise ratios.

LOD was considered 3 times the background noise signal adjacent to the

corresponding peak and LOQ was considered 10 times the background noise signal. These values
were calculated from duplicated sample analysis.

Spiked samples were used to determine

extraction method efficiency, effect of matrix, and recovery of spiked standards. Quantification
calculations were completed based on the standard curve and the internal standard vitamin K1
levels in legume samples. Standard curves were plotted to determine the concentration of
integrated peak area where the x-axis represented concentration (ng/mL) and the y-axis
represented area under the curve for each vitamin standard. Linearity was used to calculate sample
concentrations using the slope and intercept for each standard, respectively.

Statistics
Data were analyzed using ANOVA based on a completely randomized design, followed
by Fisher’s protected least significant difference test to separate means when the ANOVA
indicated a treatment effect. All statistical calculations were performed using JMP Pro 16 (Cary,
NC). P-values less than 0.05 were considered evidence of statistical significance.
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Table 3.1. The ion transitions and the corresponding MS parameters used for the vitamin K
standards in legume samples fermented with Bacillus subtilis natto.
Vitamin K1

Vitamin K2

Vitamin K2

(Phylloquinone)

(Menaquinone-4)

(Menaquinone-7)

451.22

445.160

648.50

105.01

81.00

81.06

128.17

95.08

95.07

187.04

187.04

187.1

Quantification Ion (m/z)

187.04

187.04

187.1

Cone Voltage (V)

5

70

50

54

26

40

66

24

30

26

18

34

Dwell Time (s)

0.033

0.033

0.033

Retention Time

2.40

2.81

3.96

Item

Precursor Ion (m/z)

Product Qualifier Ions (m/z)

Collision Energy (V)
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Table 3.2. Tandem quadrupole mass spectrometer conditions for vitamin K separation in legume
samples fermented with Bacillus subtilis natto.
Item
Polarity

ESI+

Capillary (kV)

3.70

Source Temperature (°C)

10

Desolvation Temperature (°C)

600

Cone Gas Flow (L/hr)

450

Desolvation Gas Flow (L/hr)

1000

Collision Gas Flow (mL/min)

0.16
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Table 3.3. UPLC gradient profile analysisa for vitamin K in natto.

a

Time (min)

Mobile Phase Ab, %

Mobile Phase Bc, %

Flow Rate (mL/min)

Initial

45.0

55.0

0.8

0.25

45.0

55.0

0.8

3.50

95.0

5.0

0.8

4.50

95.0

5.0

0.8

4.51

45.0

55.0

0.8

5.50

45.0

55.0

0.8

The sample manager was held at a constant 10°C and column temperature at 85°C. Prior to each

sample run, the needle was washed with a weak (water) and strong (5% ammonium carbonate,
95% acetonitrile, pH 10.10) wash. The seals were also washed with 20% methanol.
b

c

Mobile phase A = methanol with 0.1% formic acid adjusted to a pH of 3.18.

Mobile phase B = water with 0.1% formic acid adjusted to a pH of 4.18.

RESULTS

Solid-State Fermentation
SPC media is used for the total mesophilic aerobic plate count. Day 0 post-inoculation,
pre-fermentation microbial counts were significantly different across legumes (P <0.0001).
Ground lentils had the greatest (5.93 cfu/g) compared with chickpeas (2.09 cfu/g) and soybeans
(2.00 cfu/g; Table 3.4). Day 1 post-fermentation microbial counts were significantly different (P
<0.0001) across legumes. Soybeans (9.03 cfu/g), ground chickpeas (8.99 cfu/g) and chickpeas
(8.93 cfu/g) were greater than other legumes but were not different from one another (Table 3.4).
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Ground lentils (8.65 cfu/g) were different from ground soybeans (8.30 cfu/g), and lentils (7.46
cfu/g). Across whole beans, soybeans and chickpeas were similar (P = 0.1153), however, lentils
had lower bacterial counts than both soybeans and chickpeas (P <0.0001). Ground chickpeas (P
<0.0001) had the greatest bacterial counts followed by ground lentils and finally by ground
soybeans (P <0.0001). Whole soybeans and ground soybeans were significantly different (P
<0.0001) where soybeans contained greater mean log cfu/g bacteria. Whole chickpeas were not
different from ground chickpeas (P = 0.3498). Whole lentils and ground lentils were
significantly different (P <0.0001) where ground lentils had greater bacterial counts than whole
lentils.
Dry matter (DM) was different across legumes (P <0.0001). Soybeans had the greatest
percent DM followed in decreasing order by chickpeas, lentils, ground chickpeas, ground lentils,
and ground soybeans (Table 3.4). All legumes, whole and ground, had similar percent DM
compared with their control, uninoculated counterparts. However, inoculated ground chickpeas
(35.12%) and control, uninoculated ground chickpeas (31.75%) were statistically different (P =
0.0356) but were numerically similar (Table 3.4).
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Table 3.4. Microbial enumeration of different legume substrates and dry matter content. Whole
beans compared with ground beans (2 mm) fermented by Bacillus subtilis natto. Values not
connected by the same letter are significantly different (P <0.0001).
Percent Dry

Casein

Fibrin

Matter

Degradation

Degradation

(Y/N)

(1-5)

Log
Legume
CFU/g

Soybeans

9.03a

43.54A

Yes

3.5

Chickpeas

8.93a

37.72B,C

Yes

3.0

Lentils

7.46d

33.87D,E,F

Yes

3.0

Ground Soybeans

8.30c

30.58G,H

Yes

3.0

Ground Chickpeas

8.99a

35.12C,D,E

Yes

3.0

Ground Lentils

8.65b

30.85F,G,H

Yes

3.0

Control Soybeans

0.00e

43.44A

No

1.0

Control Chickpeas

0.00e

38.83B

No

1.0

Control Lentils

0.00e

35.46C,D

No

1.0

Control Ground Soybeans

0.00e

28.37H

No

1.0

Control Ground Chickpeas

0.00e

31.75F,G

No

1.0

Control Ground Lentils

0.00e

32.35E,F,G

No

1.0

Casein Degradation
Casein protein degradation was negative in the day 0, post-inoculation, pre-fermentation
samples and in the control, uninoculated samples. Day 1 post-fermentation samples for all whole
and ground legumes were positive for casein degradation compared with control samples (P =
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0.0127). A positive test was confirmed by a clear zone around the inoculated well cut in the
casein plate. Clearing of the casein indicated degradation of the protein by the sample.

Fibrin Degradation
Fibrin degradation was negative in the day 0, post-inoculation, pre-fermentation samples
and in the uninoculated, control samples. Day 1 post-fermentation samples were significantly
different across legumes (P <0.0001). Soybeans had the greatest degradation score of all
legumes, whole and ground (3.5 vs. 3.0, respectively; P = 0.0306). All uninoculated, control
legumes were negative for fibrin degradation.

Vitamin Analysis
Results of UPLC analysis of production of vitamin K2 vitamers from B. subtilis natto
indicate presence of vitamin K1, MK-4, and MK-7 across all inoculated and incubated samples of
whole and ground soybeans, chickpeas, and lentils. Uninoculated control samples contained
only vitamin K1 as is expected from a legume sample.

DISCUSSION
Three common legumes, soybeans, chickpeas, and lentils were fermented using Bacillus
subtilis natto bacterium to compare the products of fermentation across substrates. These
legumes were compared depending on particle size. Both whole beans and beans ground to 2
mm were fermented in duplicate. It was expected that soybeans, both whole and ground, would
ferment using Bacillus subtilis natto more readily than chickpeas and lentils. However, whole
soybeans, whole chickpeas, and ground chickpeas each had the highest bacterial enumeration
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across samples (Table 3.4). It was also expected that ground versions of each legume would
ferment more rapidly than their whole bean counterparts due to the increased surface area
available for fermentation. However, this was not observed in this study. Despite being
inoculated with the same bacterial concentration at the same rate and time, there was great
variation in the bacterial growth of each substrate. This could be due to a difference in
nutritional profile of the substrate, a difference in particle size of the whole legumes, a difference
in water absorption across whole and ground legumes during the rehydration step, or a difference
in seed shape impacting available surface area (Escamilla et al., 2019). The hydration step is
important in the fermentation of natto because soluble sugars are released once the seeds are
softened, which improves the fermentation and quality of natto (Hosoi and Kiuchi, 2003;
Escamilla et al., 2019). Small sized, uniform beans are preferred for natto consumption due to
their increased surface area compared with larger beans of the same type. Smaller surface area
allows for greater absorption of water which results in less cooking time. In this study, legumes
were uniform in size within their groups (soybeans, chickpeas, and lentils). However, compared
to each other, lentils were considered extra small (<5.5 mm) and had a flattened circular shape,
soybeans were spherical and considered small (5.5 mm to 7.3 mm) and chickpeas were bumpy
and spherical and considered medium (7.3 mm to 7.9 mm) (Escamilla et al., 2019). It was
expected that whole lentils would have greater mean log cfu/g plate counts compared with whole
soybeans due to the smaller size; however, whole lentils had significantly lower mean log cfu/g
compared to whole soybeans and chickpeas (7.46 log cfu/mL vs. 9.03 log cfu/g and 8.93 log
cfu/g, respectively). On average, soybeans by composition are 36.5% protein, 19.9% lipid, and
30.2% carbohydrate (USDA ARS, 2019). Chickpeas by composition are 8.86% protein, 2.59%
lipid, and 27.4% carbohydrate (USDA ARS, 2019). Lentils by composition are 24.6% protein,
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1.06% lipid, and 63.4% carbohydrate (USDA ARS, 2019). It was anticipated that whole lentils
would have a greater mean log cfu/g plate count than soybeans and chickpeas due to the greater
carbohydrate content of lentils. However, it is possible that the soluble carbohydrates in lentils
were lost during the cooking and/or sieving steps, thereby, reducing availability of carbohydrate
for the culture. Carbohydrate content was not measured in this study but should be measured in
future studies. Protein is also used as a substrate by B. subtilis natto (Guo et al., 2018).
According to the USDA ARS (2019) values, protein content is not the same across the three
legumes tested in this study. B. subtilis natto ferments starches and proteins and creates a variety
of functional compounds (Guo et al., 2018). The protein content is greater in soybeans and
lentils than in chickpeas. However, chickpeas had a greater mean log cfu/g plate count than
lentils, indicating that protein content alone is not responsible for the fermentation quality of
legume substrates. Likely, a combination of carbohydrate and protein matrix is involved in the
optimal fermentation of different legumes, which needs to be further studied (Guo et al., 2018).
Particle size was compared in this study where each whole legume was ground to 2 mm
and fermented with the same amount of B. subtilis natto. Particle size is known to impact
fermentation and water absorption due to the increase in surface area as particle size decreases.
Ground chickpeas were comparable to whole soybeans and whole chickpeas in mean log cfu/g
(Table 3.4). Substrate conglomeration can occur when particle size is too small during the
fermentation of natto, reducing overall bacterial growth and negatively impacting product quality
(Guo et al., 2018). It was expected that some substrate conglomeration would occur in this
study. However, ground chickpeas were comparable in mean log cfu/g plate count values to
whole soybeans and chickpeas when fermented. Although ground lentils had lower plate count
cfu/g values, they were still comparable to ground chickpeas, whole soybeans, and whole
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chickpeas as opposed to ground soybeans (Table 3.4). It is possible that substrate
conglomeration occurs in soybeans but is less influential in chickpeas and lentils.
Comparatively, ground soybeans were less sticky than ground chickpeas. Ground lentils were
almost a paste in comparison so it may be possible that a quadratic effect may be present based
on particle size; however, this hypothesis was not tested in this study.
Dry matter content of legumes was measured in this study. Compared to control legumes
of the same particle size, all legumes were similar in DM content, except for ground chickpeas
(35.12%) and control ground chickpeas (31.75%). The control and ground chickpeas were
statistically different in percent DM; however, they were numerically similar to one another,
which likely did not influence the fermentation in this study (Table 3.4). Soybeans had the
greatest percent DM and the greatest mean log cfu/g plate count compared to other treatments
(Table 3.4). Chickpeas and ground chickpeas had the next greatest percent DM compared to
ground soybeans, ground lentils, and whole lentils (Table 3.4). It is possible that the percent DM
had a negative impact on fermentation for the ground soybeans, ground lentils, and whole lentils
because the mean log cfu/g of those samples is low compared to whole soybeans, whole
chickpeas, and ground chickpeas (Table 3.4). More research is needed to determine the optimal
percent DM of chickpeas and lentils for fermentation by B. subtilis natto, and to further
understand what other factors are influencing fermentation.
Casein degradation was consistent across all samples. The degradation of casein
indicated a proteolytic enzyme was present in all legumes fermented with B. subtilis natto,
whether whole or ground. This does not quantify the amount of proteolysis; however, it does
indicate the bacterial fermentation of each substrate does produce a proteolytic enzyme. Results
indicated uninoculated control samples had no degradation of casein agar between 24 hrs and 2
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weeks. B. subtilis natto produces a variety of proteolytic enzymes including nattokinase and the
serine protease, subtilisin. Subtilisin degrades peptides which is why a confirmation method was
required to determine if the proteolytic enzyme noted on the casein agars would degrade fibrin in
blood clots. Nattokinase is capable of fibrin degradation whereas subtilisin is not. Whole
soybeans had the greatest fibrin degradation of all samples; however, all other samples were
qualitatively similar to the degradation capacity of soybean extracted nattokinase. Control,
uninoculated samples had no proteolytic activity as noted on the casein agar and blood clot
experiments. Therefore, the results of this study indicate that using soybeans, chickpeas, or
lentils during fermentation with B. subtilis natto results in similar production of nattokinase.

CONCLUSION

In this study, fermentation of whole and ground (2 mm) soybeans, chickpeas, and lentils
with B. subtilis natto results in fermented products with similar functional properties. B. subtilis
natto successfully grew on all three legumes, whole and ground, as determined by plate count
values. The impact of particle size appeared to be significant, resulting in lower plate counts.
Percent DM was different across samples with ground soybeans absorbing the most moisture.
Results of this study indicate that using soybeans, chickpeas, or lentils yields similar production
of the fibrinolytic enzyme, nattokinase. This study concludes that new functional food products
could be made by fermenting chickpeas and lentils with B. subtilis natto. Further research would
need to be conducted to determine flavor profiles and consumer acceptability.
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CHAPTER FOUR
BORON CONTENT OF RENDERED ANIMAL PRODUCTS

ABSTRACT

The boron content was measured in a variety of different rendered animal products (n =
66) and plant feedstuffs (n = 23) using an inductively coupled plasma-optical emission
spectrometer equipped with a UV-Plus Purifier gas cleaning system with argon gas flow and a
Cetac autosampler. There was a significant difference in boron content among rendered animal
products where meat and bone meal (MBM) had the greatest boron content (2.54 ± 0.24 mg/kg),
and feather meal (FM) had the lowest boron content (0.33 ± 0.13 mg/kg; P <0.0001). Of plant
feedstuffs analyzed, soybeans had the greatest boron content (31.66 ± 2.37 mg/kg), and barley
had the lowest boron content (0.97 ± 0.21 mg/kg; P <0.0001). Among all products tested,
soybeans had the greatest boron content. However, it is not known if there are differences in
nutritional absorption between plant-based boron sources versus rendered animal by-product
boron sources. Boron content varies in rendered animal products and plant feedstuffs; additional
research is needed to compare boron absorption from these products.

INTRODUCTION

Boron is an important nutrient involved in a large number of health-related processes in
the body including prevention of arthritis, enhancing hormonal function, ensuring embryonic
development, maintaining proper cell membrane function, prevention of osteoporosis and in
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formation of bones (Howe, 1998; Nielsen, 2000; Pizzorno, 2015; Ali et al., 2020). Boron is
involved in reducing risk of congestive heart failure, reducing plasma lipid levels, improving
brain function and also in fighting fungal infections (Howe, 1998; Nielsen, 2000; Pizzorno,
2015; Messner et al., 2022). Proper boron levels are associated with lower risk of lung, cervical,
and prostate cancer and even ability to inhibit progression of prostate cancer (Fernandes et al.,
2019; Ali et al., 2020; Messner et al., 2022).
Boron is considered an essential micronutrient for plant growth but is listed as a nonessential mineral in animal diets (Bialek et al., 2019; Hunter et al., 2019; Kome et al., 2019; Raj
and Raj, 2019). While plants require boron for multiple biological processes including
metabolism, structural growth, and reproduction, boron has yet to be adopted as an essential
micronutrient in human and animal diets despite the knowledge that this mineral is highly
involved in mineral metabolism, immune function, and bone health (Parr and Loughman, 1983;
Devirian and Volpe, 2003; Hunter et al., 2019; Raj and Raj, 2019). Dietary boron is derived from
consumption of plants by both humans and animals (Tolgyesi, 1989; Kome et al., 2019; U.S.
Department of Health and Human Services; Nielsen and Eckhertt, 2020). Accumulation of boron
is mainly in bone tissue, but some boron is present in soft animal tissues depending on the diet of
that animal (U.S. Department of Health and Human Services, 2010; Uluisik et al., 2018; Bialek
et al., 2019).
In plants, boron is a key component of sugar transport, cell wall structure, membrane and
plasma membrane integrity, K+ ion activity, plant reproduction, and many other developmental
processes of the plant life cycle (Parr and Loughman, 1983; Serrano, 1989; Cheng and
Rerkasem, 1993; Raj and Raj, 2019). Elemental boron is not found in the soil. However, borates
are found in sedimentary rock, shale, coal, and soil in a range of approximately 5 mg B/kg in
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basalts to approximately100 mg B/kg in shales in the Earth’s crust. The greatest quantities of
borates are found in the United States and Turkey (Whetstone et al., 1941; Hopewell et al., 2011;
Horiguchi et al., 2015; Bialek et al., 2019). The abundance and availability to plant tissues is
related to soil boron content, moisture, and pH (Bialek et al., 2019; Kome et al., 2019; Raj and
Raj, 2019). Sandy soils and soils with elevated lime content tend to have reduced boron content
and availability (Whetstone et al., 1941; Sharma et al., 2018).
In the animal, boron influences metabolism of Ca, P, Al, Mg, vitamin D, triglyceride,
glucose, as well as amino acid, estrogen, testosterone, and Vitamin D3, enzyme, and antioxidant
mechanisms (Devirian and Volpe, 2003; Rogoveanu et al., 2015; Bialek et al., 2019; Hunter et
al., 2019). Plants can use inorganic sources of boron for growth; however, humans and animals
typically consume mono- or di-sugar-borate esters, which are found in herbs, vegetables, fruits,
nuts, and seeds, but are also able to absorb inorganic forms of boron (Bialek et al., 2019; Hunter
et al., 2019; Nielsen and Eckhertt, 2020). Absorption of boron from consumed food sources is
approximately 90% (Rondanelli et al., 2020). Insufficient intake of boron compounds results in
joint inflammation, bone loss, osteoporosis, and decreased brain and immune function (Nielsen,
2008; Rogoveanu et al., 2015; Nielsen and Eckhertt, 2020; Rondanelli et al., 2020). Many of
these maladies are a result of disrupted Ca, Mg, and hormone metabolism in response to
inadequate boron intake (Naghii and Samman, 1993; Rogoveanu et al., 2015; Nielsen and
Eckhertt, 2020). Due to its extensive importance in plant growth, development, and reproduction,
it would be a fair assumption that boron should be considered an essential micronutrient in
animal nutrition. Research indicates that intake of boron from animal sources requires less daily
consumption as compared with plant sources, despite plant sources having a greater
concentration of boron (0.1 to 0.6 mg B/100g plants vs. 0.01 to 0.06 mg B/100g animals)
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(Devirian and Volpe, 2003; Hunter et al., 2019; Kome et al., 2019). Dietary boron does not
accumulate in soft animal tissues but will accumulate in larger concentrations in bone tissue
depending on consumption quantity (U.S. Department of Health and Human Services, 2010;
Uluisik et al., 2018; Bialek et al., 2019). Bones have selective uptake of boron and have greater
retention times than that of soft tissue, suggesting bone material would yield greater dietary
concentrations of boron in animal diets (Armstrong et al., 2000; Armstrong and Spears, 2001).
Rendered animal products are recycled animal tissue transformed to stable, value-added
animal feeds, chemical feedstocks, and fertilizers (Meeker and Hamilton, 2006). These products
are derived from the nutrient dense, portions of animal carcasses that are considered inedible for
humans. These tissues are processed for animal consumption by the rendering industry (Meeker
and Hamilton, 2006). Inedible portions vary greatly globally but include carcass and non-carcass
materials such as bone, liver, tongue, heart, kidney, thymus, cheek, blood, lungs, fat, and head
and meat trimmings (Meeker and Hamilton, 2006). In the United States and Canada, 56 billion
pounds of residual products are rendered into animal feeds, reducing food waste, and overfilling
of landfills (Meeker and Hamilton, 2006). The boron content of rendered animal products and
co-products has never been explored. With known deposition of boron in animal bone and soft
tissue, it is pertinent to measure the quantity of boron in a variety of common rendered animal
products and co-products. The objective of this study was to determine the boron content of
rendered animal co-product feedstuffs in addition to common plant feedstuffs.
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MATERIALS AND METHODS

Feed Samples
Rendered animal products and plant feedstuffs were collected across the United States.
Samples were oven dried for 72 hours and ground to 1 mm for analysis of boron content.
Samples (1 g) were dry ashed in a muffle furnace along with a purchased peach sample (NIST
Gaithersburg, MD) used as a control (Jones and Case, 1990; Jones et al., 1991; Plank, 1992;
Bhaskar et al., 2015). Ashed samples were then combined with 10 mL of 1N HCl and were
equilibrated for 15 min in polypropylene containers avoiding borosilicate glassware (Jones and
Case, 1990; Jones et al., 1991; Plank, 1992; Demirdogen, 2020). Samples were transferred to a
100 mL volumetric flask and combined with 90 mL of distilled, deionized water (ddH2O) (Jones
and Case, 1990; Jones et al., 1991; Plank, 1992). Samples were shaken, aliquoted, and analyzed
on an inductively coupled plasma-optical emission spectrometer (Spectro Arcos, ICP-OES;
Spectro Analytical Instruments – a division of Ametek Kleve, Germany) equipped with a UVPlus Purifier gas cleaning system with argon gas flow and a Cetac autosampler (Jones and Case,
1990; Jones et al., 1991; Plank, 1992; Demirdogen, 2020). A purchased boron standard
(Inorgainc Ventures Christiansburg, VA) was used for analysis.

Statistics
Data were analyzed using ANOVA based on a completely randomized design, followed
by Fisher’s protected least significant difference test to separate means when the ANOVA
indicated a treatment effect. All statistical calculations were performed using JMP Pro 16 (Cary,
NC). P-values less than 0.05 were considered evidence of statistical significance. Products
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analyzed include blood meat and bone meal (BMBM), chicken byproduct meal (CBPM), chicken
crax (CC), feather meal (FM), meat and bone meal (MBM), poultry blood meal (PBM), poultry
byproduct meal (PBPM), turkey byproduct meal (TBPM), turkey meal (TM), barley, corn,
soybeans, and wheat.

RESULTS

Results of the study are presented in Table 4.1. Comparing all rendered animal products,
there were significant differences among products (P <0.001). MBM had the greatest boron
content (2.54 ± 0.24 mg/kg) whereas FM had the lowest boron content (0.33 ± 0.13 mg/kg)
(Table 4.1). MBM had the greatest boron content (2.54 ± 0.24 mg/kg) whereas FM had the
lowest boron content (0.33 ± 0.13 mg/kg) (Table 4.1). Of the poultry products tested, TBPM had
the greatest boron content (2.12 ± 0.06 mg/kg) but was not different from MBM (2.54 ± 0.37
mg/kg; P = 0.2615) or TM (2.09 ± 0.09 mg/kg ; P = 0.9606). PBM (0.69 ± 0.37 mg/kg), BMBM
(0.57 ± 0.01 mg/kg), CC (0.54 ± 0.09 mg/kg), and FM (0.33 ± 0.14 mg/kg) had the lowest
concentration of boron measured but were not significantly different from each other (P ˃ 0.07).
The boron content in plant feedstuffs was significantly different among plant products (P
<0.001: Table 4.1). Barley had the lowest boron concentration (0.97 ± 0.21 mg/kg) whereas
soybeans had the greatest boron content (31.66 ± 2.37 mg/kg). Soybeans were significantly
greater in boron content than the other feed grain sources (P <0.001).
When comparing boron content of rendered animal products and plant feedstuffs,
soybeans had the greatest boron content of all products tested (31.66 ± 2.37 mg/kg) and BMBM
had the lowest boron content (0.57 ± 0.01 mg/kg; P < 0.001; Table 4.1).
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Table 4.1. Boron content (mg/kg) of rendered animal products and plant feedstuffs collected
across the United States.
Boron Content (mg/kg)
Product
Mean ± SE

Poultry

Swine/Bovine

Plant

Chicken Byproduct Meal B, C; γ

1.48 ± 0.11

Chicken Crax D, E; β, γ

0.54 ± 0.09

Feather Meal E; β, γ

0.33 ± 0.14

Poultry Blood Meal C, D, E; β, γ

0.69 ± 0.37

Poultry Byproduct Meal C, D; β

1.31 ± 0.16

Turkey Byproduct Meal A, B; β, γ

2.12 ± 0.06

Turkey Meal A, B; β, γ

2.09 ± 0.09

Blood, Meat and Bone Meal C, D, E; β, γ

0.57 ± 0.01

Meat and Bone Meal A; β

2.54 ± 0.24

Barley b; γ

0.97 ± 0.21

Corn b; β, γ

2.83 ± 0.35

Soybean a; α

31.66 ± 2.37

Wheat b; γ

1.63 ± 0.61

*Uppercase letters compare rendered animal products, lowercase letters compare plant
feedstuffs, Greek letters compare all products. Products not connected by the same letter are
significantly different. Significance was declared at P ≤ 0.05.
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DISCUSSION

Boron is listed as a non-essential mineral in animal diets but based on the vast functional
properties boron has in many essential processes, it seems this status should be reassessed.
Plants use boron for metabolism, reproduction, and structural growth and is considered essential
for plants (Devirian and Volpe, 2003; Hunter et al., 2019; Raj and Raj, 2019). However, boron
has not been identified as an essential micronutrient in human and animal diets although there is
considerable information regarding its involvement in immune function, bone health, and
mineral metabolism (Parr and Loughman, 1983; Devirian and Volpe, 2003; Hunter et al., 2019;
Raj and Raj, 2019). Humans and animals consume plants which contain dietary boron in the
form of boronic acids and sugar-borate esters (Tolgyesi, 1989; Kome et al., 2019; U.S.
Department of Health and Human Services, 2010; Nielsen and Eckhertt, 2020). It is known that
boron is present in soft animal tissues depending on the animal’s diet, but boron is primarily
accumulated in the bone (U.S. Department of Health and Human Services, 2010; Uluisik et al.,
2018; Bialek et al., 2019). To our knowledge, boron content has never been analyzed in
rendered animal products. When analyzing rendered animal products, products containing bone
tissue had a greater boron concentration than products without bone tissue (Table 4.1). This is in
accordance with what has been observed in boron metabolism where bone tissue yields greater
concentrations compared with soft tissue (Armstrong et al., 2000; Armstrong and Spears, 2001).
Comparatively, boron content of rendered animal products containing blood had the lowest
concentration reported in this dataset. In humans, boron concentration of the blood varies
between 0.0153 to 0.0795 mg/kg which is comparable to PBM with a concentration of 0.69 ±
0.37 mg/kg in this study (Devirian and Volpe, 2003). Boron values for soft tissues were reported
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by Devirian and Volpe (2003) and are similar to the values reported in this study for rendered
animal products. Devirian and Volpe (2003) reported brain tissue had the lowest concentration
of boron (0.06 mg/kg) and the heart had the greatest concentration of boron (28 mg/kg). Human
liver (2.31 mg/kg) and spleen (2.57) had similar values to what was reported in the present study
for TBPM and TM and are comparable to liver samples (2.41 ± 0.63) of poultry species
supplemented with 50 mg B/kg (Wilson and Ruszler, 1998; Devirian and Volpe, 2003) (Table
4.1). Human rib tissue (10.2 mg/kg) is comparable to poultry species supplemented with 200 mg
B/kg and would likely be comparable to bone meal; however, bone meal was not measured in
this study but instead products that included bone tissue were analyzed (Wilson and Ruszler,
1998; Devirian and Volpe, 2003). As a result of combining bone tissue with soft tissue, total
boron content of the rendered animal product was likely decreased. When supplemented in
excess, boron concentration reaches a plateau of 15 mg/kg in soft tissues but does not reach a
plateau in bone tissue, suggesting that rendered animal products containing bone tissue could
provide a source of boron supplementation for animal diets (Wilson and Ruszler, 1998; Devirian
and Volpe, 2003).
Boron content in plant feedstuffs in this study were compared to the boron content of
rendered animal products. Barley, corn, and wheat contained similar boron concentrations to that
of PBM, MBM and CBPM (Table 4.1). However, the boron content of soybeans was much
greater than any of the rendered animal products. As a result, it would be possible to assume
soybeans would be the best plant feedstuff source of boron of all the products in this study.
However, some organic forms of boron are unavailable for absorption from plant sources
(Tolgyesi, 1989; Hunt, 1998; Devirian and Volpe, 2003; Abdelnour et al., 2018). Animals are
capable of 100% absorption of inorganic boron sources. However, absorption from plant sources
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is limited due to phyto-boron compounds (Hunt, 1998; Hunter et al., 2019). Phyto-boron
compounds are physiologically stable sugar-borate-esters of which two types are found in plants:
water soluble sap fraction (sugar- and sugar-alcohol -borate-esters) and insoluble structural
compounds (pectic polysaccharide rhamnogalacturonan II). These sugar-borate-esters provide
organic but not inorganic boron (Hunter et al., 2019).
Procedures in this study included dry ashing which measures total boron content but does
not differentiate between the organic and inorganic fractions (Jones and Case, 1990; Jones et al.,
1991; Plank, 1992; Hunter et al., 2019). People who consume plant-based diets require as much
as 5.0 mg B/person per day whereas those consuming animal-based diets require only 0.5 to 3.0
mg B/person per day (Penn et al., 1997; Rainey et al., 1999; National Academy of Sciences,
2001; Hunter et al., 2019).
Boron manipulates hormone and enzyme systems in animals, indirectly impacting the
metabolism of vitamin D, Ca, P, and Mg, which are directly related to bone health including
density and structure (Wilson and Ruszler, 1998; Abdelnour et al., 2018; Hegested et al., 1991;
Demirdogen, 2020). Broilers currently have bone health issues such as osteoporosis, fractures,
and soft bones, which may be caused by a deficiency of inorganic boron in their diet (Wilson and
Ruszler, 1997; Wilson and Ruszler, 1998; Fassani et al., 2004). When supplemented with 50 mg
B/kg daily, shear force, stress, fracture energy, bone ash, as well as breast and thigh boron
content increased in tibia and femur bones in pullets and laying hens (Wilson and Ruszler, 1997;
Wilson and Ruszler, 1998; King et al., 1991; Fassani et al., 2004). With a vitamin D deficient
and boron supplemented diet, rats had improved retention and absorption of P and Ca with
promotion of femur Mg content (Abdelnour et al., 2018; Hegested et al., 1991; Nielsen and
Stoecker, 2009). Similar results were reported in vitamin D deficient chicks supplemented with
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boron where hatchability and bone ash increased in boron supplemented birds (King et al., 1991;
Nielsen and Stoecker, 2009; Fassani et al., 2004). A study using rabbits reported similar findings
with increased bone density resulting from boron supplementation. However, this study reported
decreased phosphorus retention in the teeth of these animals, which is not an issue in poultry
species (Hakki et al., 2015).
In current U.S. poultry industry practices, poultry species are fed vegetarian diets to meet
consumer demands for vegetarian-fed meat products (U.S. Poultry and Egg, 2022). These diets
contain soybeans which contain boron but likely bound in sugar-borate-esters. This is likely a
poor source of boron. Poultry diets are not currently supplemented to meet boron needs since
boron is not considered a required micronutrient in animal diets (U.S. Poultry and Egg, 2022).
However, since boron has such an important impact on bone health and structural integrity as
well as mineral metabolism and immune function, it is only logical that health problems would
begin to occur in poultry species being fed only plant-based diets which contain boron bound in
organic complexes (Abdelnour et al., 2018; Wilson and Ruszler, 1998; Wilson and Ruszler,
1997).

CONCLUSION
Replacing the plant-based diet with a diet rich in rendered animal products may be a
solution to bone health issues in broilers and laying hens. Future studies should be conducted to
compare absorption of boron from animal by-product and plant feedstuffs in poultry species.
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CHAPTER FIVE
ONLINE VERSUS IN-PERSON INSTRUCTION IN A LABORATORY-BASED ANIMAL
AND VETERINARY SCIENCE COURSE

ABSTRACT

Online educational modalities are used extensively in courses that do not require handson laboratory experiences. However, due to the COVID-19 pandemic, there has been a need for
transition from in-person to online laboratory-based courses, especially in animal and veterinary
science courses. This study evaluated 163 undergraduate students enrolled in an introductory
animal and veterinary science laboratory in the fall 2020 semester. Using surveys throughout the
semester, student responses were collected and evaluated. Results indicated student performance
on quizzes and exams were better during online instruction compared with in-person instruction,
which contradicted previous studies reported in the literature. As a majority of these students
were first-year, first-semester students, their metacognitive abilities were likely not fully
developed. This laboratory course was taught initially online for the first half of the semester and
then transitioned to in-person instruction as the university public health regulations allowed.
Socially shared metacognitive regulation was only exercised during the in-person portion of the
class. Results indicate an animal and veterinary science laboratory can successfully be taught
online.
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INTRODUCTION

Online teaching and learning have been rapidly integrated into educational environments
across all disciplines over the past two decades (Gallagher, 2019; Gallagher and Palmer, 2020;
Oliver, 1999). While this transition has been occurring in university level courses in years
previous, the integration of traditionally hands-on courses has been a struggle for instructors and
students (Gallagher, 2019; Wang and Wang, 2021; Wingo et al., 2017). The 2019 COVID-19
pandemic hastened the urgency for online integration and decreased total undergraduate student
enrollment across all course types (Gallagher and Palmer, 2020; National Student Clearinghouse
Research, 2021). While consumer demand, awareness, and acceptance of online education have
been steadily increasing, business, health, education, and computer science are the most common
online programs offered, likely because there is seamless transition between in-person and
virtual instruction (Gallagher, 2019; Pellas and Kazanidis, 2015). These programs account for 60
percent of the exclusively online programs offered in the United States (Gallagher, 2019).
However, educational institutions have struggled to meet online needs in science-based courses
(Gallagher 2019; Gallagher and Palmer, 2020). Laboratory-based courses are more difficult to
teach online due to their reliance on hands-on instruction and learning and are among the least
common courses to be offered in an online format (Gallagher, 2019). Due to the need for peer
collaboration in laboratory-based courses, students have a significant loss of social and
intellectual connection in online courses (Meyers, 2008; Pellas and Kazanidis, 2015; Wang and
Wang, 2021). As a result of the COVID-19 pandemic, laboratory-based courses experienced the
most rapid transition from traditional, hands-on instruction to virtual experiences. Synchronous
versus asynchronous instruction impacts the quality and perception of learning in virtual classes
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(Wang and Wang, 2021). Synchronous instruction is better suited for social connection and
learning (Wang and Wang, 2021). However, studies indicate asynchronous instruction creates a
stronger intellectual connection with the material (Wang and Wang, 2021). The impact of a
global pandemic on pedagogy and learning in science is difficult to measure; thus, the current
study was conducted (Gallagher, 2019). With such abrupt transition from in-person to online
instruction, the quality, depth, and integrity of traditional instruction needs to be examined.
Historically, it has been assumed that online classes are comparable with traditionally
taught classes (Meyers, 2008; Pellas and Kazanidis, 2015; Wang and Wang, 2021). However,
this assumption may only apply to the majority of degree programs that do not involve
laboratory-based education (i.e., those that have already transitioned to an online format)
(Gallagher, 2019; McGraw, 2020; Wang and Wang, 2021). The benefits of online educational
programs include providing wider access for a greater variety of students and reducing the cost
of traditional instruction by using computer supported collaborative learning approaches (Iiskala
et al., 2015; McGraw, 2020; Oliver, 1999; Wallis, 2020). Increased meeting time flexibility,
learning and teaching tools, as well as new opportunities with course design are desirable
benefits of providing an online option (Oliver, 1999; Pellas and Kazanidis, 2015; Wallis, 2020;
Wang and Wang, 2021). A knowledge gap exists on the efficacy of online instruction for
laboratory-based science classes (Pellas and Kazanidis, 2015; Wang and Wang, 2021). In this
case, the question arises regarding quality in classes taught completely online versus a blended
format (Baleni, 2015; Pellas and Kazanidis, 2015; Wang and Wang, 2021).
Student perception and metacognition are parameters that can be used to measure quality
of virtual laboratory-based science classes (Avargil et al., 2018; McGraw, 2020; Stanton et al.,
2015; Wingo et al., 2017). Metacognition, as defined by Avargil et al. (2018), is the awareness of
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and reflection upon a person’s cognitive processes (Jacobs and Paris, 1987; Stephanou and
Mpiontini, 2017). Jacobs and Paris (1987) reported metacognitive knowledge and metacognitive
regulation are two methods of evaluating student performance (Avargil et al., 2018; Stanton et
al., 2015; Stephanou and Mpiontini, 2017). Metacognitive knowledge is defined as student
awareness of what they know in relation to what they need to study (Avargil et al., 2018; Jacobs
and Paris, 1987; Stanton et al., 2015; Stephanou and Mpiontini, 2017). This is considered the
process where students think about thinking (Avargil et al., 2018; Stephanou and Mpiontini,
2017). Metacognitive regulation is defined as the actions students take to learn and control their
personal performance (Jacobs and Paris, 1987; Stanton et al., 2015; Stephanou and Mpiontini,
2017). While metacognition is not the only factor involved in student performance, it has a large
impact on scientific literacy and life-long learning in science education (Avargil et al., 2018;
Stephanou and Mpiontini, 2017). Often, students feel that online courses are less important and
consequently, are commonly ignored (McGraw 2020; Wang and Wang, 2021). Students in
online courses spend more time off-task, have less engagement in active learning strategies and
interact less with their instructor and peers (Pellas and Kazanidis, 2015; Wang and Wang, 2021).
Problems with online courses increase with technical issues, feelings of isolation, a lack of
previous online learning experience and a difference in student expectations for the course
compared with previous instructional background (Pellas and Kazanidis, 2015). As a result,
student perception of a completely online course or blended course format can be impacted
negatively (Pellas and Kazanidis, 2015). The other perception commonly noted by students is
that online courses are more difficult than those taught in-person for the same reasons listed
above (McGraw, 2020; Pellas and Kazanidis, 2015).
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Blended learning could offer a potential solution, especially in the sciences, for classes to
transition to a partial online format (Baleni, 2015; Pellas and Kazanidis, 2015). To address
whether an introductory animal and veterinary science laboratory course could be taught
virtually, this study was designed to explore the relationships between student perception of
learning animal handling online or in-person, and quality of the course via student questionnaires
and class performance. The objective of this study was to determine if student perception and
performance in an introductory animal and veterinary science laboratory-based course would
change depending on online versus in-person instruction.

MATERIALS AND METHODS

All experimental procedures and protocols were approved and deemed exempt by the
Clemson University Institutional Review Board, and all participants provided written, informed
consent prior to participation in the study (CU IRB# 2021-0284). This study evaluated 163
undergraduate students enrolled in an introductory animal and veterinary science laboratory
(AVS 1510) in the fall 2020 semester. The majority of the students were in the animal and
veterinary science major with the remainder in genetics, agricultural education, agribusiness, and
biology. The 110-minute laboratory course met once per week throughout the semester; the first
three weeks were dedicated to orientation and material acquisition; so, no assessments were
given during these laboratories. The students had the option to take this laboratory course along
with the lecture course, which met 50 minutes per day, three times a week. However, the two
courses could be taken in separate semesters. Course material focused on animal handling and
husbandry skills using equine, swine, dairy cattle, beef cattle, sheep, goats, and poultry.
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Due to the COVID-19 pandemic, the course was initiated online and was transitioned
mid-semester to in-person instruction to abide by the Clemson University COVID-19
regulations. Due to these regulations, all instructors were required to make class materials
available in an online format for any student who may have been exposed to the virus. Virtual
laboratories were posted on the university learning platform, Canvas™ (Instructure, Salt Lake
City, UT), for students to view at their convenience. The laboratories covered a different species
each week (Figure 5.1). Species covered virtually included equine, dairy cattle, swine, poultry,
and goats. The videos included guest lectures from departmental faculty and farm staff
associated with the species of interest for that laboratory. The in-person laboratories were held at
a different farm each week where students had to travel to each farm. Species covered in-person
included equine, dairy cattle, swine, sheep, and beef cattle. Assessments included a weekly quiz
on the species discussed that week in addition to a midterm and non-cumulative final exam. Due
to semester time restrictions, the goat quiz was added to the midterm exam and students were
given 75 minutes to complete the assessment. All assessments were given online using
LockDown Browser© (Respondus, Redmond, WA). Students had 60 minutes to take exams and
15 minutes to take quizzes. During online exercises, students worked alone on their virtual
course material, quizzes, and midterm exam. During in-person exercises, students were divided
into groups of four to five . In each group, where available, students with prior species
experience were evenly dispersed throughout the groups. Where unavailable, a teaching assistant
filled this role. This was an example of using socially shared metacognitive regulation in the
groups (Iiskala et al., 2015; Wang and Wang, 2021). The goal was to include a student or
teaching assistant in each group who had previous experience with that species and who could
help the others understand the exercise for the day. This action may have provided a
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confounding effect in this study. Through visual observation of student interactions, we
determined that working in groups helped students transition from the online to in-person
modality change mid-semester. Instructors encouraged students to take detailed notes during
both the virtual and in-person versions of the laboratory to practice and reflect on metacognitive
skills. Students took the quizzes and final exam individually.
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Figure 5.1. Class timeline for assessments. The species of interest is depicted above each respective week. Quizzes are represented by
the black vertical arrows and exams are represented by the grey vertical arrows. The black horizontal arrow represents the semester
progression.
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Throughout the semester, students were asked to answer a series of voluntary
questionnaires administered through Qualtrics™ (Qualtrics, Provo, UT). Student perceptions of
the course and assessments were gathered using four questionnaires administered before and
after the midterm and final exams (Figure 5.2). Pre-exam questionnaires were designed to
encourage student awareness of personal understanding of the material and recognizing what
they needed to study. In short, the pre-exam surveys were an assessment of student
metacognitive knowledge. Pre-exam questionnaires were active for two weeks prior to the
midterm or final exam. Post-exam questionnaires were designed to assess student reflection on
their personal performance and to encourage formation of a plan to change or improve their
performance on the next assessment. The post-exam surveys were an assessment of student
metacognitive regulation. Post-exam questionnaires were active for two weeks after the midterm
or final exam. The pre- and post-midterm questionnaires had 16 and 15 questions, respectively,
whereas the pre- and post-final questionnaires had 20 questions each. Questions included a
variety of multiple choice, Likert-scale and open-ended questions. Data were analyzed using
JMP Pro 16 for all datasets (JMP Pro 16, JMP, Cary, NC). Questionnaire responses were recoded
and analyzed using Chi square analysis to assess proportional differences in responses between
modalities. Analysis of student performance was compared using t-tests. Statistical significance
was set at P < 0.05.
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Figure 5.2. Class timeline for student questionnaire release. Each grey vertical arrow indicates an examination. Each black vertical
arrow indicates where a survey was given. Each box indicates the timeframe in which the survey was active for students to take.
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RESULTS

Student Perception of Modality Pre-Assessment (Online vs. In-Person)
Student pre-exam perceptions across modality (online vs. in-person) are presented in
Table 5.1. There were no differences across modality in student perception of pre-exam grade
expectation (P = 0.1318), the amount of time students spent on this class (P = 0.4758), student
motivation for this course (P = 0.9960), student motivation for other courses (P = 0.2492),
student perception of class enjoyment (P = 0.4278), and student preference of virtual modality (P
= 0.1396), such as online, mixed, or in-person instruction (Table 5.1).

Table 5.1 Student Perceptions of Online vs. In-Person Class Modality Pre-Exam
Question

Response

Online

In-Person

(Percent)

(Percent)

A

79.1

73.5

B

18.7

24.9

C

0.7

1.7

D or lower

1.4

0

A lot

6.5

4.4

Moderate

43.2

49.2

A little

50.4

46.4

Yes

84.9

84.5

Maybe

8.6

8.8

p-value

0.1318

Grade Expectation

Time Spent on AVS

Motivation for AVS
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0.4758

0.9960

No

6.5

6.6

Yes

67.6

58.9

Maybe

22.3

26.7

No

10.1

14.4

Yes

92.8

93.9

Maybe

6.5

6.1

No

0.7

0

Asynchronous

40.3

11.6

Mix

39.6

63.5

Synchronous

20.1

24.9

Online

12.2

6.1

Mix

36.7

42.0

In-Person

51.1

51.9

Yes

78.4

36.5

Maybe

10.8

41.4

No

10.8

22.1

Yes

73.4

82.3

Maybe

18.7

5.0

No

7.9

12.7

0.2492

Motivation for Other
Courses

Enjoyment AVS

0.4278

<0.0001

Meeting Style
Preference

Virtual Preference

Note Taking

0.1396

<0.0001

0.0003

Quiz Question
Fairness
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Student perception of meeting style preference was significantly different across modality
(P < 0.01). During the online portion of the course, students preferred asynchronous presentation
(40.3%) and a mix between asynchronous and synchronous (39.6%) as compared to synchronous
class meetings (20.1%) (Table 5.1). During the in-person portion of the class, some students
were unable to attend because of COVID-19 illness. However, during the in-person portion of
the class, students reported a preference for a mixture of asynchronous and synchronous class
meetings (63.5%) as opposed to only asynchronous (11.6%) or only synchronous class meetings
(24.9%) (Table 5.1). Some lectures were viewed later by individuals who missed class or were
feeling unwell.
From the questionnaire, students reported their note taking behavior was significantly
different across modality (P < 0.01). Students reported taking more notes (78.4%) during the
online portion of the class than the in-person portion (36.5%) of the class (Table 5.1).
Perception of quiz question fairness was rated significantly different across modality (P =
0.0003). During the online portion of the class, most of the students reported that quiz questions
were fair (73.4%) (Table 5.1). However, during the in-person portion of the class, only 36.5% of
students reported that quiz questions were fair and 41.4% of students were unsure if quiz
questions were fair (Table 5.1).

Student Perception of Modality Post-Assessment (Online vs. In-Person)
Student perceptions post-exam across modality are presented in Table 5.2. Students
reported no significant difference in their understanding of class material (P = 0.5459),
perception of exam difficulty (P = 0.2492) and whether they studied sufficiently for the exam (P
= 0.6383) across modality (Table 5.2).
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Table 5.2. Student Perception of Online vs. In-Person Class Modality Post-Exam
Question

Online

In-Person

(Percent)

(Percent)

Better

36.3

30.3

Same

39.2

31.6

Worse

24.6

38.2

Yes

73.7

57.9

Maybe

19.3

23.0

No

7.0

19.1

Study Amount

More

77.2

59.2

Compared with

Same

22.8

28.3

Midterm

Less

0

12.5

Yes

36.3

17.1

Maybe

30.4

32.9

No

33.3

50.0

Good

81.3

84.2

18.1

14.5

Poor

0.6

1.3

Easy

39.8

30.9

Neither

28.1

32.9

Difficult

32.2

36.2

Yes

58.5

40.8

Exam Performance

Response

p-value

0.0304

0.0015

Exam Question
Fairness

Class Difficulty

Understanding Level Average

Exam Difficulty

Overwhelmed

<0.0001

0.0002

0.5459

0.2492

0.0002
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Maybe

17.0

13.2

No

24.6

46.1

Yes

71.9

75.0

Maybe

20.5

16.4

No

7.6

8.6

0.6383

Spent Enough Time
Studying

After taking each of the two exams, students reported performing significantly different
than they had expected on the exam across modality (P = 0.0304). Students thought they
performed better (36.3%) or the same as they expected (39.2%) during the online portion of the
course (Table 5.2). During the in-person portion of the course, students reported they performed
better than expected (30.3%) or the same as expected (31.6%). In comparing online vs. in-person
exam expectations, there was a shift across modality from 24.6% to 38.2%, respectively, of
students who believed they performed worse than expected (Table 5.2).
Student perception of exam question fairness was significantly different across modality
(P = 0.0015). During the online portion of the class, students reported exam questions were fair
(73.7%) (Table 5.2). Students (19.3%) were unsure if exam questions were fair or reported exam
questions were unfair (7.0%) during the online portion of the class. During the in-person portion
of the class, students reported exam questions were fair (57.9%), being unsure of exam question
fairness (23.0%) or exam questions were unfair (19.1%) (Table 5.2).
The amount students planned to study for exams was significantly different across
modalities (P < 0.001). Students reported having studied more (77.2%) for the exam in the online
portion of the class versus the in-person portion of the class (Table 5.2). The students further
reported they felt they should have studied more for the exam during the in-person portion of the
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class (59.2%) (Table 5.2). Among the student responses, only 22.8% indicated they studied
enough during the online portion of the class and only 28.3% reported they studied enough
during the in-person portion of the class (Table 5.2). No students reported wishing they had
studied less for the exam during the online portion of the class, but 12.5% of students reported
they had studied less for the exam during in-person portion of the class (Table 5.2).
Student perception of class difficulty was significantly different across modalities (P =
0.0002). During the online portion of the course, there was a fairly even spread across student
perception of class difficulty (36.3% responded yes, 30.4% responded maybe, 33.3% responded
no) (Table 5.2). During the in-person portion of the course, students thought the class difficulty
decreased (17.1% responded yes, 32.9% responded maybe, 50.0% responded no) (Table 5.2).
When asked if the students felt overwhelmed with course material, there were significant
differences across modalities (P = 0.0002). Students reported feeling overwhelmed (58.5%)
during the online portion of the course (Table 5.2). During the in-person portion of the course,
students reported a decrease in feeling overwhelmed (40.8%) (Table 5.2). Students who felt they
could manage their coursework effectively during the online portion of the class (24.6%)
increased during the in-person portion of the class (46.1%) (Table 5.2).

Student Performance
Student grades are reported in Table 5.3. For the dairy cattle quiz, average scores were
greater in the online section compared with the in-person section, respectively (90.24 ± 0.81 vs.
78.36 ± 0.81). The horse quiz average scores were greater in the online compared with the inperson section, respectively (88.18 ± 1.41 vs. 79.16 ± 1.41). Quiz scores for the swine section
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were lower in the online portion of the course compared with the in-person portion, respectively
(79.60 ± 1.07 vs. 83.37 ± 1.07).

Table 5.3. Student Performance in Online vs. In-Person Class Modality Across all Quizzes
Assessment

Online Mean In-Person Mean

Standard Error

Mean Difference

p-value

Dairy Quiz (%)

90.25*

78.36

0.81

11.88

<0.0001

Horse Quiz (%)

88.18*

79.16

1.41

9.02

<0.0001

Swine Quiz (%)

79.60*

83.37

1.08

3.77

0.0145

Exams (%)

92.72*

87.73

0.66

4.99

<0.0001

Canvas™ Time (mins)

466.53*

367.00

27.14

99.53

0.0104

*Data not shown; no significant differences were noted (P > 0.05) between Canvas™ Time
(mins) and student assessment scores.

Student exam averages were greater in the online portion of the course compared with the
in-person portion, respectively (92.72 ± 0.65 vs. 87.73 ± 0.65). When analyzing student time
spent on Canvas™, students spent a greater amount of time (minutes) on Canvas™ in the online
portion of the class compared with the in-person portion, respectively (466.53 ± 27.13 vs. 367.00
± 27.13; P = 0.0104). For the in-person portion of the class, students had access to video
recordings of all laboratories. When analyzing the impact Canvas™ time had during the online
modality, on each of the three quizzes (horse, dairy, and swine) and the midterm exam, there
were no significant differences (P = 0.4140, P = 0.5277, P = 0.4027, P = 0.2931, respectively).
When analyzing the impact Canvas™ time had during the in-person modality, on each of the
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three quizzes (horse, dairy, and swine) and the final exam, there were no significant differences
(P = 0.6847, P = 0.5277, P = 0.2998, P = 0.1556, respectively).

DISCUSSION

The differences between online and in-person instruction were evaluated for an
introductory animal and veterinary sciences laboratory-based course. Student perceptions of the
course and of their personal standing in the course were assessed prior to and after each
examination. The pre-exam questionnaires were designed to measure student awareness of their
understanding of the class material, or student metacognitive knowledge. The post-exam
questionnaires were designed to evaluate student perception of class performance, self-reflection,
and motivation to organize and improve their personal performance, or student metacognitive
recognition. Throughout the semester, student motivation for the course remained high as did
enjoyment for the course material (Table 5.1). Student motivation is directly linked to the degree
of student success in a course (Pellas and Kazanidis, 2015). Specifically, in a blended course,
student motivation impacts the connections between students and their peers, as well as
interactions with the class material (Pellas and Kazanidis, 2015). When motivation is high,
interactions are also high, indicating students are engaging in the course and the provided
material is suitable for the effective instruction of the course (Pellas and Kazanidis, 2015).
As a one credit course, in this study it was expected students would report spending a
little (0 to 4 hours) to a moderate (4 to 8 hours) amount of time on this course (Table 5.1).
Anything beyond studying 8 hours per week for this laboratory (outside of the class period)
would possibly indicate that student understanding of the material and student metacognitive
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regulation skills were poor (Carr, 2010; Stanton et al., 2015; Stephanou and Mpiontini, 2017).
Student self-assessment of their understanding of the material was positive throughout the
semester. Other studies have indicated when students report positively on their self-evaluation,
there is an improvement in self-regulation of learning (Ackerman and Goldsmith, 2011; Avargil
et al., 2018). In the present study, this positive response of capability from the students indicated
a majority of the students were able to effectively use their metacognitive regulation skills when
approaching the material and, as a result, this may have influenced their overall class
performance (Ackerman and Goldsmith, 2011; Avargil et al., 2018; Stanton et al., 2015).
Perception of individual performance has a direct impact on student confidence, comprehension,
and metacognitive regulation in science learning (Ackerman and Goldsmith, 2011; Avargil et al.,
2018; Carr, 2010).
The amount of time students spent on this course and their self-reported understanding of
the material are consistent (Table 5.1 and Table 5.2). This relationship is also consistent with
student grade expectation where students believed they would earn an A grade in this course,
prior to taking their examinations (Table 5.1). As per self-reported attributes including personal
study habits, comfort with the subject material, feeling motivated for this course, spending an
adequate amount of time on the material, enjoying the class subject, and understanding the
material, all provide insight that students felt confident in this class and expected to receive an A
grade in the course (Ackerman and Goldsmith, 2011; Pellas and Kazinidis, 2015).
When asked about exam difficulty after taking the exam, there was a fairly even
distribution of responses across yes/maybe/no for both instructional modalities. Results indicated
some students may be less developed in their metacognitive skills than others (Carr, 2010;
Stanton et al., 2015). Students were asked after taking the exam if they thought they had spent
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enough time studying, to which a majority of the students replied “yes” (Table 5.2). From this
response, it is clear students were able to employ their metacognitive skills because students
were encouraged through the surveys to reflect on their performance based on previous study
efforts (Stanton et al., 2015). A student’s metacognitive knowledge indicates they can
differentiate between what they know and what they need to study (Carr, 2010; Stanton et al.,
2015). Metacognitive regulation involves a student’s ability to understand and control their
thinking in a way that they can understand the task at hand, identify their personal strengths and
weaknesses regarding that task, create a plan to achieve the task, monitor the plan for success
and adjust the plan, as necessary (Carr, 2010; Stanton et al., 2015). After taking the exam, a
disconnect between the student’s metacognitive knowledge and metacognitive regulation was
noted. Results of the study indicated the amount of time students spent studying in relation to the
material studied influenced class performance (Carr, 2010; Stanton et al., 2015). Most of the
students were first-year (freshman) students who may or may not have developed metacognitive
abilities (Avargil et al., 2018; Carr, 2010; Stanton et al., 2015). Metacognition is a skill that can
be developed in science education over time; it is imperfect and age-dependent (Avargil et al.,
2015; Brown, 1978; Stephanou and Mpiontini, 2017). From the responses on questionnaires and
student performance on the exams (Table 5.3), students were aware of what they needed to study
and the majority of the class acted on those needs (Avargil et al., 2018; Stanton et al., 2015).
There were seven out of 163 students who earned a D or F grade in the class. In this case, it
would appear there was a disconnect in metacognitive regulation, which is commonly witnessed
in students who do not change their actions after receiving a poor grade (Carr, 2010; Jacobs and
Paris, 1987; Stanton et al., 2015; Stephanou and Mpiontini, 2017). It can be noted that from the
survey responses, despite students being encouraged to reflect on their understanding of the
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material, some students were unable to bridge the gap between metacognitive knowledge and
metacognitive regulation. It appears these seven students did not form or commit to a plan to
change their class behavior when the post-exam survey encouraged adequate reflection on their
performance in the class. The high percentage of A and B grades (67.48% and 25.15%,
respectively) is contradictory to the responses students provided when asked if they thought
exams were difficult (Table 5.2). For this question, students responded fairly equally across
yes/maybe/no regarding test difficulty, which indicates student reporting of exam difficulty was
inaccurate (Table 5.2). Students reported on questionnaire 2 that they planned to study less for
the final than for the midterm. Later responses on questionnaire 4 indicated students did indeed
study less for the final than the midterm. Grades on the final reflected this. Therefore, it is
assumed that the student reports of exam difficulty were emotional responses and a result of poor
metacognitive regulation (Stanton et al., 2015).
When comparing student performance on exams, there was a shift across modality where
students performed better during the online portion of the course compared with the in-person
portion of the course (Table 5.3). Student interactions during the in-person portion of the class
should have increased student engagement due to peer interactions and collaborative learning
(Pellas and Kazinidis, 2015). However, Pellas and Kazinidis (2015) reported similar results to
the present study. Students in a blended learning course were compared to a completely online
course format by Pellas and Kazinidis (2015) and their results indicated students in the online
section had greater engagement with the material and performed better in the course. In the
present study, after taking the final exam, students reported they had spent enough time studying
and they understood the material, so it would be expected that students would report the exam as
easy to moderate in difficulty. It is possible the metacognitive skills of students were lower
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during the in-person portion of the class because there were more stressors involved such as
transportation to the laboratory, handling of live animals, and interacting with classmates (Iiskala
et al., 2015; Stanton et al., 2015). Many students were not engaged with the instructor due to
their distraction with handling the animals (Pellas and Kazinidis, 2015; Wang and Wang, 2021).
Engagement with the instructor, peers, and material are all necessary for student success in a
course, especially with a blended format (Pellas and Kazanidis, 2015; Wang and Wang, 2021).
However, because the modality of the laboratory course in the present study changed midsemester due to the pandemic, we expected an increase in socially shared metacognitive
regulation and, thus, an increase in student performance (Iiskala et al., 2015).
There was a clear decrease in Canvas™ usage during the in-person portion of the class
(Table 5.3). However, analysis of data indicated there was no significant difference in time spent
on Canvas™ in relation to quiz or exam scores (Table 5.3). If students felt they had studied
sufficiently during both modalities, this perception should be reflected in performance on
assessments. The decrease in Canvas™ usage may be a function of students reporting they took
fewer notes during the in-person portion of the class, despite being encouraged each week to take
detailed notes on class material, which is another indicator that metacognitive skills in this group
of students may have been underdeveloped (Avargil et al., 2018; Stanton et al., 2015).
Students reported a shift in assessment fairness. During the online portion of the class,
both quizzes and exams were thought to be fair. During the in-person portion of the class, half of
the students had changed their opinion and expressed the quizzes were unfair. Similarly, students
also thought exam questions during the in-person portion of the class were either unfair or less
fair than the online portion of the class (Table 5.1 and 5.2). This perception could be a function
of students taking fewer notes in addition to reporting they had planned to study less for the in191

person final exam compared with the online midterm exam. Planning to study less for a future
exam indicates students were aware of their knowledge base and study needs, but when
comparing student perceptions to the class performance on exams, a lack of adequate
metacognitive abilities in this group of students was observed (Stanton et al., 2015; Stephanou
and Mpiontini, 2017).
Students reported an overall decrease in feeling overwhelmed from the online to the inperson portion of the course (Table 5.2). Students reported thinking the difficulty of the course
decreased in-person, so it is unclear why student performance decreased in the in-person portion
of the course (Table 5.3). Overall, it appears that student performance decreased due to a
reduction in note taking, an intentional decrease in time spent studying, and students becoming
too comfortable with the course when it transitioned to the in-person modality. This concept is
demonstrated when comparing student perceptions of expected grade prior to taking the exam
and reflective exam performance post-exam (Stanton et al., 2015). In surveys 1 and 3 conducted
prior to each exam, most students reported across both modalities that they expected to receive
an A grade for the course (Table 5.1). In survey 2, conducted after the midterm exam but prior to
grades being returned, students reported having performed better than expected on the midterm
(Table 5.2). In survey 4, students reported performing the same or worse than they expected on
the final (Table 5.2). After completion of the exams, actual student performance was better
during the online (midterm exam) than the in-person (final exam) portion of the course (Table
5.3). Having performed the same or better than expected during the first half of the semester
(online) likely led to a decrease in study habits and note taking behavior and an increase in
student confidence regarding their assessments. It is speculated this led to the decrease in
assessment scores during the second half of the semester (in-person). The responses indicate that
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students were stressed prior to taking their examinations. The students were reflective of their
class standing after the assessment and after having made the choice to decrease studying and
note taking. Students perceived that the difficulty of the class decreased as well. The shift in
modality could also have impacted student behaviors, perceptions, and metacognitive regulation
(Stanton et al., 2015; Stephanou and Mpiontini, 2017). When taking an online course, mental
stimulation is different compared with an in-person course or with blended learning (Pellas and
Kazanidis, 2015; Wang and Wang, 2021).
There was a clear shift across modality for preference of meeting style (Table 5.1).
Students preferred to meet asynchronously for online instruction. Students preferred a mixture of
asynchronous and synchronous meeting styles during in-person instruction. Across both
modalities, students had a strong preference for in-person meeting style (Table 5.1). This
preference shift is likely due to the nature of online courses where students tend to perform
individually compared with a more collaborative learning style when instructed in-person
(Iiskala et al., 2015; Pellas and Kazinidis, 2015; Wang and Wang, 2021). Additionally, the desire
of the students to interact with the animals likely strongly influenced the preference for in-person
meeting style. In collaborative settings, the quality of learning improves as a result of improved
student engagement and stimulation of individual cognition (Iiskala et al., 2015; Pellas and
Kazinidis, 2015). Asynchronous learning can prove beneficial in discussion-based courses as it
provides a greater amount of time for thought and reflection on subject material (Wang and
Wang, 2021).
Asynchronous learning can be detrimental as student engagement and interaction are less
compared with synchronous learning styles (Wang and Wang, 2021). As was recorded in student
performance in the present study, there was a difference in quiz performance for all species
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(Table 5.3). Additionally, exam performance between the two modalities were significant (Table
5.3). As a general trend, students performed better during the online portion of the course
compared with the in-person portion of the course, which is in direct contradiction with the
concept that students perform better when instructed in-person (Iiskala et al., 2015; Pellas and
Kazinidis, 2015).

CONCLUSION

When evaluating student motivation, there were no differences across modalities of
instruction for in-person versus online. Motivation is directly linked to self-regulated learning,
which did not change during the semester (Pellas and Kazinidis, 2015). This is in contradiction
with the student performance on quizzes and exams as students performed better during the
online portion of the course (Iiskala et al., 2015; Pellas and Kazinidis, 2015). Despite having
spent more time on Canvas™ during the online portion of the class, there was no impact of time
spent on Canvas™ compared with any assessment. Therefore, the amount of time spent online
was not a factor in student performance in this class across modality (Iiskala et al., 2015; Pellas
and Kazinidis, 2015). Interaction time with the virtual platform should have been an indicator for
class performance as an example of student management of the material and subsequent
performance on assessments (Pellas and Kazinidis, 2015). If the class scenario were reversed,
and students had started the course in-person and completed the semester online, there is a
question if changes in socially shared metacognitive regulation and metacognition would have
occurred. Other factors not considered in this study, which could have influenced results, include
actual differences in difficulty of quizzes and exams, external factors, etc. If this study were to be
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repeated, a reduction in the number of variables such as species under study, student maturation,
and team vs. no-team would be beneficial to prevent spurious variables. Such future studies
should be designed to evaluate additional factors which may influence student responses.
However, in conclusion, this study supports online educational modalities as an effective method
for teaching an introductory animal and veterinary science laboratory-based course.
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CHAPTER SIX
CONCLUSION

Functional components of food and feed products are compounds that provide a health
benefit to the consumer. Authentic kefir is a fermented dairy product using kefir grains that
improves gastrointestinal health, reduces blood pressure, acts as an antimicrobial,
anticarcinogenic, antiviral, antifungal, and antiparasitic agent as well as alleviates symptoms of
heart disease (Garrote et al., 2000; Guzel-Seydim et al., 2000; Liu et al., 2002; Marquina et al.,
2002; Santos et al., 2003; Sarkar, 2007; Guzel-Seydim et al., 2011; Ahmed et al., 2013). Kefir is
known to produce kefiran, which is a functional component that acts as a prebiotic, has an
immunomodulatory effect, and is antimutagenic, antiulceric, antitumor, and antiallergic
(Abraham and de Antoni, 1999; Line et al., 1999; Marquina et al., 2002; Ozer and Kirmaci,
2014). Kefir is also thought to produce vitamin K2, which is involved in activation of matrix γcarboxyglutamic acid protein (MGP), removal of calcium from blood vessels, and management
of trabecular bone matrix (Hodges et al., 1993; Wen et al., 2018; Walenga, 2020). Vitamin K2 is
responsible for post-translational carboxylation of glutamate residues to form γcarboxyglutamate proteins (Gla) (Wen et al., 2018; Walenga, 2020). Gla residues are able to
bind calcium ions and are vitamin K-dependent (Wen et al., 2018; Walenga, 2020). Many Gla
residues are present in the coagulation cascade, such as prothrombin, and others are found in
bone such as osteocalcin, or bone Gla protein, and growth arrest-specific protein 6 (Gas6)
(Ferland, 2012; Wen et al., 2018). Gla residues bind free calcium and phosphate ions in the
blood and calcium deposited in vascular and cartilaginous tissue. These bound calcium and
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phosphate groups are then redirected to the hydroxyapatite matrix in bone where they are
deposited (Schurgers et al., 2010; Houben et al., 2017; Weber and Czaerniecki, 2018).
Japanese natto made from fermented soybeans is another functional food. Bacillus
subtilis natto is used to ferment legumes and functional components include glutamic acids,
enzymes, such as nattokinase and subtilisin, and vitamins, specifically vitamin K2 (Kiuchi et al.,
1976; Ichishima et al., 1982; Sumi et al., 1995; Matsubara et al., 1998; Sumi et al., 2004; Oshugi
et al., 2005). Glutamic acids are produced in the mucoid strings of natto and are precursor
molecules for vitamin k-dependent carboxylation by the vitamin K2, specifically menaquinone-7
(MK-7), produced post-fermentation, which also stimulate osteocalcin (Schurgers et al., 2007;
Berenjian et al., 2012). Nattokinase and subtilisin are proteolytic enzymes which break peptide
bonds within the legume substrate as well as having a proteolytic effect in the body as functional
components (Fujita et al., 1993; Matsubara et al., 1998; Shurtleff and Aoyagi, 2012).
Nattokinase, however, is also a fibrinolytic enzyme which degrades fibrin in blood clots (Kwon
et al., 2011; Chen et al., 2018). It is one of the only naturally occurring enzymes on the market
that is able to degrade a blood clot after it has formed in the vessel (Fujita et al., 1993; Sumi et
al., 2004; Chen et al., 2018).
Elemental boron is not yet considered an essential micronutrient in human and animal
diets but is known to have functional properties (Pizzorno, 2015; Messner et al., 2022). Boron
compounds are involved in the metabolism of calcium, phosphorus, and vitamin D3, can improve
growth rate and efficiency of livestock species, improves immune function, are anticancer
compounds, and reduce the incidence and severity of osteoporosis and cardiovascular disease
(Elliot and Edwards, 1991; Devirian and Volpe, 2003; Bialek et al., 2019). Vitamin K
compounds and boron containing compounds are known to have an impact on the coagulation
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cascade, which in turn impacts cardiovascular and bone health through Gla residues.
Osteocalcin and steroid ring compounds such as testosterone, estrogen, and vitamin D3 are
stimulated by boron compounds, all of which are involved in bone health and metabolism
(Naghii and Samman, 1997; Devirian and Volpe, 2003). Boron compounds are also able to
inhibit serine proteases, of which many are involved in the coagulation cascade such as thrombin
(Wen, 2018; Walenga, 2020). Inhibition of serine proteases can decrease incidence of abnormal
blood clotting by disrupting the coagulation cascade (Weber and Czarniecki, 2018).
Cardiovascular disease is caused by poor diet, oxidative stress, chronic inflammation,
obesity, hypertension, hyperlipidemia, and tobacco use, all of which can lead to an impaired
calcium and phosphorus metabolism (Schurgers et al., 2010; Houben et al., 2017). Osteoporosis
can be caused by mineral deficiency and decreased stimulation of osteoblast activity (Boyacioglu
et al., 2018). With these functional components, vitamin K2 from kefir and natto, nattokinase
from natto, and boron containing compounds, there are natural solutions to improving and
reversing the impacts of cardiovascular disease and osteoporosis in humans and animals.
Stimulation of MGP, Gla residues, osteocalcin, and steroid hormones reduce incidence of vessel
calcification and drive bound calcium and phosphate ions back into the hydroxyapatite matrix,
improving both cardiovascular disease symptoms and decreasing symptoms of osteoporosis.
Through a combination of these functional foods and feed components, improvement of human
and animal health through natural methods is possible.
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